#Chr	Start	End	Ref	Alt	Ref.Gene	Func.refGene	ExonicFunc.refGene	Gene.ensGene	avsnp147	AAChange.ensGene	AAChange.refGene	clinvar: Clinvar 	 CancerVar: CancerVar and Evidence 	Freq_ExAC_ALL	Freq_esp6500siv2_all	Freq_1000g2015aug_all	CADD_raw	CADD_phred	SIFT_score	GERP++_RS	phyloP46way_placental	dbscSNV_ADA_SCORE	dbscSNV_RF_SCORE	Interpro_domain	AAChange.knownGene	MetaSVM_score	Freq_ExAC_POPs	OMIM	Phenotype_MIM	OrphaNumber	Orpha	Otherinfo
10	104850745	104850745	T	G	NT5C2	exonic	nonsynonymous SNV	ENSG00000076685	.	ENSG00000076685:ENST00000421281:exon5:c.A320C:p.D107A,ENSG00000076685:ENST00000404739:exon15:c.A1220C:p.D407A,ENSG00000076685:ENST00000423468:exon15:c.A1133C:p.D378A,ENSG00000076685:ENST00000343289:exon16:c.A1220C:p.D407A	NT5C2:NM_001134373:exon16:c.A1220C:p.D407A,NT5C2:NM_012229:exon17:c.A1220C:p.D407A	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 1, 0, None] 	.	.	.	6.730	32	0.056	6.06	10	.	.	HAD-like domain	NT5C2:uc010qqp.2:exon15:c.A1133C:p.D378A,NT5C2:uc001kwq.3:exon16:c.A1220C:p.D407A,NT5C2:uc001kwo.3:exon17:c.A1220C:p.D407A,NT5C2:uc001kwp.3:exon17:c.A761C:p.D254A	-0.908	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	600417	613162;	320396;	320396|Autosomal recessive spastic paraplegia type 65<br>SPG45<br>SPG65|<1 / 1 000 000|-|Neonatal<br>Infancy|613162 ~	TCALL
10	104852955	104852955	C	T	NT5C2	exonic	nonsynonymous SNV	ENSG00000076685	.	ENSG00000076685:ENST00000421281:exon3:c.G200A:p.R67Q,ENSG00000076685:ENST00000404739:exon13:c.G1100A:p.R367Q,ENSG00000076685:ENST00000423468:exon13:c.G1013A:p.R338Q,ENSG00000076685:ENST00000343289:exon14:c.G1100A:p.R367Q	NT5C2:NM_001134373:exon14:c.G1100A:p.R367Q,NT5C2:NM_012229:exon15:c.G1100A:p.R367Q	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 0, None] 	.	.	.	6.832	33	0.002	5.76	10	.	.	HAD-like domain	NT5C2:uc010qqp.2:exon13:c.G1013A:p.R338Q,NT5C2:uc001kwq.3:exon14:c.G1100A:p.R367Q,NT5C2:uc001kwo.3:exon15:c.G1100A:p.R367Q,NT5C2:uc001kwp.3:exon15:c.G641A:p.R214Q	-0.331	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	600417	613162;	320396;	320396|Autosomal recessive spastic paraplegia type 65<br>SPG45<br>SPG65|<1 / 1 000 000|-|Neonatal<br>Infancy|613162 ~	TCALL
10	104852980	104852980	T	G	NT5C2	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000076685	.	ENSG00000076685:ENST00000421281:exon3:c.A175C:p.K59Q,ENSG00000076685:ENST00000404739:exon13:c.A1075C:p.K359Q,ENSG00000076685:ENST00000423468:exon13:c.A988C:p.K330Q,ENSG00000076685:ENST00000343289:exon14:c.A1075C:p.K359Q;ENSG00000076685:ENST00000421281:exon3:c.A175C:p.K59Q,ENSG00000076685:ENST00000404739:exon13:c.A1075C:p.K359Q,ENSG00000076685:ENST00000423468:exon13:c.A988C:p.K330Q,ENSG00000076685:ENST00000343289:exon14:c.A1075C:p.K359Q	NT5C2:NM_001134373:exon14:c.A1075C:p.K359Q,NT5C2:NM_012229:exon15:c.A1075C:p.K359Q;NT5C2:NM_001134373:exon14:c.A1075C:p.K359Q,NT5C2:NM_012229:exon15:c.A1075C:p.K359Q	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	6.232	28.8	0.005	5.76	10	.	.	HAD-like domain	NT5C2:uc010qqp.2:exon13:c.A988C:p.K330Q,NT5C2:uc001kwq.3:exon14:c.A1075C:p.K359Q,NT5C2:uc001kwo.3:exon15:c.A1075C:p.K359Q,NT5C2:uc001kwp.3:exon15:c.A616C:p.K206Q;NT5C2:uc010qqp.2:exon13:c.A988C:p.K330Q,NT5C2:uc001kwq.3:exon14:c.A1075C:p.K359Q,NT5C2:uc001kwo.3:exon15:c.A1075C:p.K359Q,NT5C2:uc001kwp.3:exon15:c.A616C:p.K206Q	-0.738	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	600417	613162;	320396;	320396|Autosomal recessive spastic paraplegia type 65<br>SPG45<br>SPG65|<1 / 1 000 000|-|Neonatal<br>Infancy|613162 ~	ALL
10	104852980	104852980	T	G	NT5C2	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000076685	.	ENSG00000076685:ENST00000421281:exon3:c.A175C:p.K59Q,ENSG00000076685:ENST00000404739:exon13:c.A1075C:p.K359Q,ENSG00000076685:ENST00000423468:exon13:c.A988C:p.K330Q,ENSG00000076685:ENST00000343289:exon14:c.A1075C:p.K359Q;ENSG00000076685:ENST00000421281:exon3:c.A175C:p.K59Q,ENSG00000076685:ENST00000404739:exon13:c.A1075C:p.K359Q,ENSG00000076685:ENST00000423468:exon13:c.A988C:p.K330Q,ENSG00000076685:ENST00000343289:exon14:c.A1075C:p.K359Q	NT5C2:NM_001134373:exon14:c.A1075C:p.K359Q,NT5C2:NM_012229:exon15:c.A1075C:p.K359Q;NT5C2:NM_001134373:exon14:c.A1075C:p.K359Q,NT5C2:NM_012229:exon15:c.A1075C:p.K359Q	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	6.232	28.8	0.005	5.76	10	.	.	HAD-like domain	NT5C2:uc010qqp.2:exon13:c.A988C:p.K330Q,NT5C2:uc001kwq.3:exon14:c.A1075C:p.K359Q,NT5C2:uc001kwo.3:exon15:c.A1075C:p.K359Q,NT5C2:uc001kwp.3:exon15:c.A616C:p.K206Q;NT5C2:uc010qqp.2:exon13:c.A988C:p.K330Q,NT5C2:uc001kwq.3:exon14:c.A1075C:p.K359Q,NT5C2:uc001kwo.3:exon15:c.A1075C:p.K359Q,NT5C2:uc001kwp.3:exon15:c.A616C:p.K206Q	-0.738	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	600417	613162;	320396;	320396|Autosomal recessive spastic paraplegia type 65<br>SPG45<br>SPG65|<1 / 1 000 000|-|Neonatal<br>Infancy|613162 ~	TCALL
10	123258034	123258034	A	T	FGFR2	exonic	nonsynonymous SNV	ENSG00000066468	rs121913476	ENSG00000066468:ENST00000429361:exon4:c.T423A:p.N141K,ENSG00000066468:ENST00000369061:exon9:c.T1311A:p.N437K,ENSG00000066468:ENST00000356226:exon10:c.T1296A:p.N432K,ENSG00000066468:ENST00000369059:exon10:c.T1305A:p.N435K,ENSG00000066468:ENST00000369060:exon10:c.T1299A:p.N433K,ENSG00000066468:ENST00000336553:exon11:c.T1374A:p.N458K,ENSG00000066468:ENST00000346997:exon11:c.T1641A:p.N547K,ENSG00000066468:ENST00000357555:exon11:c.T1380A:p.N460K,ENSG00000066468:ENST00000360144:exon11:c.T1383A:p.N461K,ENSG00000066468:ENST00000369056:exon11:c.T1650A:p.N550K,ENSG00000066468:ENST00000478859:exon11:c.T963A:p.N321K,ENSG00000066468:ENST00000351936:exon12:c.T1641A:p.N547K,ENSG00000066468:ENST00000358487:exon12:c.T1647A:p.N549K,ENSG00000066468:ENST00000369058:exon12:c.T1650A:p.N550K,ENSG00000066468:ENST00000457416:exon12:c.T1650A:p.N550K	FGFR2:NM_001144914:exon9:c.T1311A:p.N437K,FGFR2:NM_001144916:exon9:c.T1302A:p.N434K,FGFR2:NM_001144917:exon10:c.T1299A:p.N433K,FGFR2:NM_001144918:exon10:c.T1296A:p.N432K,FGFR2:NM_023029:exon10:c.T1380A:p.N460K,FGFR2:NM_001144913:exon11:c.T1650A:p.N550K,FGFR2:NM_001144915:exon11:c.T1380A:p.N460K,FGFR2:NM_001144919:exon11:c.T1383A:p.N461K,FGFR2:NM_000141:exon12:c.T1647A:p.N549K,FGFR2:NM_022970:exon12:c.T1650A:p.N550K	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	5.591	26.5	0.0	2.67	10	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	FGFR2:uc001lfg.4:exon5:c.T471A:p.N157K,FGFR2:uc021pzv.1:exon9:c.T1311A:p.N437K,FGFR2:uc021pzw.1:exon9:c.T1302A:p.N434K,FGFR2:uc010qtl.2:exon10:c.T1299A:p.N433K,FGFR2:uc010qtm.2:exon10:c.T1296A:p.N432K,FGFR2:uc031pxk.1:exon10:c.T1380A:p.N460K,FGFR2:uc001lfn.5:exon11:c.T477A:p.N159K,FGFR2:uc021pzx.1:exon11:c.T1380A:p.N460K,FGFR2:uc021qaa.1:exon11:c.T1650A:p.N550K,FGFR2:uc021qab.1:exon11:c.T1383A:p.N461K,FGFR2:uc021qac.1:exon11:c.T1434A:p.N478K,FGFR2:uc021pzy.1:exon12:c.T1650A:p.N550K,FGFR2:uc021pzz.1:exon12:c.T1647A:p.N549K	0.135	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	176943	101200;101400;101600;123150;123500;123790;149730;207410;609579;613659;614592;	313855;168624;83;2363;1555;207;1540;710;794;87;	313855|Perinatal lethal bent bone dysplasia|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614592 ~168624|Scaphocephaly-macrocephaly-maxillary retrusion-intellectual disability syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609579 ~83|-|<1 / 1 000 000|Autosomal recessive|Neonatal|207410 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~1555|Beare-Stevenson cutis gyrata syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|123790 ~207|Crouzon craniofacial dysostosis|1-9 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123500 ~1540|Craniosynostosis-midfacial hypoplasia-foot abnormalities syndrome<br>JWS|<1 / 1 000 000|Autosomal dominant|Neonatal|123150 ~710|ACS5<br>Acrocephalosyndactyly type 5|Unknown|Autosomal dominant|Antenatal<br>Neonatal|101600 ~794|ACS3<br>Acrocephalosyndactyly type 3<br>SCS|1-9 / 100 000|Autosomal dominant|Neonatal|101400 ~87|ACS1<br>Acrocephalosyndactyly type 1|1-9 / 100 000|Autosomal dominant|Antenatal<br>Neonatal|101200 ~	EDA
10	131265545	131265545	C	T	MGMT	exonic	synonymous SNV	ENSG00000170430	rs16906252	ENSG00000170430:ENST00000306010:exon1:c.C66T:p.R22R	MGMT:NM_002412:exon1:c.C66T:p.R22R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 1, 0, 0, None] 	0.0686	0.0437	0.0245607	.	.	.	.	10	.	.	.	MGMT:uc001lkh.2:exon1:c.C66T:p.R22R	.	AFR:0.0165,AMR:0.0423,EAS:0,FIN:0.2047,NFE:0.1028,OTH:0.075,SAS:0.0491	156569	.	.	.	GBM
10	43609950	43609950	C	G	RET	exonic	nonsynonymous SNV	ENSG00000165731	rs77709286	ENSG00000165731:ENST00000498820:exon5:c.C453G:p.C151W,ENSG00000165731:ENST00000340058:exon11:c.C1902G:p.C634W,ENSG00000165731:ENST00000355710:exon11:c.C1902G:p.C634W	RET:NM_020630:exon11:c.C1902G:p.C634W,RET:NM_020975:exon11:c.C1902G:p.C634W	clinvar: Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[2, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	6.012	27.9	0.003	3.62	10	.	.	.	RET:uc010qez.1:exon8:c.C1140G:p.C380W,RET:uc001jak.1:exon11:c.C1902G:p.C634W,RET:uc001jal.3:exon11:c.C1902G:p.C634W	1.119	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	THM
10	43617416	43617416	T	C	RET	exonic	nonsynonymous SNV	ENSG00000165731	rs74799832	ENSG00000165731:ENST00000340058:exon16:c.T2753C:p.M918T,ENSG00000165731:ENST00000355710:exon16:c.T2753C:p.M918T	RET:NM_020630:exon16:c.T2753C:p.M918T,RET:NM_020975:exon16:c.T2753C:p.M918T	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[2, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	6.098	28.2	0.0	5.43	10	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	RET:uc010qez.1:exon13:c.T1991C:p.M664T,RET:uc001jak.1:exon16:c.T2753C:p.M918T,RET:uc001jal.3:exon16:c.T2753C:p.M918T	0.776	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	THM
10	89692904	89692904	C	T	PTEN	exonic	stopgain	ENSG00000171862	rs121909224	ENSG00000171862:ENST00000371953:exon5:c.C388T:p.R130X	PTEN:NM_000314:exon5:c.C388T:p.R130X,PTEN:NM_001304717:exon6:c.C907T:p.R303X	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 2, 2, 0, 2, None] 	8.237e-06	.	.	12.360	39	.	5.22	10	.	.	Dual specificity phosphatase, catalytic domain;Protein-tyrosine phosphatase-like;Tensin phosphatase, lipid phosphatase domain	PTEN:uc001kfb.3:exon5:c.C388T:p.R130X	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.056e-05	601728	153480;155600;158350;176807;275355;276950;605309;607174;608089;613028;	182067;263662;210548;3412;67037;1331;201;2969;65285;404560;618;109;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~263662|-|Unknown|Autosomal dominant|All ages|607174 ~210548|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|605309 ~3412|Sujansky-Leonard syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|276950 314390 ~67037|HNSCC<br>Head and neck squamous cell carcinoma|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|275355 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~2969|Cohen-Hayden syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|158350 ~65285|Dysplastic gangliocytoma of the cerebellum<br>LDD|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|158350 ~404560|B-K mole syndrome<br>FAMM-PC syndrome<br>FAMMM syndrome<br>Familial Clark nevus syndrome<br>Familial atypical mole syndrome<br>Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome<br>Familial dysplastic nevus syndrome<br>Melanoma-pancreatic cancer syndrome|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|155600 606719 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~109|BRRS<br>Myhre-Riley-Smith syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|153480 ~	TH
10	89717672	89717672	C	T	PTEN	exonic;exonic	stopgain;stopgain	ENSG00000171862	rs121909219	ENSG00000171862:ENST00000371953:exon7:c.C697T:p.R233X;ENSG00000171862:ENST00000371953:exon7:c.C697T:p.R233X	PTEN:NM_000314:exon7:c.C697T:p.R233X,PTEN:NM_001304718:exon7:c.C106T:p.R36X,PTEN:NM_001304717:exon8:c.C1216T:p.R406X;PTEN:NM_000314:exon7:c.C697T:p.R233X,PTEN:NM_001304718:exon7:c.C106T:p.R36X,PTEN:NM_001304717:exon8:c.C1216T:p.R406X	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 2, 2, 0, 2, None] 	.	.	.	11.451	37	.	0.533	10	.	.	C2 domain;Tensin phosphatase, C2 domain	PTEN:uc001kfb.3:exon7:c.C697T:p.R233X;PTEN:uc001kfb.3:exon7:c.C697T:p.R233X	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	601728	153480;155600;158350;176807;275355;276950;605309;607174;608089;613028;	182067;263662;210548;3412;67037;1331;201;2969;65285;404560;618;109;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~263662|-|Unknown|Autosomal dominant|All ages|607174 ~210548|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|605309 ~3412|Sujansky-Leonard syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|276950 314390 ~67037|HNSCC<br>Head and neck squamous cell carcinoma|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|275355 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~2969|Cohen-Hayden syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|158350 ~65285|Dysplastic gangliocytoma of the cerebellum<br>LDD|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|158350 ~404560|B-K mole syndrome<br>FAMM-PC syndrome<br>FAMMM syndrome<br>Familial Clark nevus syndrome<br>Familial atypical mole syndrome<br>Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome<br>Familial dysplastic nevus syndrome<br>Melanoma-pancreatic cancer syndrome|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|155600 606719 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~109|BRRS<br>Myhre-Riley-Smith syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|153480 ~	BRACA
10	89717672	89717672	C	T	PTEN	exonic;exonic	stopgain;stopgain	ENSG00000171862	rs121909219	ENSG00000171862:ENST00000371953:exon7:c.C697T:p.R233X;ENSG00000171862:ENST00000371953:exon7:c.C697T:p.R233X	PTEN:NM_000314:exon7:c.C697T:p.R233X,PTEN:NM_001304718:exon7:c.C106T:p.R36X,PTEN:NM_001304717:exon8:c.C1216T:p.R406X;PTEN:NM_000314:exon7:c.C697T:p.R233X,PTEN:NM_001304718:exon7:c.C106T:p.R36X,PTEN:NM_001304717:exon8:c.C1216T:p.R406X	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 2, 2, 0, 2, None] 	.	.	.	11.451	37	.	0.533	10	.	.	C2 domain;Tensin phosphatase, C2 domain	PTEN:uc001kfb.3:exon7:c.C697T:p.R233X;PTEN:uc001kfb.3:exon7:c.C697T:p.R233X	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	601728	153480;155600;158350;176807;275355;276950;605309;607174;608089;613028;	182067;263662;210548;3412;67037;1331;201;2969;65285;404560;618;109;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~263662|-|Unknown|Autosomal dominant|All ages|607174 ~210548|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|605309 ~3412|Sujansky-Leonard syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|276950 314390 ~67037|HNSCC<br>Head and neck squamous cell carcinoma|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|275355 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~2969|Cohen-Hayden syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|158350 ~65285|Dysplastic gangliocytoma of the cerebellum<br>LDD|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|158350 ~404560|B-K mole syndrome<br>FAMM-PC syndrome<br>FAMMM syndrome<br>Familial Clark nevus syndrome<br>Familial atypical mole syndrome<br>Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome<br>Familial dysplastic nevus syndrome<br>Melanoma-pancreatic cancer syndrome|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|155600 606719 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~109|BRRS<br>Myhre-Riley-Smith syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|153480 ~	GBM
11	108218044	108218044	A	C	ATM	exonic	nonsynonymous SNV	ENSG00000149311	.	ENSG00000149311:ENST00000278616:exon59:c.A8623C:p.N2875H,ENSG00000149311:ENST00000452508:exon60:c.A8623C:p.N2875H	ATM:NM_000051:exon59:c.A8623C:p.N2875H	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	5.506	26.3	0.0	5.52	11	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Phosphatidylinositol 3/4-kinase, conserved site;Protein kinase-like domain	ATM:uc001pke.2:exon33:c.A4579C:p.N1527H,ATM:uc001pkb.1:exon59:c.A8623C:p.N2875H,ATM:uc009yxr.1:exon60:c.A8623C:p.N2875H	1.103	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	PRAD
1	11177096	11177096	C	A	MTOR	exonic	nonsynonymous SNV	ENSG00000198793	.	ENSG00000198793:ENST00000376838:exon12:c.G1596T:p.M532I,ENSG00000198793:ENST00000361445:exon50:c.G6981T:p.M2327I	MTOR:NM_004958:exon50:c.G6981T:p.M2327I	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	7.249	34	0.001	5.69	1	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Phosphatidylinositol 3/4-kinase, conserved site;Protein kinase-like domain	MTOR:uc001asc.3:exon12:c.G1596T:p.M532I,MTOR:uc001asd.3:exon50:c.G6981T:p.M2327I	0.474	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	BRACA
1	11184573	11184573	G	T	MTOR	exonic	nonsynonymous SNV	ENSG00000198793	.	ENSG00000198793:ENST00000376838:exon9:c.C1259A:p.S420Y,ENSG00000198793:ENST00000361445:exon47:c.C6644A:p.S2215Y	MTOR:NM_004958:exon47:c.C6644A:p.S2215Y	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.788	32	0.004	5.8	1	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	MTOR:uc001asc.3:exon9:c.C1259A:p.S420Y,MTOR:uc001asd.3:exon47:c.C6644A:p.S2215Y	0.424	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	EDA
1	11184580	11184580	G	A	MTOR	exonic	nonsynonymous SNV	ENSG00000198793	.	ENSG00000198793:ENST00000376838:exon9:c.C1252T:p.P418S,ENSG00000198793:ENST00000361445:exon47:c.C6637T:p.P2213S	MTOR:NM_004958:exon47:c.C6637T:p.P2213S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 1, 2, None] 	.	.	.	4.986	25.1	0.826	5.8	1	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	MTOR:uc001asc.3:exon9:c.C1252T:p.P418S,MTOR:uc001asd.3:exon47:c.C6637T:p.P2213S	-0.734	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	M
1	11187094	11187094	G	T	MTOR	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000198793	.	ENSG00000198793:ENST00000376838:exon7:c.C939A:p.F313L,ENSG00000198793:ENST00000361445:exon45:c.C6324A:p.F2108L;ENSG00000198793:ENST00000376838:exon7:c.C939A:p.F313L,ENSG00000198793:ENST00000361445:exon45:c.C6324A:p.F2108L	MTOR:NM_004958:exon45:c.C6324A:p.F2108L;MTOR:NM_004958:exon45:c.C6324A:p.F2108L	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	6.458	29.9	0.002	3.19	1	.	.	Protein kinase-like domain;Rapamycin-binding domain	MTOR:uc001asc.3:exon7:c.C939A:p.F313L,MTOR:uc001asd.3:exon45:c.C6324A:p.F2108L;MTOR:uc001asc.3:exon7:c.C939A:p.F313L,MTOR:uc001asd.3:exon45:c.C6324A:p.F2108L	0.556	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	BRACA
1	11187094	11187094	G	T	MTOR	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000198793	.	ENSG00000198793:ENST00000376838:exon7:c.C939A:p.F313L,ENSG00000198793:ENST00000361445:exon45:c.C6324A:p.F2108L;ENSG00000198793:ENST00000376838:exon7:c.C939A:p.F313L,ENSG00000198793:ENST00000361445:exon45:c.C6324A:p.F2108L	MTOR:NM_004958:exon45:c.C6324A:p.F2108L;MTOR:NM_004958:exon45:c.C6324A:p.F2108L	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	6.458	29.9	0.002	3.19	1	.	.	Protein kinase-like domain;Rapamycin-binding domain	MTOR:uc001asc.3:exon7:c.C939A:p.F313L,MTOR:uc001asd.3:exon45:c.C6324A:p.F2108L;MTOR:uc001asc.3:exon7:c.C939A:p.F313L,MTOR:uc001asd.3:exon45:c.C6324A:p.F2108L	0.556	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	THCA
1	11187796	11187796	G	A	MTOR	exonic	nonsynonymous SNV	ENSG00000198793	.	ENSG00000198793:ENST00000376838:exon6:c.C716T:p.A239V,ENSG00000198793:ENST00000361445:exon44:c.C6101T:p.A2034V	MTOR:NM_004958:exon44:c.C6101T:p.A2034V	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	7.013	33	0.001	5.8	1	.	.	Rapamycin-binding domain	MTOR:uc001asc.3:exon6:c.C716T:p.A239V,MTOR:uc001asd.3:exon44:c.C6101T:p.A2034V	-0.618	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	BRACA
1	11188519	11188519	G	A	MTOR	exonic	nonsynonymous SNV	ENSG00000198793	.	ENSG00000198793:ENST00000376838:exon4:c.C517T:p.H173Y,ENSG00000198793:ENST00000361445:exon42:c.C5902T:p.H1968Y	MTOR:NM_004958:exon42:c.C5902T:p.H1968Y	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	6.533	31	0.051	5.43	1	.	.	PIK-related kinase	MTOR:uc001asc.3:exon4:c.C517T:p.H173Y,MTOR:uc001asd.3:exon42:c.C5902T:p.H1968Y	0.578	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	M
1	11190804	11190804	C	T	MTOR	exonic	nonsynonymous SNV	ENSG00000198793	rs863225264	ENSG00000198793:ENST00000376838:exon1:c.G10A:p.E4K,ENSG00000198793:ENST00000361445:exon39:c.G5395A:p.E1799K	MTOR:NM_004958:exon39:c.G5395A:p.E1799K	clinvar: Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 1, 2, None] 	.	.	.	6.878	33	0.133	5.54	1	.	.	PIK-related kinase;PIK-related kinase, FAT	MTOR:uc001asc.3:exon1:c.G10A:p.E4K,MTOR:uc001asd.3:exon39:c.G5395A:p.E1799K	-0.456	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	RCCC
1	11217230	11217230	C	T	MTOR	exonic	nonsynonymous SNV	ENSG00000198793	.	ENSG00000198793:ENST00000361445:exon30:c.G4448A:p.C1483Y	MTOR:NM_004958:exon30:c.G4448A:p.C1483Y	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	6.627	32	0.0	5.32	1	.	.	Armadillo-type fold;PIK-related kinase;Tetratricopeptide-like helical domain	MTOR:uc001asd.3:exon30:c.G4448A:p.C1483Y	0.269	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	TCALL
1	115256529	115256529	T	A	NRAS	exonic	nonsynonymous SNV	ENSG00000213281	rs11554290	ENSG00000213281:ENST00000369535:exon3:c.A182T:p.Q61L	NRAS:NM_002524:exon3:c.A182T:p.Q61L	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	4.627	24.5	0.002	5.08	1	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	NRAS:uc009wgu.3:exon3:c.A182T:p.Q61L	0.785	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164790	114500;137550;162900;163200;188470;249400;613224;614470;	268114;648;2481;319487;2612;79414;626;	268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~2481|NCM<br>Neurocutaneous melanosis|1-9 / 100 000|Not applicable|Childhood|249400 ~319487|FNMTC<br>Familial pure nonmedullary thyroid carcinoma|-|-|-|188470 188550 603386 603744 606240 616534 616535 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~626|Congenital pigmented nevus<br>GMN<br>Giant congenital melanocytic nevus<br>Giant pigmented hairy nevus<br>LCMN|1-9 / 100 000|-|Infancy<br>Neonatal|137550 ~	M
1	115256529	115256529	T	C	NRAS	exonic	nonsynonymous SNV	ENSG00000213281	rs11554290	ENSG00000213281:ENST00000369535:exon3:c.A182G:p.Q61R	NRAS:NM_002524:exon3:c.A182G:p.Q61R	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	3.571	23.1	0.029	5.08	1	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	NRAS:uc009wgu.3:exon3:c.A182G:p.Q61R	0.292	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164790	114500;137550;162900;163200;188470;249400;613224;614470;	268114;648;2481;319487;2612;79414;626;	268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~2481|NCM<br>Neurocutaneous melanosis|1-9 / 100 000|Not applicable|Childhood|249400 ~319487|FNMTC<br>Familial pure nonmedullary thyroid carcinoma|-|-|-|188470 188550 603386 603744 606240 616534 616535 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~626|Congenital pigmented nevus<br>GMN<br>Giant congenital melanocytic nevus<br>Giant pigmented hairy nevus<br>LCMN|1-9 / 100 000|-|Infancy<br>Neonatal|137550 ~	M
1	115256530	115256530	G	T	NRAS	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000213281	rs121913254	ENSG00000213281:ENST00000369535:exon3:c.C181A:p.Q61K;ENSG00000213281:ENST00000369535:exon3:c.C181A:p.Q61K	NRAS:NM_002524:exon3:c.C181A:p.Q61K;NRAS:NM_002524:exon3:c.C181A:p.Q61K	clinvar: Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	4.363	24.1	0.009	5.08	1	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	NRAS:uc009wgu.3:exon3:c.C181A:p.Q61K;NRAS:uc009wgu.3:exon3:c.C181A:p.Q61K	0.702	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164790	114500;137550;162900;163200;188470;249400;613224;614470;	268114;648;2481;319487;2612;79414;626;	268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~2481|NCM<br>Neurocutaneous melanosis|1-9 / 100 000|Not applicable|Childhood|249400 ~319487|FNMTC<br>Familial pure nonmedullary thyroid carcinoma|-|-|-|188470 188550 603386 603744 606240 616534 616535 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~626|Congenital pigmented nevus<br>GMN<br>Giant congenital melanocytic nevus<br>Giant pigmented hairy nevus<br>LCMN|1-9 / 100 000|-|Infancy<br>Neonatal|137550 ~	NB
1	115256530	115256530	G	T	NRAS	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000213281	rs121913254	ENSG00000213281:ENST00000369535:exon3:c.C181A:p.Q61K;ENSG00000213281:ENST00000369535:exon3:c.C181A:p.Q61K	NRAS:NM_002524:exon3:c.C181A:p.Q61K;NRAS:NM_002524:exon3:c.C181A:p.Q61K	clinvar: Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	4.363	24.1	0.009	5.08	1	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	NRAS:uc009wgu.3:exon3:c.C181A:p.Q61K;NRAS:uc009wgu.3:exon3:c.C181A:p.Q61K	0.702	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164790	114500;137550;162900;163200;188470;249400;613224;614470;	268114;648;2481;319487;2612;79414;626;	268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~2481|NCM<br>Neurocutaneous melanosis|1-9 / 100 000|Not applicable|Childhood|249400 ~319487|FNMTC<br>Familial pure nonmedullary thyroid carcinoma|-|-|-|188470 188550 603386 603744 606240 616534 616535 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~626|Congenital pigmented nevus<br>GMN<br>Giant congenital melanocytic nevus<br>Giant pigmented hairy nevus<br>LCMN|1-9 / 100 000|-|Infancy<br>Neonatal|137550 ~	Skin Melanoma
1	115258744	115258744	C	T	NRAS	exonic	nonsynonymous SNV	ENSG00000213281	rs121434596	ENSG00000213281:ENST00000369535:exon2:c.G38A:p.G13D	NRAS:NM_002524:exon2:c.G38A:p.G13D	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 2, 2, 1, 2, None] 	8.236e-06	.	.	4.984	25.1	0.029	5.58	1	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	NRAS:uc009wgu.3:exon2:c.G38A:p.G13D	-0.083	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.498e-05,OTH:0,SAS:0	164790	114500;137550;162900;163200;188470;249400;613224;614470;	268114;648;2481;319487;2612;79414;626;	268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~2481|NCM<br>Neurocutaneous melanosis|1-9 / 100 000|Not applicable|Childhood|249400 ~319487|FNMTC<br>Familial pure nonmedullary thyroid carcinoma|-|-|-|188470 188550 603386 603744 606240 616534 616535 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~626|Congenital pigmented nevus<br>GMN<br>Giant congenital melanocytic nevus<br>Giant pigmented hairy nevus<br>LCMN|1-9 / 100 000|-|Infancy<br>Neonatal|137550 ~	M
1	11856378	11856378	G	A	MTHFR	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000177000	rs1801133	ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V;ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V;ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V	MTHFR:NM_005957:exon5:c.C665T:p.A222V;MTHFR:NM_005957:exon5:c.C665T:p.A222V;MTHFR:NM_005957:exon5:c.C665T:p.A222V	clinvar: Benign|Uncertain significance|not provided|drug response|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 0, 0, 1, 2, 0, None] 	0.3037	0.2706	0.245407	4.914	25.0	0.027	5.08	1	.	.	FAD-linked oxidoreductase-like	MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V;MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V;MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V	-1.455	AFR:0.1124,AMR:0.5141,EAS:0.3052,FIN:0.2227,NFE:0.3450,OTH:0.3062,SAS:0.1409	607093	181500;188050;236250;601634;	268357;823;395;	268357|-|Unknown|-|-|182940 301410 601634 ~823|-|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182940 301410 601634 ~395|MTHFR deficiency<br>Methylene tetrahydrofolate reductase deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|236250 ~	PA
1	11856378	11856378	G	A	MTHFR	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000177000	rs1801133	ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V;ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V;ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V	MTHFR:NM_005957:exon5:c.C665T:p.A222V;MTHFR:NM_005957:exon5:c.C665T:p.A222V;MTHFR:NM_005957:exon5:c.C665T:p.A222V	clinvar: Benign|Uncertain significance|not provided|drug response|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 0, 0, 1, 2, 0, None] 	0.3037	0.2706	0.245407	4.914	25.0	0.027	5.08	1	.	.	FAD-linked oxidoreductase-like	MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V;MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V;MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V	-1.455	AFR:0.1124,AMR:0.5141,EAS:0.3052,FIN:0.2227,NFE:0.3450,OTH:0.3062,SAS:0.1409	607093	181500;188050;236250;601634;	268357;823;395;	268357|-|Unknown|-|-|182940 301410 601634 ~823|-|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182940 301410 601634 ~395|MTHFR deficiency<br>Methylene tetrahydrofolate reductase deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|236250 ~	REC
1	11856378	11856378	G	A	MTHFR	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000177000	rs1801133	ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V;ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V;ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V	MTHFR:NM_005957:exon5:c.C665T:p.A222V;MTHFR:NM_005957:exon5:c.C665T:p.A222V;MTHFR:NM_005957:exon5:c.C665T:p.A222V	clinvar: Benign|Uncertain significance|not provided|drug response|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 0, 0, 1, 2, 0, None] 	0.3037	0.2706	0.245407	4.914	25.0	0.027	5.08	1	.	.	FAD-linked oxidoreductase-like	MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V;MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V;MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V	-1.455	AFR:0.1124,AMR:0.5141,EAS:0.3052,FIN:0.2227,NFE:0.3450,OTH:0.3062,SAS:0.1409	607093	181500;188050;236250;601634;	268357;823;395;	268357|-|Unknown|-|-|182940 301410 601634 ~823|-|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182940 301410 601634 ~395|MTHFR deficiency<br>Methylene tetrahydrofolate reductase deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|236250 ~	ST-PR
11	534285	534285	C	T	HRAS	exonic	nonsynonymous SNV	ENSG00000174775	rs104894226	ENSG00000174775:ENST00000397594:exon1:c.G38A:p.G13D,ENSG00000174775:ENST00000311189:exon2:c.G38A:p.G13D,ENSG00000174775:ENST00000397596:exon2:c.G38A:p.G13D,ENSG00000174775:ENST00000417302:exon2:c.G38A:p.G13D,ENSG00000174775:ENST00000451590:exon2:c.G38A:p.G13D,ENSG00000174775:ENST00000493230:exon2:c.G38A:p.G13D	HRAS:NM_001130442:exon2:c.G38A:p.G13D,HRAS:NM_005343:exon2:c.G38A:p.G13D,HRAS:NM_176795:exon2:c.G38A:p.G13D	clinvar: Pathogenic,Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	4.718	24.6	0.031	3.0	11	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	HRAS:uc001lpv.3:exon2:c.G38A:p.G13D,HRAS:uc010qvw.2:exon2:c.G38A:p.G13D,HRAS:uc010qvx.2:exon2:c.G38A:p.G13D	0.297	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190020	109800;137550;162900;163200;188470;218040;	3071;319487;2612;79414;626;	3071|FCS syndrome<br>Faciocutaneoskeletal syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|218040 ~319487|FNMTC<br>Familial pure nonmedullary thyroid carcinoma|-|-|-|188470 188550 603386 603744 606240 616534 616535 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~626|Congenital pigmented nevus<br>GMN<br>Giant congenital melanocytic nevus<br>Giant pigmented hairy nevus<br>LCMN|1-9 / 100 000|-|Infancy<br>Neonatal|137550 ~	COREAD
1	161479745	161479745	A	G	FCGR2A	exonic	nonsynonymous SNV	ENSG00000143226	rs1801274	ENSG00000143226:ENST00000467525:exon2:c.A395G:p.H132R,ENSG00000143226:ENST00000271450:exon4:c.A500G:p.H167R,ENSG00000143226:ENST00000367972:exon4:c.A497G:p.H166R	FCGR2A:NM_001136219:exon4:c.A500G:p.H167R,FCGR2A:NM_021642:exon4:c.A497G:p.H166R	clinvar: other|other|other|drug response 	 CancerVar: Benign/Likely benign EVS=[0, None, None, 0, None, None, 0, 0, 0, 1, 0, None] 	0.4791	0.5310	0.441693	-1.872	0.002	0.173	-4.15	1	.	.	Immunoglobulin subtype;Immunoglobulin-like domain;Immunoglobulin-like fold	FCGR2A:uc001gam.3:exon4:c.A497G:p.H166R,FCGR2A:uc001gan.3:exon4:c.A500G:p.H167R,FCGR2A:uc021pcz.2:exon4:c.A83G:p.H28R,FCGR2A:uc021pda.2:exon4:c.A83G:p.H28R	-0.958	AFR:0.5458,AMR:0.5211,EAS:0.3274,FIN:0.5091,NFE:0.4942,OTH:0.4537,SAS:0.4153	146790	152700;219700;611162;	673;586;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~586|CF<br>Mucoviscidosis|1-9 / 100 000|Autosomal recessive|All ages|219700 ~	BRACA
1	161514542	161514542	A	C	FCGR3A	exonic	nonsynonymous SNV	ENSG00000203747	rs396991	ENSG00000203747:ENST00000367969:exon4:c.T634G:p.F212V,ENSG00000203747:ENST00000443193:exon4:c.T631G:p.F211V,ENSG00000203747:ENST00000540048:exon4:c.T526G:p.F176V,ENSG00000203747:ENST00000367967:exon5:c.T526G:p.F176V,ENSG00000203747:ENST00000436743:exon5:c.T526G:p.F176V	FCGR3A:NM_000569:exon4:c.T634G:p.F212V,FCGR3A:NM_001127592:exon4:c.T631G:p.F211V,FCGR3A:NM_001127593:exon5:c.T526G:p.F176V,FCGR3A:NM_001127595:exon5:c.T526G:p.F176V,FCGR3A:NM_001127596:exon5:c.T523G:p.F175V	clinvar: drug response|drug response|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 1, 1, 0, None] 	0.3289	0.2739	.	-1.789	0.002	0.212	-0.103	1	.	.	Immunoglobulin subtype;Immunoglobulin-like domain;Immunoglobulin-like fold	FCGR3A:uc001gar.3:exon4:c.T634G:p.F212V,FCGR3A:uc001gas.3:exon4:c.T631G:p.F211V,FCGR3A:uc001gat.4:exon5:c.T526G:p.F176V,FCGR3A:uc009wuh.3:exon5:c.T523G:p.F175V,FCGR3A:uc009wui.3:exon5:c.T526G:p.F176V	-0.916	AFR:0.3321,AMR:0.2327,EAS:0.3273,FIN:0.2790,NFE:0.3468,OTH:0.3367,SAS:0.3428	146740	615707;	437552;	437552|Autosomal recessive primary immunodeficiency with defective spontaneous NK cell cytotoxicity<br>CD16 deficiency|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|615707 ~	BRACA
1	161643798	161643798	T	C	FCGR2B	exonic	nonsynonymous SNV	ENSG00000072694	rs1050501	ENSG00000072694:ENST00000367960:exon4:c.T674C:p.I225T,ENSG00000072694:ENST00000367961:exon4:c.T674C:p.I225T,ENSG00000072694:ENST00000236937:exon5:c.T695C:p.I232T,ENSG00000072694:ENST00000358671:exon5:c.T695C:p.I232T,ENSG00000072694:ENST00000367962:exon5:c.T695C:p.I232T,ENSG00000072694:ENST00000403078:exon5:c.T695C:p.I232T	FCGR2B:NM_001190828:exon4:c.T674C:p.I225T,FCGR2B:NM_001002273:exon5:c.T692C:p.I231T,FCGR2B:NM_001002274:exon5:c.T695C:p.I232T,FCGR2B:NM_001002275:exon5:c.T692C:p.I231T,FCGR2B:NM_004001:exon5:c.T695C:p.I232T	clinvar: other|other 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 1, 1, 0, None] 	0.2369	.	0.185903	0.457	7.094	0.258	2.85	1	.	.	.	FCGR2B:uc009wun.2:exon4:c.T674C:p.I225T,FCGR2B:uc001gay.2:exon5:c.T692C:p.I231T,FCGR2B:uc001gaz.2:exon5:c.T695C:p.I232T,FCGR2B:uc001gba.2:exon5:c.T692C:p.I231T,FCGR2B:uc001gbb.2:exon5:c.T695C:p.I232T	-1.039	AFR:0.3122,AMR:0.1404,EAS:0.3407,FIN:0.3947,NFE:0.1959,OTH:0.2222,SAS:0.2588	604590	152700;611162;	673;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~	BRACA
1	162724415	162724415	C	G	DDR2	exonic	nonsynonymous SNV	ENSG00000162733	rs144594252	ENSG00000162733:ENST00000367921:exon5:c.C187G:p.L63V,ENSG00000162733:ENST00000415555:exon5:c.C187G:p.L63V,ENSG00000162733:ENST00000446985:exon5:c.C187G:p.L63V,ENSG00000162733:ENST00000367922:exon6:c.C187G:p.L63V	DDR2:NM_006182:exon5:c.C187G:p.L63V,DDR2:NM_001014796:exon6:c.C187G:p.L63V	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	6.594e-05	7.7e-05	0.000199681	3.306	22.9	0.146	3.51	1	0.0110	0.144	Coagulation factor 5/8 C-terminal type domain;Galactose-binding domain-like	DDR2:uc001gcg.3:exon5:c.C187G:p.L63V,DDR2:uc001gcf.3:exon6:c.C187G:p.L63V	1.091	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0001,OTH:0,SAS:0	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	NSCLC
1	162729630	162729630	T	G	DDR2	exonic	nonsynonymous SNV	ENSG00000162733	.	ENSG00000162733:ENST00000367921:exon8:c.T716G:p.L239R,ENSG00000162733:ENST00000367922:exon9:c.T716G:p.L239R	DDR2:NM_006182:exon8:c.T716G:p.L239R,DDR2:NM_001014796:exon9:c.T716G:p.L239R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 1, 0, None] 	.	.	.	1.191	11.70	0.241	4.6	1	.	.	.	DDR2:uc001gcg.3:exon8:c.T716G:p.L239R,DDR2:uc001gcf.3:exon9:c.T716G:p.L239R	-1.002	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	NSCLC
1	162729671	162729671	G	T	DDR2	exonic	nonsynonymous SNV	ENSG00000162733	.	ENSG00000162733:ENST00000367921:exon8:c.G757T:p.G253C,ENSG00000162733:ENST00000367922:exon9:c.G757T:p.G253C	DDR2:NM_006182:exon8:c.G757T:p.G253C,DDR2:NM_001014796:exon9:c.G757T:p.G253C	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	6.382	29.5	0.001	4.71	1	.	.	.	DDR2:uc001gcg.3:exon8:c.G757T:p.G253C,DDR2:uc001gcf.3:exon9:c.G757T:p.G253C	-0.699	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	NSCLC
1	162741822	162741822	G	A	DDR2	exonic	nonsynonymous SNV	ENSG00000162733	rs115169993	ENSG00000162733:ENST00000367921:exon13:c.G1513A:p.G505S,ENSG00000162733:ENST00000367922:exon14:c.G1513A:p.G505S	DDR2:NM_006182:exon13:c.G1513A:p.G505S,DDR2:NM_001014796:exon14:c.G1513A:p.G505S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 1, 0, None] 	0.0015	0.0029	0.00279553	1.288	12.21	0.259	1.98	1	.	.	.	DDR2:uc001gcg.3:exon13:c.G1513A:p.G505S,DDR2:uc001gcf.3:exon14:c.G1513A:p.G505S	-1.031	AFR:0.0144,AMR:0.0004,EAS:0,FIN:0,NFE:8.605e-05,OTH:0,SAS:0	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	NSCLC
1	162745497	162745497	A	T	DDR2	exonic	nonsynonymous SNV	ENSG00000162733	.	ENSG00000162733:ENST00000367921:exon15:c.A1912T:p.I638F,ENSG00000162733:ENST00000367922:exon16:c.A1912T:p.I638F	DDR2:NM_006182:exon15:c.A1912T:p.I638F,DDR2:NM_001014796:exon16:c.A1912T:p.I638F	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	6.199	28.7	0.005	5.11	1	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	DDR2:uc001gcg.3:exon15:c.A1912T:p.I638F,DDR2:uc001gcf.3:exon16:c.A1912T:p.I638F	0.843	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	NSCLC
1	162748390	162748390	T	A	DDR2	exonic	nonsynonymous SNV	ENSG00000162733	.	ENSG00000162733:ENST00000367921:exon17:c.T2304A:p.S768R,ENSG00000162733:ENST00000367922:exon18:c.T2304A:p.S768R	DDR2:NM_006182:exon17:c.T2304A:p.S768R,DDR2:NM_001014796:exon18:c.T2304A:p.S768R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	5.359	25.9	0.001	1.93	1	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	DDR2:uc001gcg.3:exon17:c.T2304A:p.S768R,DDR2:uc001gcf.3:exon18:c.T2304A:p.S768R	0.671	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	NSCLC
1	162748407	162748407	G	T	DDR2	exonic	nonsynonymous SNV	ENSG00000162733	.	ENSG00000162733:ENST00000367921:exon17:c.G2321T:p.G774V,ENSG00000162733:ENST00000367922:exon18:c.G2321T:p.G774V	DDR2:NM_006182:exon17:c.G2321T:p.G774V,DDR2:NM_001014796:exon18:c.G2321T:p.G774V	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	6.160	28.5	0.002	5.49	1	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	DDR2:uc001gcg.3:exon17:c.G2321T:p.G774V,DDR2:uc001gcf.3:exon18:c.G2321T:p.G774V	0.998	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	NSCLC
11	64572092	64572092	C	-	MEN1	exonic	frameshift deletion	ENSG00000133895	.	ENSG00000133895:ENST00000377316:exon8:c.1382delG:p.R461fs,ENSG00000133895:ENST00000377313:exon9:c.1562delG:p.R521fs,ENSG00000133895:ENST00000377326:exon9:c.1547delG:p.R516fs,ENSG00000133895:ENST00000312049:exon10:c.1547delG:p.R516fs,ENSG00000133895:ENST00000315422:exon10:c.1547delG:p.R516fs,ENSG00000133895:ENST00000337652:exon10:c.1562delG:p.R521fs,ENSG00000133895:ENST00000377321:exon10:c.1442delG:p.R481fs,ENSG00000133895:ENST00000394374:exon10:c.1562delG:p.R521fs,ENSG00000133895:ENST00000443283:exon10:c.1562delG:p.R521fs,ENSG00000133895:ENST00000394376:exon11:c.1562delG:p.R521fs	MEN1:NM_000244:exon10:c.1562delG:p.R521fs,MEN1:NM_130799:exon10:c.1547delG:p.R516fs,MEN1:NM_130800:exon10:c.1562delG:p.R521fs,MEN1:NM_130801:exon10:c.1562delG:p.R521fs,MEN1:NM_130802:exon10:c.1562delG:p.R521fs,MEN1:NM_130803:exon10:c.1562delG:p.R521fs,MEN1:NM_130804:exon11:c.1562delG:p.R521fs	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	11	.	.	.	MEN1:uc001obj.3:exon10:c.1562delG:p.R521fs,MEN1:uc001obk.3:exon10:c.1562delG:p.R521fs,MEN1:uc001obl.3:exon10:c.1442delG:p.R481fs,MEN1:uc001obm.3:exon10:c.1547delG:p.R516fs,MEN1:uc001obn.3:exon10:c.1562delG:p.R521fs,MEN1:uc001obo.3:exon10:c.1562delG:p.R521fs,MEN1:uc001obr.3:exon10:c.1562delG:p.R521fs,MEN1:uc001obq.3:exon11:c.1562delG:p.R521fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	613733	131100;	652;	652|MEN1<br>Wermer syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|131100 ~	Thyroid Hurthle Cell Carcinoma
11	67352689	67352689	A	G	GSTP1	exonic	nonsynonymous SNV	ENSG00000084207	rs1695	ENSG00000084207:ENST00000398603:exon5:c.A313G:p.I105V,ENSG00000084207:ENST00000398606:exon5:c.A313G:p.I105V	GSTP1:NM_000852:exon5:c.A313G:p.I105V	clinvar: drug response|drug response|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 1, 1, 2, None] 	0.3335	0.3608	0.352636	-2.678	0.001	1.0	-1.16	11	.	.	Glutathione S-transferase, C-terminal;Glutathione S-transferase, C-terminal-like	GSTP1:uc001omf.3:exon5:c.A313G:p.I105V	-0.938	AFR:0.4442,AMR:0.5351,EAS:0.1807,FIN:0.2749,NFE:0.3191,OTH:0.2962,SAS:0.2887	134660	.	.	.	COREAD
12	111884608	111884608	T	C	SH2B3	exonic	nonsynonymous SNV	ENSG00000111252	rs3184504	ENSG00000111252:ENST00000538307:exon2:c.T178C:p.W60R,ENSG00000111252:ENST00000341259:exon3:c.T784C:p.W262R	SH2B3:NM_001291424:exon2:c.T178C:p.W60R,SH2B3:NM_005475:exon3:c.T784C:p.W262R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 0, 0, 0, 1, 0, None] 	0.6625	0.6340	0.852636	-1.068	0.012	1.0	2.97	12	.	.	Pleckstrin homology domain	SH2B3:uc001tsf.3:exon2:c.T784C:p.W262R,SH2B3:uc010syf.2:exon2:c.T784C:p.W262R,SH2B3:uc010syg.2:exon2:c.T178C:p.W60R,SH2B3:uc001tse.3:exon3:c.T784C:p.W262R	-0.956	AFR:0.9271,AMR:0.8031,EAS:0.9991,FIN:0.6183,NFE:0.5145,OTH:0.6584,SAS:0.9069	605093	133100;187950;254450;	824;3318;71493;90042;	824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~90042|Congenital erythrocytosis due to erythropoietin receptor mutation<br>Congenital polycythemia due to erythropoietin receptor mutation<br>Familial erythrocytosis<br>PFCP<br>Primary congenital erythrocytosis<br>Primary familial and congenital polycythemia|Unknown|Autosomal dominant|All ages|133100 ~	COREAD
12	21329738	21329738	A	G	SLCO1B1	exonic	nonsynonymous SNV	ENSG00000134538	rs2306283	ENSG00000134538:ENST00000256958:exon5:c.A388G:p.N130D	SLCO1B1:NM_006446:exon5:c.A388G:p.N130D	clinvar: Benign 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 0, 1, 1, 1, 0, None] 	0.4795	0.5263	0.622404	-1.733	0.002	0.45	-2.63	12	.	.	Major facilitator superfamily domain	SLCO1B1:uc001req.4:exon5:c.A388G:p.N130D	-0.983	AFR:0.7680,AMR:0.4303,EAS:0.7499,FIN:0.4494,NFE:0.4107,OTH:0.5022,SAS:0.4795	604843	237450;	3111;	3111|Hyperbilirubinemia, Rotor type|<1 / 1 000 000|Autosomal recessive|All ages|237450 ~	CANCER
12	21331549	21331549	T	C	SLCO1B1	exonic	nonsynonymous SNV	ENSG00000134538	rs4149056	ENSG00000134538:ENST00000256958:exon6:c.T521C:p.V174A	SLCO1B1:NM_006446:exon6:c.T521C:p.V174A	clinvar: drug response|drug response|drug response|drug response|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 0, 0, 0, 1, 0, None] 	0.1294	0.1149	0.0876597	3.340	22.9	0.001	3.62	12	.	.	Major facilitator superfamily domain	SLCO1B1:uc001req.4:exon6:c.T521C:p.V174A	-0.941	AFR:0.0284,AMR:0.1065,EAS:0.1263,FIN:0.2136,NFE:0.1603,OTH:0.1667,SAS:0.0503	604843	237450;	3111;	3111|Hyperbilirubinemia, Rotor type|<1 / 1 000 000|Autosomal recessive|All ages|237450 ~	CANCER
12	25360224	25360224	A	C	KRAS	UTR3;UTR3	.	ENSG00000133703	rs61764370	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 0, 0, 2, None] 	.	.	0.0347444	.	.	.	.	12	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	Epithelial Ovarian Cancer
12	25360224	25360224	A	C	KRAS	UTR3;UTR3	.	ENSG00000133703	rs61764370	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 0, 0, 2, None] 	.	.	0.0347444	.	.	.	.	12	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	HNSC
12	25378561	25378561	G	A	KRAS	exonic	nonsynonymous SNV	ENSG00000133703	.	ENSG00000133703:ENST00000256078:exon4:c.C437T:p.A146V,ENSG00000133703:ENST00000311936:exon4:c.C437T:p.A146V	KRAS:NM_004985:exon4:c.C437T:p.A146V,KRAS:NM_033360:exon4:c.C437T:p.A146V	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.934	33	0.0	5.52	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon4:c.C437T:p.A146V,KRAS:uc001rgq.1:exon4:c.C437T:p.A146V	0.877	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	NSCLC
12	25398255	25398255	G	A	KRAS	exonic	stopgain	ENSG00000133703	.	ENSG00000133703:ENST00000256078:exon2:c.C64T:p.Q22X,ENSG00000133703:ENST00000311936:exon2:c.C64T:p.Q22X,ENSG00000133703:ENST00000556131:exon2:c.C64T:p.Q22X,ENSG00000133703:ENST00000557334:exon2:c.C64T:p.Q22X	KRAS:NM_004985:exon2:c.C64T:p.Q22X,KRAS:NM_033360:exon2:c.C64T:p.Q22X	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 0, 2, None] 	.	.	.	11.904	38	.	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.C64T:p.Q22X,KRAS:uc001rgq.1:exon2:c.C64T:p.Q22X	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	Colon Mucinous Adenocarcinoma
12	25398281	25398281	C	T	KRAS	exonic	nonsynonymous SNV	ENSG00000133703	rs112445441	ENSG00000133703:ENST00000256078:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000311936:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000556131:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000557334:exon2:c.G38A:p.G13D	KRAS:NM_004985:exon2:c.G38A:p.G13D,KRAS:NM_033360:exon2:c.G38A:p.G13D	clinvar: Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	6.222	28.8	0.032	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G38A:p.G13D,KRAS:uc001rgq.1:exon2:c.G38A:p.G13D	0.569	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	COREAD
12	25398284	25398284	C	A	KRAS	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913529	ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V;ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V;ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V	KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V;KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V;KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	6.463	29.9	0.01	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V;KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V;KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V	0.543	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	CANCER
12	25398284	25398284	C	A	KRAS	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913529	ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V;ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V;ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V	KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V;KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V;KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	6.463	29.9	0.01	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V;KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V;KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V	0.543	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	COREAD
12	25398284	25398284	C	A	KRAS	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913529	ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V;ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V;ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V	KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V;KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V;KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	6.463	29.9	0.01	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V;KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V;KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V	0.543	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	NSCLC
12	25398284	25398284	C	G	KRAS	exonic	nonsynonymous SNV	ENSG00000133703	rs121913529	ENSG00000133703:ENST00000256078:exon2:c.G35C:p.G12A,ENSG00000133703:ENST00000311936:exon2:c.G35C:p.G12A,ENSG00000133703:ENST00000556131:exon2:c.G35C:p.G12A,ENSG00000133703:ENST00000557334:exon2:c.G35C:p.G12A	KRAS:NM_004985:exon2:c.G35C:p.G12A,KRAS:NM_033360:exon2:c.G35C:p.G12A	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	5.811	27.2	0.03	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G35C:p.G12A,KRAS:uc001rgq.1:exon2:c.G35C:p.G12A	0.215	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	LUAD
12	25398284	25398284	C	T	KRAS	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913529	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.976e-05	.	.	5.090	25.3	0.024	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	0.267	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:1.873e-05,OTH:0,SAS:0	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	COREAD
12	25398284	25398284	C	T	KRAS	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913529	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.976e-05	.	.	5.090	25.3	0.024	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	0.267	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:1.873e-05,OTH:0,SAS:0	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	HCL
12	25398284	25398284	C	T	KRAS	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913529	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.976e-05	.	.	5.090	25.3	0.024	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	0.267	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:1.873e-05,OTH:0,SAS:0	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	L
12	25398284	25398284	C	T	KRAS	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913529	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.976e-05	.	.	5.090	25.3	0.024	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	0.267	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:1.873e-05,OTH:0,SAS:0	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	NSCLC
12	25398284	25398284	C	T	KRAS	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913529	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.976e-05	.	.	5.090	25.3	0.024	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	0.267	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:1.873e-05,OTH:0,SAS:0	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	PA
12	25398284	25398284	C	T	KRAS	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913529	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.976e-05	.	.	5.090	25.3	0.024	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	0.267	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:1.873e-05,OTH:0,SAS:0	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	PA
12	25398284	25398284	C	T	KRAS	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913529	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.976e-05	.	.	5.090	25.3	0.024	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	0.267	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:1.873e-05,OTH:0,SAS:0	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	Pancreatic Ductal Carcinoma
12	25398284	25398284	C	T	KRAS	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913529	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.976e-05	.	.	5.090	25.3	0.024	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	0.267	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:1.873e-05,OTH:0,SAS:0	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	Tumor Of Exocrine Pancreas
12	25398285	25398285	C	A	KRAS	exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913530	ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C	KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C	clinvar: Pathogenic|Pathogenic|not provided,Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|not provided|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.976e-05	.	.	7.016	33	0.02	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C	0.548	AFR:0,AMR:0,EAS:0.0001,FIN:0,NFE:1.873e-05,OTH:0,SAS:0	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	CANCER
12	25398285	25398285	C	A	KRAS	exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913530	ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C	KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C	clinvar: Pathogenic|Pathogenic|not provided,Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|not provided|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.976e-05	.	.	7.016	33	0.02	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C	0.548	AFR:0,AMR:0,EAS:0.0001,FIN:0,NFE:1.873e-05,OTH:0,SAS:0	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	COREAD
12	25398285	25398285	C	A	KRAS	exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913530	ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C	KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C	clinvar: Pathogenic|Pathogenic|not provided,Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|not provided|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.976e-05	.	.	7.016	33	0.02	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C	0.548	AFR:0,AMR:0,EAS:0.0001,FIN:0,NFE:1.873e-05,OTH:0,SAS:0	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	L
12	25398285	25398285	C	A	KRAS	exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs121913530	ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C	KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C	clinvar: Pathogenic|Pathogenic|not provided,Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|not provided|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.976e-05	.	.	7.016	33	0.02	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C	0.548	AFR:0,AMR:0,EAS:0.0001,FIN:0,NFE:1.873e-05,OTH:0,SAS:0	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	NSCLC
12	25398285	25398285	C	G	KRAS	exonic	nonsynonymous SNV	ENSG00000133703	rs121913530	ENSG00000133703:ENST00000256078:exon2:c.G34C:p.G12R,ENSG00000133703:ENST00000311936:exon2:c.G34C:p.G12R,ENSG00000133703:ENST00000556131:exon2:c.G34C:p.G12R,ENSG00000133703:ENST00000557334:exon2:c.G34C:p.G12R	KRAS:NM_004985:exon2:c.G34C:p.G12R,KRAS:NM_033360:exon2:c.G34C:p.G12R	clinvar: Pathogenic|Pathogenic|not provided,Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|not provided|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	4.956	25.0	0.02	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G34C:p.G12R,KRAS:uc001rgq.1:exon2:c.G34C:p.G12R	0.190	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	PA
12	56478851	56478851	C	G	ERBB3	exonic	nonsynonymous SNV	ENSG00000065361	.	ENSG00000065361:ENST00000267101:exon3:c.C307G:p.R103G,ENSG00000065361:ENST00000411731:exon3:c.C307G:p.R103G,ENSG00000065361:ENST00000549672:exon3:c.C130G:p.R44G,ENSG00000065361:ENST00000551085:exon3:c.C307G:p.R103G,ENSG00000065361:ENST00000551242:exon3:c.C307G:p.R103G,ENSG00000065361:ENST00000415288:exon4:c.C130G:p.R44G,ENSG00000065361:ENST00000549061:exon4:c.C130G:p.R44G,ENSG00000065361:ENST00000549282:exon4:c.C307G:p.R103G	ERBB3:NM_001005915:exon3:c.C307G:p.R103G,ERBB3:NM_001982:exon3:c.C307G:p.R103G	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	5.654	26.7	0.002	3.85	12	.	.	Receptor L-domain	ERBB3:uc001sjg.3:exon3:c.C307G:p.R103G,ERBB3:uc001sjh.3:exon3:c.C307G:p.R103G,ERBB3:uc010sqc.2:exon4:c.C130G:p.R44G	0.607	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190151	607598;	137776;	137776|LCCS2<br>Multiple contracture syndrome, Israeli-Bedouin type|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|607598 ~	UTH
12	56481922	56481922	G	A	ERBB3	exonic	nonsynonymous SNV	ENSG00000065361	.	ENSG00000065361:ENST00000267101:exon7:c.G850A:p.G284R,ENSG00000065361:ENST00000551085:exon7:c.G850A:p.G284R,ENSG00000065361:ENST00000551242:exon7:c.G850A:p.G284R,ENSG00000065361:ENST00000415288:exon8:c.G673A:p.G225R	ERBB3:NM_001982:exon7:c.G850A:p.G284R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 1, 0, None] 	.	.	.	5.381	25.9	0.001	3.07	12	.	.	Furin-like cysteine-rich domain;Insulin-like growth factor binding protein, N-terminal	ERBB3:uc001sjh.3:exon7:c.G850A:p.G284R,ERBB3:uc010sqc.2:exon8:c.G673A:p.G225R	-0.936	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190151	607598;	137776;	137776|LCCS2<br>Multiple contracture syndrome, Israeli-Bedouin type|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|607598 ~	UTH
12	56491672	56491672	T	C	ERBB3	exonic	nonsynonymous SNV	ENSG00000065361	.	ENSG00000065361:ENST00000553131:exon4:c.T287C:p.V96A,ENSG00000065361:ENST00000450146:exon8:c.T635C:p.V212A,ENSG00000065361:ENST00000267101:exon21:c.T2564C:p.V855A,ENSG00000065361:ENST00000551085:exon21:c.T2564C:p.V855A,ENSG00000065361:ENST00000415288:exon22:c.T2387C:p.V796A	ERBB3:NM_001982:exon21:c.T2564C:p.V855A	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	6.053	28.0	0.002	5.87	12	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ERBB3:uc001sjk.3:exon4:c.T287C:p.V96A,ERBB3:uc010sqb.2:exon8:c.T635C:p.V212A,ERBB3:uc001sjh.3:exon21:c.T2564C:p.V855A,ERBB3:uc010sqc.2:exon22:c.T2387C:p.V796A	0.253	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190151	607598;	137776;	137776|LCCS2<br>Multiple contracture syndrome, Israeli-Bedouin type|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|607598 ~	NSCLC
12	58145431	58145431	G	A	CDK4	exonic	nonsynonymous SNV	ENSG00000135446	rs11547328	ENSG00000135446:ENST00000552254:exon1:c.C70T:p.R24C,ENSG00000135446:ENST00000257904:exon2:c.C70T:p.R24C,ENSG00000135446:ENST00000312990:exon2:c.C70T:p.R24C,ENSG00000135446:ENST00000550419:exon2:c.C70T:p.R24C,ENSG00000135446:ENST00000552388:exon2:c.C70T:p.R24C,ENSG00000135446:ENST00000552862:exon2:c.C70T:p.R24C,ENSG00000135446:ENST00000553237:exon2:c.C70T:p.R24C	CDK4:NM_000075:exon2:c.C70T:p.R24C	clinvar: other|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.239e-06	.	.	5.138	25.4	0.021	4.28	12	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine/threonine/dual specificity protein kinase, catalytic  domain	CDK4:uc001spv.3:exon2:c.C70T:p.R24C	-0.794	AFR:0,AMR:0,EAS:0.0001,FIN:0,NFE:0,OTH:0,SAS:0	123829	609048;	618;	618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~	Skin Melanoma
12	69202580	69202580	T	G	MDM2	intronic	.	ENSG00000135679	rs2279744	.	.	clinvar: other 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 0, 0, 2, None] 	.	.	0.366613	.	.	.	.	12	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164785	614401;	.	.	HNC
12	69234988	69234988	A	-	MDM2	UTR3	.	ENSG00000135679	rs34886328	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 0, 0, 2, None] 	.	.	0.384585	.	.	.	.	12	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164785	614401;	.	.	ESSC
13	103498198	103498199	A	G	.	.	.	.	.	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	13	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	.	.	.	.	Parietal Lobe Ependymoma
13	28592642	28592642	C	A	FLT3	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000122025	rs121913488	ENSG00000122025:ENST00000241453:exon20:c.G2503T:p.D835Y,ENSG00000122025:ENST00000380982:exon20:c.G2503T:p.D835Y;ENSG00000122025:ENST00000241453:exon20:c.G2503T:p.D835Y,ENSG00000122025:ENST00000380982:exon20:c.G2503T:p.D835Y	FLT3:NM_004119:exon20:c.G2503T:p.D835Y;FLT3:NM_004119:exon20:c.G2503T:p.D835Y	clinvar: Pathogenic|Pathogenic,Pathogenic,Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	7.508	34	0.001	5.84	13	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	FLT3:uc001urw.3:exon20:c.G2503T:p.D835Y;FLT3:uc001urw.3:exon20:c.G2503T:p.D835Y	0.312	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	AML
13	28592642	28592642	C	G	FLT3	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000122025	rs121913488	ENSG00000122025:ENST00000241453:exon20:c.G2503C:p.D835H,ENSG00000122025:ENST00000380982:exon20:c.G2503C:p.D835H;ENSG00000122025:ENST00000241453:exon20:c.G2503C:p.D835H,ENSG00000122025:ENST00000380982:exon20:c.G2503C:p.D835H	FLT3:NM_004119:exon20:c.G2503C:p.D835H;FLT3:NM_004119:exon20:c.G2503C:p.D835H	clinvar: Pathogenic|Pathogenic,Pathogenic,Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	6.967	33	0.015	5.84	13	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	FLT3:uc001urw.3:exon20:c.G2503C:p.D835H;FLT3:uc001urw.3:exon20:c.G2503C:p.D835H	0.374	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	AML
13	28592642	28592642	C	A	FLT3	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000122025	rs121913488	ENSG00000122025:ENST00000241453:exon20:c.G2503T:p.D835Y,ENSG00000122025:ENST00000380982:exon20:c.G2503T:p.D835Y;ENSG00000122025:ENST00000241453:exon20:c.G2503T:p.D835Y,ENSG00000122025:ENST00000380982:exon20:c.G2503T:p.D835Y	FLT3:NM_004119:exon20:c.G2503T:p.D835Y;FLT3:NM_004119:exon20:c.G2503T:p.D835Y	clinvar: Pathogenic|Pathogenic,Pathogenic,Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	7.508	34	0.001	5.84	13	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	FLT3:uc001urw.3:exon20:c.G2503T:p.D835Y;FLT3:uc001urw.3:exon20:c.G2503T:p.D835Y	0.312	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	AML
13	28592642	28592642	C	G	FLT3	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000122025	rs121913488	ENSG00000122025:ENST00000241453:exon20:c.G2503C:p.D835H,ENSG00000122025:ENST00000380982:exon20:c.G2503C:p.D835H;ENSG00000122025:ENST00000241453:exon20:c.G2503C:p.D835H,ENSG00000122025:ENST00000380982:exon20:c.G2503C:p.D835H	FLT3:NM_004119:exon20:c.G2503C:p.D835H;FLT3:NM_004119:exon20:c.G2503C:p.D835H	clinvar: Pathogenic|Pathogenic,Pathogenic,Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	6.967	33	0.015	5.84	13	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	FLT3:uc001urw.3:exon20:c.G2503C:p.D835H;FLT3:uc001urw.3:exon20:c.G2503C:p.D835H	0.374	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	AML
13	28624294	28624294	G	A	FLT3	exonic	nonsynonymous SNV	ENSG00000122025	rs1933437	ENSG00000122025:ENST00000241453:exon6:c.C680T:p.T227M,ENSG00000122025:ENST00000380982:exon6:c.C680T:p.T227M,ENSG00000122025:ENST00000380987:exon6:c.C680T:p.T227M,ENSG00000122025:ENST00000537084:exon6:c.C680T:p.T227M	FLT3:NM_004119:exon6:c.C680T:p.T227M	clinvar: not provided 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 0, 0, 1, 1, 2, None] 	0.5988	0.5229	0.558706	4.144	23.8	0.042	3.85	13	.	.	.	FLT3:uc001urw.3:exon6:c.C680T:p.T227M,FLT3:uc010tdn.2:exon6:c.C680T:p.T227M	-0.903	AFR:0.3338,AMR:0.6219,EAS:0.7669,FIN:0.5893,NFE:0.6048,OTH:0.6090,SAS:0.6402	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	R
13	32968854	32968854	C	A	BRCA2	exonic	nonsynonymous SNV	ENSG00000139618	.	ENSG00000139618:ENST00000380152:exon25:c.C9285A:p.D3095E,ENSG00000139618:ENST00000544455:exon25:c.C9285A:p.D3095E	BRCA2:NM_000059:exon25:c.C9285A:p.D3095E	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	5.158	25.4	0.0	3.53	13	.	.	BRCA2, oligonucleotide/oligosaccharide-binding 3;Nucleic acid-binding, OB-fold	BRCA2:uc001uub.1:exon25:c.C9285A:p.D3095E	0.663	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
13	49033946	49033947	-	A	.	.	.	.	.	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	13	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	.	.	.	.	Estrogen-receptor Positive Breast Cancer
14	105243048	105243048	G	T	AKT1	exonic	nonsynonymous SNV	ENSG00000142208	.	ENSG00000142208:ENST00000544168:exon2:c.C49A:p.Q17K,ENSG00000142208:ENST00000554581:exon3:c.C235A:p.Q79K,ENSG00000142208:ENST00000555380:exon3:c.C49A:p.Q17K,ENSG00000142208:ENST00000402615:exon4:c.C235A:p.Q79K,ENSG00000142208:ENST00000407796:exon4:c.C235A:p.Q79K,ENSG00000142208:ENST00000554848:exon4:c.C235A:p.Q79K,ENSG00000142208:ENST00000555528:exon4:c.C235A:p.Q79K,ENSG00000142208:ENST00000349310:exon5:c.C235A:p.Q79K,ENSG00000142208:ENST00000555926:exon5:c.C235A:p.Q79K	AKT1:NM_001014431:exon4:c.C235A:p.Q79K,AKT1:NM_005163:exon4:c.C235A:p.Q79K,AKT1:NM_001014432:exon5:c.C235A:p.Q79K	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	4.997	25.1	0.023	4.55	14	.	.	Pleckstrin homology domain;Pleckstrin homology-like domain	AKT1:uc010tyk.2:exon2:c.C49A:p.Q17K,AKT1:uc001ypl.3:exon3:c.C235A:p.Q79K,AKT1:uc001ypk.3:exon4:c.C235A:p.Q79K,AKT1:uc001ypn.3:exon4:c.C235A:p.Q79K,AKT1:uc010axa.3:exon4:c.C235A:p.Q79K,AKT1:uc001ypm.3:exon5:c.C235A:p.Q79K	0.177	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164730	114480;114500;167000;176920;181500;615109;	201;744;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~744|Partial gigantism-nevi-hemihypertrophy-macrocephaly syndrome|<1 / 1 000 000|Not applicable|Infancy|176920 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	M
14	105246551	105246551	C	T	AKT1	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000142208	rs121434592	ENSG00000142208:ENST00000554581:exon2:c.G49A:p.E17K,ENSG00000142208:ENST00000402615:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000407796:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000554848:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000555528:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000349310:exon4:c.G49A:p.E17K,ENSG00000142208:ENST00000555926:exon4:c.G49A:p.E17K;ENSG00000142208:ENST00000554581:exon2:c.G49A:p.E17K,ENSG00000142208:ENST00000402615:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000407796:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000554848:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000555528:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000349310:exon4:c.G49A:p.E17K,ENSG00000142208:ENST00000555926:exon4:c.G49A:p.E17K	AKT1:NM_001014431:exon3:c.G49A:p.E17K,AKT1:NM_005163:exon3:c.G49A:p.E17K,AKT1:NM_001014432:exon4:c.G49A:p.E17K;AKT1:NM_001014431:exon3:c.G49A:p.E17K,AKT1:NM_005163:exon3:c.G49A:p.E17K,AKT1:NM_001014432:exon4:c.G49A:p.E17K	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.427e-06	.	.	6.534	31	0.01	4.61	14	.	.	Pleckstrin homology domain;Pleckstrin homology-like domain	AKT1:uc001ypl.3:exon2:c.G49A:p.E17K,AKT1:uc001ypk.3:exon3:c.G49A:p.E17K,AKT1:uc001ypn.3:exon3:c.G49A:p.E17K,AKT1:uc010axa.3:exon3:c.G49A:p.E17K,AKT1:uc001ypm.3:exon4:c.G49A:p.E17K;AKT1:uc001ypl.3:exon2:c.G49A:p.E17K,AKT1:uc001ypk.3:exon3:c.G49A:p.E17K,AKT1:uc001ypn.3:exon3:c.G49A:p.E17K,AKT1:uc010axa.3:exon3:c.G49A:p.E17K,AKT1:uc001ypm.3:exon4:c.G49A:p.E17K	-0.641	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.535e-05,OTH:0,SAS:0	164730	114480;114500;167000;176920;181500;615109;	201;744;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~744|Partial gigantism-nevi-hemihypertrophy-macrocephaly syndrome|<1 / 1 000 000|Not applicable|Infancy|176920 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
14	105246551	105246551	C	T	AKT1	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000142208	rs121434592	ENSG00000142208:ENST00000554581:exon2:c.G49A:p.E17K,ENSG00000142208:ENST00000402615:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000407796:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000554848:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000555528:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000349310:exon4:c.G49A:p.E17K,ENSG00000142208:ENST00000555926:exon4:c.G49A:p.E17K;ENSG00000142208:ENST00000554581:exon2:c.G49A:p.E17K,ENSG00000142208:ENST00000402615:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000407796:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000554848:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000555528:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000349310:exon4:c.G49A:p.E17K,ENSG00000142208:ENST00000555926:exon4:c.G49A:p.E17K	AKT1:NM_001014431:exon3:c.G49A:p.E17K,AKT1:NM_005163:exon3:c.G49A:p.E17K,AKT1:NM_001014432:exon4:c.G49A:p.E17K;AKT1:NM_001014431:exon3:c.G49A:p.E17K,AKT1:NM_005163:exon3:c.G49A:p.E17K,AKT1:NM_001014432:exon4:c.G49A:p.E17K	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.427e-06	.	.	6.534	31	0.01	4.61	14	.	.	Pleckstrin homology domain;Pleckstrin homology-like domain	AKT1:uc001ypl.3:exon2:c.G49A:p.E17K,AKT1:uc001ypk.3:exon3:c.G49A:p.E17K,AKT1:uc001ypn.3:exon3:c.G49A:p.E17K,AKT1:uc010axa.3:exon3:c.G49A:p.E17K,AKT1:uc001ypm.3:exon4:c.G49A:p.E17K;AKT1:uc001ypl.3:exon2:c.G49A:p.E17K,AKT1:uc001ypk.3:exon3:c.G49A:p.E17K,AKT1:uc001ypn.3:exon3:c.G49A:p.E17K,AKT1:uc010axa.3:exon3:c.G49A:p.E17K,AKT1:uc001ypm.3:exon4:c.G49A:p.E17K	-0.641	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.535e-05,OTH:0,SAS:0	164730	114480;114500;167000;176920;181500;615109;	201;744;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~744|Partial gigantism-nevi-hemihypertrophy-macrocephaly syndrome|<1 / 1 000 000|Not applicable|Infancy|176920 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	M
14	62213848	62213848	T	C	HIF1A-AS2	ncRNA_exonic	.	ENSG00000258667,ENSG00000258964	rs2057482	.	.	clinvar: UNK 	 CancerVar: Benign/Likely benign EVS=[0, None, None, 0, None, None, 0, 0, 0, 0, 0, None] 	0.8289	0.7862	0.757588	.	.	.	.	14	.	.	.	.	.	AFR:0.6626,AMR:0.8968,EAS:0.8056,FIN:0.9310,NFE:0.8546,OTH:0.8184,SAS:0.7377	614529	.	.	.	PA
14	65453063	65453063	G	C	CHURC1-FNTB	intronic	.	ENSG00000125954,ENSG00000257365	rs11623866	.	.	clinvar: UNK 	 CancerVar: Benign/Likely benign EVS=[0, None, None, 0, None, None, 0, 0, 0, 0, 0, None] 	.	.	0.376597	.	.	.	.	14	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	.	.	.	.	OV-PR
15	66727451	66727451	A	C	MAP2K1	exonic	nonsynonymous SNV	ENSG00000169032	.	ENSG00000169032:ENST00000307102:exon2:c.A167C:p.Q56P	MAP2K1:NM_002755:exon2:c.A167C:p.Q56P	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	5.184	25.5	0.013	5.07	15	.	.	.	MAP2K1:uc010bhq.3:exon2:c.A167C:p.Q56P,MAP2K1:uc010ujp.2:exon2:c.A101C:p.Q34P	0.940	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	176872	615279;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	M
15	66729154	66729154	G	C	MAP2K1	exonic	nonsynonymous SNV	ENSG00000169032	.	ENSG00000169032:ENST00000307102:exon3:c.G362C:p.C121S	MAP2K1:NM_002755:exon3:c.G362C:p.C121S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.080	28.2	0.001	5.15	15	.	.	Protein kinase domain;Protein kinase-like domain;Serine/threonine/dual specificity protein kinase, catalytic  domain	MAP2K1:uc010bhq.3:exon3:c.G362C:p.C121S,MAP2K1:uc010ujp.2:exon3:c.G296C:p.C99S	-0.531	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	176872	615279;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	M
15	66729162	66729162	C	T	MAP2K1	exonic	nonsynonymous SNV	ENSG00000169032	.	ENSG00000169032:ENST00000307102:exon3:c.C370T:p.P124S	MAP2K1:NM_002755:exon3:c.C370T:p.P124S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.548	31	0.029	5.15	15	.	.	Protein kinase domain;Protein kinase-like domain;Serine/threonine/dual specificity protein kinase, catalytic  domain	MAP2K1:uc010bhq.3:exon3:c.C370T:p.P124S,MAP2K1:uc010ujp.2:exon3:c.C304T:p.P102S	0.076	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	176872	615279;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	M
15	74315213	74315213	C	T	PML	exonic	nonsynonymous SNV	ENSG00000140464	.	ENSG00000140464:ENST00000268058:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000268059:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000354026:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000359928:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000395132:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000395135:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000435786:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000436891:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000563500:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000564428:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000565898:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000567543:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000569477:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000569965:exon3:c.C647T:p.A216V	PML:NM_002675:exon3:c.C647T:p.A216V,PML:NM_033238:exon3:c.C647T:p.A216V,PML:NM_033239:exon3:c.C647T:p.A216V,PML:NM_033240:exon3:c.C647T:p.A216V,PML:NM_033244:exon3:c.C647T:p.A216V,PML:NM_033246:exon3:c.C647T:p.A216V,PML:NM_033247:exon3:c.C647T:p.A216V,PML:NM_033249:exon3:c.C647T:p.A216V,PML:NM_033250:exon3:c.C647T:p.A216V	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 1, 2, None] 	.	.	.	5.140	25.4	0.62	4.82	15	.	.	Zinc finger, B-box	PML:uc002aww.1:exon2:c.C392T:p.A131V,PML:uc002awj.1:exon3:c.C647T:p.A216V,PML:uc002awk.3:exon3:c.C647T:p.A216V,PML:uc002awl.3:exon3:c.C647T:p.A216V,PML:uc002awm.3:exon3:c.C647T:p.A216V,PML:uc002awn.3:exon3:c.C647T:p.A216V,PML:uc002awo.3:exon3:c.C647T:p.A216V,PML:uc002awp.3:exon3:c.C647T:p.A216V,PML:uc002awq.3:exon3:c.C647T:p.A216V,PML:uc002awr.3:exon3:c.C647T:p.A216V,PML:uc002aws.3:exon3:c.C647T:p.A216V,PML:uc002awt.3:exon3:c.C647T:p.A216V,PML:uc002awu.3:exon3:c.C647T:p.A216V,PML:uc002awv.3:exon3:c.C647T:p.A216V	-0.746	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	102578	.	.	.	APML
15	74315219	74315219	T	C	PML	exonic	nonsynonymous SNV	ENSG00000140464	.	ENSG00000140464:ENST00000268058:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000268059:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000354026:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000359928:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000395132:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000395135:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000435786:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000436891:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000563500:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000564428:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000565898:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000567543:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000569477:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000569965:exon3:c.T653C:p.L218P	PML:NM_002675:exon3:c.T653C:p.L218P,PML:NM_033238:exon3:c.T653C:p.L218P,PML:NM_033239:exon3:c.T653C:p.L218P,PML:NM_033240:exon3:c.T653C:p.L218P,PML:NM_033244:exon3:c.T653C:p.L218P,PML:NM_033246:exon3:c.T653C:p.L218P,PML:NM_033247:exon3:c.T653C:p.L218P,PML:NM_033249:exon3:c.T653C:p.L218P,PML:NM_033250:exon3:c.T653C:p.L218P	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	5.146	25.4	0.007	4.82	15	.	.	Zinc finger, B-box	PML:uc002aww.1:exon2:c.T398C:p.L133P,PML:uc002awj.1:exon3:c.T653C:p.L218P,PML:uc002awk.3:exon3:c.T653C:p.L218P,PML:uc002awl.3:exon3:c.T653C:p.L218P,PML:uc002awm.3:exon3:c.T653C:p.L218P,PML:uc002awn.3:exon3:c.T653C:p.L218P,PML:uc002awo.3:exon3:c.T653C:p.L218P,PML:uc002awp.3:exon3:c.T653C:p.L218P,PML:uc002awq.3:exon3:c.T653C:p.L218P,PML:uc002awr.3:exon3:c.T653C:p.L218P,PML:uc002aws.3:exon3:c.T653C:p.L218P,PML:uc002awt.3:exon3:c.T653C:p.L218P,PML:uc002awu.3:exon3:c.T653C:p.L218P,PML:uc002awv.3:exon3:c.T653C:p.L218P	-0.647	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	102578	.	.	.	APML
15	88476265	88476265	C	T	NTRK3	exonic	nonsynonymous SNV	ENSG00000140538	.	ENSG00000140538:ENST00000557856:exon13:c.G1843A:p.G615R,ENSG00000140538:ENST00000558676:exon13:c.G1843A:p.G615R,ENSG00000140538:ENST00000357724:exon14:c.G1843A:p.G615R,ENSG00000140538:ENST00000542733:exon14:c.G1573A:p.G525R,ENSG00000140538:ENST00000355254:exon15:c.G1867A:p.G623R,ENSG00000140538:ENST00000360948:exon15:c.G1867A:p.G623R,ENSG00000140538:ENST00000394480:exon16:c.G1867A:p.G623R	NTRK3:NM_001243101:exon15:c.G1843A:p.G615R,NTRK3:NM_001012338:exon16:c.G1867A:p.G623R,NTRK3:NM_002530:exon16:c.G1867A:p.G623R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	6.811	32	0.0	5.49	15	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	NTRK3:uc002bmh.2:exon13:c.G1843A:p.G615R,NTRK3:uc010bnh.1:exon13:c.G1843A:p.G615R,NTRK3:uc010upl.1:exon14:c.G1573A:p.G525R,NTRK3:uc021sua.1:exon15:c.G1843A:p.G615R,NTRK3:uc002bme.2:exon16:c.G1867A:p.G623R,NTRK3:uc002bmf.2:exon16:c.G1867A:p.G623R	0.954	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	191316	.	.	.	BRACA
15	90631838	90631838	C	T	IDH2	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000182054	rs121913503	ENSG00000182054:ENST00000539790:exon2:c.G125A:p.R42K,ENSG00000182054:ENST00000330062:exon4:c.G515A:p.R172K,ENSG00000182054:ENST00000540499:exon4:c.G359A:p.R120K;ENSG00000182054:ENST00000539790:exon2:c.G125A:p.R42K,ENSG00000182054:ENST00000330062:exon4:c.G515A:p.R172K,ENSG00000182054:ENST00000540499:exon4:c.G359A:p.R120K	IDH2:NM_001290114:exon2:c.G125A:p.R42K,IDH2:NM_001289910:exon4:c.G359A:p.R120K,IDH2:NM_002168:exon4:c.G515A:p.R172K;IDH2:NM_001290114:exon2:c.G125A:p.R42K,IDH2:NM_001289910:exon4:c.G359A:p.R120K,IDH2:NM_002168:exon4:c.G515A:p.R172K	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 0, None] 	.	.	.	4.687	24.6	0.001	4.07	15	.	.	Isopropylmalate dehydrogenase-like domain	IDH2:uc010uqc.2:exon2:c.G125A:p.R42K,IDH2:uc002box.3:exon4:c.G515A:p.R172K,IDH2:uc010uqb.2:exon4:c.G359A:p.R120K;IDH2:uc010uqc.2:exon2:c.G125A:p.R42K,IDH2:uc002box.3:exon4:c.G515A:p.R172K,IDH2:uc010uqb.2:exon4:c.G359A:p.R120K	0.823	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	147650	613657;	79315;	79315|D-2-HGA<br>D-2-hydroxyglutaric acidemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Infancy<br>Childhood|600721 613657 ~	AML
15	90631838	90631838	C	T	IDH2	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000182054	rs121913503	ENSG00000182054:ENST00000539790:exon2:c.G125A:p.R42K,ENSG00000182054:ENST00000330062:exon4:c.G515A:p.R172K,ENSG00000182054:ENST00000540499:exon4:c.G359A:p.R120K;ENSG00000182054:ENST00000539790:exon2:c.G125A:p.R42K,ENSG00000182054:ENST00000330062:exon4:c.G515A:p.R172K,ENSG00000182054:ENST00000540499:exon4:c.G359A:p.R120K	IDH2:NM_001290114:exon2:c.G125A:p.R42K,IDH2:NM_001289910:exon4:c.G359A:p.R120K,IDH2:NM_002168:exon4:c.G515A:p.R172K;IDH2:NM_001290114:exon2:c.G125A:p.R42K,IDH2:NM_001289910:exon4:c.G359A:p.R120K,IDH2:NM_002168:exon4:c.G515A:p.R172K	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 0, None] 	.	.	.	4.687	24.6	0.001	4.07	15	.	.	Isopropylmalate dehydrogenase-like domain	IDH2:uc010uqc.2:exon2:c.G125A:p.R42K,IDH2:uc002box.3:exon4:c.G515A:p.R172K,IDH2:uc010uqb.2:exon4:c.G359A:p.R120K;IDH2:uc010uqc.2:exon2:c.G125A:p.R42K,IDH2:uc002box.3:exon4:c.G515A:p.R172K,IDH2:uc010uqb.2:exon4:c.G359A:p.R120K	0.823	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	147650	613657;	79315;	79315|D-2-HGA<br>D-2-hydroxyglutaric acidemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Infancy<br>Childhood|600721 613657 ~	MDS
15	90631934	90631934	C	-	IDH2	exonic;exonic	frameshift deletion;frameshift deletion	ENSG00000182054	.	ENSG00000182054:ENST00000539790:exon2:c.29delG:p.R10fs,ENSG00000182054:ENST00000330062:exon4:c.419delG:p.R140fs,ENSG00000182054:ENST00000540499:exon4:c.263delG:p.R88fs;ENSG00000182054:ENST00000539790:exon2:c.29delG:p.R10fs,ENSG00000182054:ENST00000330062:exon4:c.419delG:p.R140fs,ENSG00000182054:ENST00000540499:exon4:c.263delG:p.R88fs	IDH2:NM_001290114:exon2:c.29delG:p.R10fs,IDH2:NM_001289910:exon4:c.263delG:p.R88fs,IDH2:NM_002168:exon4:c.419delG:p.R140fs;IDH2:NM_001290114:exon2:c.29delG:p.R10fs,IDH2:NM_001289910:exon4:c.263delG:p.R88fs,IDH2:NM_002168:exon4:c.419delG:p.R140fs	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	15	.	.	.	IDH2:uc010uqc.2:exon2:c.29delG:p.R10fs,IDH2:uc002box.3:exon4:c.419delG:p.R140fs,IDH2:uc010uqb.2:exon4:c.263delG:p.R88fs;IDH2:uc010uqc.2:exon2:c.29delG:p.R10fs,IDH2:uc002box.3:exon4:c.419delG:p.R140fs,IDH2:uc010uqb.2:exon4:c.263delG:p.R88fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	147650	613657;	79315;	79315|D-2-HGA<br>D-2-hydroxyglutaric acidemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Infancy<br>Childhood|600721 613657 ~	AML
15	90631934	90631934	C	-	IDH2	exonic;exonic	frameshift deletion;frameshift deletion	ENSG00000182054	.	ENSG00000182054:ENST00000539790:exon2:c.29delG:p.R10fs,ENSG00000182054:ENST00000330062:exon4:c.419delG:p.R140fs,ENSG00000182054:ENST00000540499:exon4:c.263delG:p.R88fs;ENSG00000182054:ENST00000539790:exon2:c.29delG:p.R10fs,ENSG00000182054:ENST00000330062:exon4:c.419delG:p.R140fs,ENSG00000182054:ENST00000540499:exon4:c.263delG:p.R88fs	IDH2:NM_001290114:exon2:c.29delG:p.R10fs,IDH2:NM_001289910:exon4:c.263delG:p.R88fs,IDH2:NM_002168:exon4:c.419delG:p.R140fs;IDH2:NM_001290114:exon2:c.29delG:p.R10fs,IDH2:NM_001289910:exon4:c.263delG:p.R88fs,IDH2:NM_002168:exon4:c.419delG:p.R140fs	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	15	.	.	.	IDH2:uc010uqc.2:exon2:c.29delG:p.R10fs,IDH2:uc002box.3:exon4:c.419delG:p.R140fs,IDH2:uc010uqb.2:exon4:c.263delG:p.R88fs;IDH2:uc010uqc.2:exon2:c.29delG:p.R10fs,IDH2:uc002box.3:exon4:c.419delG:p.R140fs,IDH2:uc010uqb.2:exon4:c.263delG:p.R88fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	147650	613657;	79315;	79315|D-2-HGA<br>D-2-hydroxyglutaric acidemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Infancy<br>Childhood|600721 613657 ~	MDS
16	2130300	2130300	C	T	TSC2	exonic	stopgain	ENSG00000103197	rs45517297	ENSG00000103197:ENST00000382538:exon28:c.C3256T:p.Q1086X,ENSG00000103197:ENST00000439673:exon28:c.C3292T:p.Q1098X,ENSG00000103197:ENST00000353929:exon29:c.C3403T:p.Q1135X,ENSG00000103197:ENST00000401874:exon29:c.C3400T:p.Q1134X,ENSG00000103197:ENST00000568454:exon29:c.C3433T:p.Q1145X,ENSG00000103197:ENST00000219476:exon30:c.C3532T:p.Q1178X,ENSG00000103197:ENST00000350773:exon30:c.C3532T:p.Q1178X	TSC2:NM_001077183:exon29:c.C3400T:p.Q1134X,TSC2:NM_000548:exon30:c.C3532T:p.Q1178X,TSC2:NM_001114382:exon30:c.C3532T:p.Q1178X	clinvar: Uncertain significance,not provided 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	8.977	35	.	1.33	16	.	.	.	TSC2:uc002cop.3:exon26:c.C2800T:p.Q934X,TSC2:uc010uvv.2:exon28:c.C3292T:p.Q1098X,TSC2:uc010uvw.2:exon28:c.C3256T:p.Q1086X,TSC2:uc002coo.3:exon29:c.C3400T:p.Q1134X,TSC2:uc002con.3:exon30:c.C3532T:p.Q1178X,TSC2:uc010bsd.3:exon30:c.C3532T:p.Q1178X	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	191092	606690;613254;	805;538;	805|Bourneville syndrome<br>Tuberous sclerosis|1-5 / 10 000|Autosomal dominant|All ages|191100 613254 ~538|LAM|1-9 / 1 000 000|Not applicable|Adult|606690 ~	THCA
16	23646276	23646276	A	-	PALB2	exonic	frameshift deletion	ENSG00000083093	.	ENSG00000083093:ENST00000261584:exon4:c.1591delT:p.L531fs	PALB2:NM_024675:exon4:c.1591delT:p.L531fs	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	16	.	.	.	PALB2:uc002dlx.1:exon4:c.1591delT:p.L531fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	610355	114480;610832;613348;	1333;84;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
1	65321333	65321333	G	A	JAK1	exonic	stopgain	ENSG00000162434	.	ENSG00000162434:ENST00000342505:exon11:c.C1507T:p.Q503X	JAK1:NM_002227:exon11:c.C1507T:p.Q503X	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 0, 1, None] 	.	.	.	11.881	38	.	3.54	1	.	.	SH2 domain	JAK1:uc001dbu.1:exon11:c.C1507T:p.Q503X,JAK1:uc009wam.1:exon12:c.C1507T:p.Q503X	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	147795	.	.	.	Skin Melanoma
16	69745145	69745145	G	A	NQO1	exonic	nonsynonymous SNV	ENSG00000181019	rs1800566	ENSG00000181019:ENST00000439109:exon4:c.C343T:p.P115S,ENSG00000181019:ENST00000379046:exon5:c.C445T:p.P149S,ENSG00000181019:ENST00000379047:exon5:c.C457T:p.P153S,ENSG00000181019:ENST00000561500:exon5:c.C445T:p.P149S,ENSG00000181019:ENST00000320623:exon6:c.C559T:p.P187S,ENSG00000181019:ENST00000564043:exon6:c.C496T:p.P166S	NQO1:NM_001286137:exon4:c.C343T:p.P115S,NQO1:NM_001025433:exon5:c.C457T:p.P153S,NQO1:NM_001025434:exon5:c.C445T:p.P149S,NQO1:NM_000903:exon6:c.C559T:p.P187S	clinvar: other|other|Pathogenic|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 2, 1, 1, 0, None] 	0.2452	0.1974	0.288938	6.611	32	0.176	5.41	16	.	.	Flavodoxin-like fold;Flavoprotein-like	NQO1:uc010vll.2:exon4:c.C343T:p.P115S,NQO1:uc002exq.3:exon5:c.C457T:p.P153S,NQO1:uc002exr.3:exon5:c.C445T:p.P149S,NQO1:uc002exp.3:exon6:c.C559T:p.P187S	-0.903	AFR:0.1919,AMR:0.4056,EAS:0.4502,FIN:0.1834,NFE:0.1880,OTH:0.2124,SAS:0.3163	125860	.	.	.	L
17	33433425	33433425	G	A	RAD51D	exonic	stopgain	ENSG00000185379,ENSG00000267618	rs387906843	ENSG00000185379:ENST00000590631:exon2:c.C25T:p.R9X,ENSG00000267618:ENST00000593039:exon2:c.C79T:p.R27X,ENSG00000185379:ENST00000335858:exon3:c.C220T:p.R74X,ENSG00000267618:ENST00000591723:exon3:c.C25T:p.R9X,ENSG00000185379:ENST00000587405:exon4:c.C199T:p.R67X,ENSG00000185379:ENST00000588372:exon4:c.C199T:p.R67X,ENSG00000185379:ENST00000360276:exon5:c.C421T:p.R141X,ENSG00000185379:ENST00000460118:exon5:c.C199T:p.R67X,ENSG00000267618:ENST00000592181:exon5:c.C199T:p.R67X,ENSG00000185379:ENST00000345365:exon6:c.C556T:p.R186X,ENSG00000185379:ENST00000590016:exon6:c.C616T:p.R206X,ENSG00000185379:ENST00000592577:exon6:c.C562T:p.R188X,ENSG00000185379:ENST00000394589:exon7:c.C556T:p.R186X	RAD51D:NM_133629:exon3:c.C220T:p.R74X,RAD51D:NM_001142571:exon6:c.C616T:p.R206X,RAD51D:NM_002878:exon6:c.C556T:p.R186X	clinvar: other|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 0, 0, 0, None] 	5.276e-05	.	.	12.383	39	.	3.98	17	.	.	AAA+ ATPase domain;DNA recombination and repair protein Rad51, C-terminal;DNA recombination and repair protein RecA-like, ATP-binding domain;P-loop containing nucleoside triphosphate hydrolase	RAD51L3-RFFL:uc002hiq.2:exon2:c.C79T:p.R27X,RAD51D:uc002his.2:exon3:c.C220T:p.R74X,RAD51D:uc002hiu.2:exon4:c.C25T:p.R9X,RAD51D:uc002hit.2:exon5:c.C199T:p.R67X,RAD51D:uc010ctk.2:exon5:c.C199T:p.R67X,RAD51D:uc002hir.2:exon6:c.C556T:p.R186X,RAD51D:uc010wcd.1:exon6:c.C616T:p.R206X,RAD51D:uc010wce.1:exon6:c.C199T:p.R67X	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:9.562e-05,OTH:0,SAS:0	602954	614291;	145;	145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~	BRACA
17	37868205	37868205	G	C	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	.	ENSG00000141736:ENST00000445658:exon2:c.G98C:p.G33A,ENSG00000141736:ENST00000582648:exon3:c.G250C:p.D84H,ENSG00000141736:ENST00000269571:exon8:c.G926C:p.G309A,ENSG00000141736:ENST00000540042:exon8:c.G836C:p.G279A,ENSG00000141736:ENST00000540147:exon8:c.G836C:p.G279A,ENSG00000141736:ENST00000541774:exon8:c.G881C:p.G294A,ENSG00000141736:ENST00000584450:exon8:c.G926C:p.G309A,ENSG00000141736:ENST00000406381:exon10:c.G836C:p.G279A,ENSG00000141736:ENST00000578199:exon11:c.G836C:p.G279A,ENSG00000141736:ENST00000584601:exon12:c.G836C:p.G279A	ERBB2:NM_001289937:exon8:c.G926C:p.G309A,ERBB2:NM_004448:exon8:c.G926C:p.G309A,ERBB2:NM_001005862:exon11:c.G836C:p.G279A,ERBB2:NM_001289938:exon11:c.G836C:p.G279A,ERBB2:NM_001289936:exon12:c.G881C:p.G294A	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	3.375	22.9	0.03	5.83	17	.	.	Furin-like cysteine-rich domain;Insulin-like growth factor binding protein, N-terminal	ERBB2:uc010wek.2:exon2:c.G98C:p.G33A,ERBB2:uc002hsn.1:exon8:c.G926C:p.G309A,ERBB2:uc002hso.3:exon8:c.G926C:p.G309A,ERBB2:uc002hsp.3:exon8:c.G335C:p.G112A,ERBB2:uc010cwb.3:exon8:c.G926C:p.G309A,ERBB2:uc002hsl.3:exon11:c.G836C:p.G279A,ERBB2:uc002hsm.3:exon11:c.G836C:p.G279A,ERBB2:uc010cwa.3:exon12:c.G881C:p.G294A	-0.120	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	BRACA
17	37868208	37868208	C	T	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	.	ENSG00000141736:ENST00000445658:exon2:c.C101T:p.S34F,ENSG00000141736:ENST00000582648:exon3:c.C253T:p.P85S,ENSG00000141736:ENST00000269571:exon8:c.C929T:p.S310F,ENSG00000141736:ENST00000540042:exon8:c.C839T:p.S280F,ENSG00000141736:ENST00000540147:exon8:c.C839T:p.S280F,ENSG00000141736:ENST00000541774:exon8:c.C884T:p.S295F,ENSG00000141736:ENST00000584450:exon8:c.C929T:p.S310F,ENSG00000141736:ENST00000406381:exon10:c.C839T:p.S280F,ENSG00000141736:ENST00000578199:exon11:c.C839T:p.S280F,ENSG00000141736:ENST00000584601:exon12:c.C839T:p.S280F	ERBB2:NM_001289937:exon8:c.C929T:p.S310F,ERBB2:NM_004448:exon8:c.C929T:p.S310F,ERBB2:NM_001005862:exon11:c.C839T:p.S280F,ERBB2:NM_001289938:exon11:c.C839T:p.S280F,ERBB2:NM_001289936:exon12:c.C884T:p.S295F	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.634	32	0.026	5.83	17	.	.	Furin-like cysteine-rich domain;Insulin-like growth factor binding protein, N-terminal	ERBB2:uc010wek.2:exon2:c.C101T:p.S34F,ERBB2:uc002hsn.1:exon8:c.C929T:p.S310F,ERBB2:uc002hso.3:exon8:c.C929T:p.S310F,ERBB2:uc002hsp.3:exon8:c.C338T:p.S113F,ERBB2:uc010cwb.3:exon8:c.C929T:p.S310F,ERBB2:uc002hsl.3:exon11:c.C839T:p.S280F,ERBB2:uc002hsm.3:exon11:c.C839T:p.S280F,ERBB2:uc010cwa.3:exon12:c.C884T:p.S295F	-0.180	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	COC-PR
17	37879658	37879658	G	A	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	.	ENSG00000141736:ENST00000445658:exon11:c.G1205A:p.R402Q,ENSG00000141736:ENST00000269571:exon17:c.G2033A:p.R678Q,ENSG00000141736:ENST00000540147:exon17:c.G1943A:p.R648Q,ENSG00000141736:ENST00000541774:exon17:c.G1988A:p.R663Q,ENSG00000141736:ENST00000584450:exon17:c.G2033A:p.R678Q,ENSG00000141736:ENST00000406381:exon19:c.G1943A:p.R648Q,ENSG00000141736:ENST00000584601:exon21:c.G1943A:p.R648Q	ERBB2:NM_001289937:exon17:c.G2033A:p.R678Q,ERBB2:NM_004448:exon17:c.G2033A:p.R678Q,ERBB2:NM_001005862:exon20:c.G1943A:p.R648Q,ERBB2:NM_001289936:exon21:c.G1988A:p.R663Q	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 1, 2, None] 	.	.	.	4.666	24.5	0.103	4.97	17	.	.	.	ERBB2:uc010wek.2:exon11:c.G1205A:p.R402Q,ERBB2:uc002hso.3:exon17:c.G2033A:p.R678Q,ERBB2:uc002hsp.3:exon17:c.G1442A:p.R481Q,ERBB2:uc010cwb.3:exon17:c.G2033A:p.R678Q,ERBB2:uc002hsm.3:exon20:c.G1943A:p.R648Q,ERBB2:uc010cwa.3:exon21:c.G1988A:p.R663Q	-0.403	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	BRACA
17	37880220	37880220	T	C	ERBB2	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141736	rs121913470	ENSG00000141736:ENST00000445658:exon13:c.T1436C:p.L479S,ENSG00000141736:ENST00000269571:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000540147:exon19:c.T2174C:p.L725S,ENSG00000141736:ENST00000541774:exon19:c.T2219C:p.L740S,ENSG00000141736:ENST00000584450:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000406381:exon21:c.T2174C:p.L725S,ENSG00000141736:ENST00000584601:exon23:c.T2174C:p.L725S;ENSG00000141736:ENST00000445658:exon13:c.T1436C:p.L479S,ENSG00000141736:ENST00000269571:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000540147:exon19:c.T2174C:p.L725S,ENSG00000141736:ENST00000541774:exon19:c.T2219C:p.L740S,ENSG00000141736:ENST00000584450:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000406381:exon21:c.T2174C:p.L725S,ENSG00000141736:ENST00000584601:exon23:c.T2174C:p.L725S	ERBB2:NM_001289937:exon19:c.T2264C:p.L755S,ERBB2:NM_004448:exon19:c.T2264C:p.L755S,ERBB2:NM_001005862:exon22:c.T2174C:p.L725S,ERBB2:NM_001289936:exon23:c.T2219C:p.L740S;ERBB2:NM_001289937:exon19:c.T2264C:p.L755S,ERBB2:NM_004448:exon19:c.T2264C:p.L755S,ERBB2:NM_001005862:exon22:c.T2174C:p.L725S,ERBB2:NM_001289936:exon23:c.T2219C:p.L740S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.490	30	0.0	5.18	17	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ERBB2:uc010wek.2:exon13:c.T1436C:p.L479S,ERBB2:uc002hso.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsp.3:exon19:c.T1673C:p.L558S,ERBB2:uc010cwb.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsm.3:exon22:c.T2174C:p.L725S,ERBB2:uc010cwa.3:exon23:c.T2219C:p.L740S;ERBB2:uc010wek.2:exon13:c.T1436C:p.L479S,ERBB2:uc002hso.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsp.3:exon19:c.T1673C:p.L558S,ERBB2:uc010cwb.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsm.3:exon22:c.T2174C:p.L725S,ERBB2:uc010cwa.3:exon23:c.T2219C:p.L740S	0.206	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	BRACA
17	37880220	37880220	T	C	ERBB2	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141736	rs121913470	ENSG00000141736:ENST00000445658:exon13:c.T1436C:p.L479S,ENSG00000141736:ENST00000269571:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000540147:exon19:c.T2174C:p.L725S,ENSG00000141736:ENST00000541774:exon19:c.T2219C:p.L740S,ENSG00000141736:ENST00000584450:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000406381:exon21:c.T2174C:p.L725S,ENSG00000141736:ENST00000584601:exon23:c.T2174C:p.L725S;ENSG00000141736:ENST00000445658:exon13:c.T1436C:p.L479S,ENSG00000141736:ENST00000269571:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000540147:exon19:c.T2174C:p.L725S,ENSG00000141736:ENST00000541774:exon19:c.T2219C:p.L740S,ENSG00000141736:ENST00000584450:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000406381:exon21:c.T2174C:p.L725S,ENSG00000141736:ENST00000584601:exon23:c.T2174C:p.L725S	ERBB2:NM_001289937:exon19:c.T2264C:p.L755S,ERBB2:NM_004448:exon19:c.T2264C:p.L755S,ERBB2:NM_001005862:exon22:c.T2174C:p.L725S,ERBB2:NM_001289936:exon23:c.T2219C:p.L740S;ERBB2:NM_001289937:exon19:c.T2264C:p.L755S,ERBB2:NM_004448:exon19:c.T2264C:p.L755S,ERBB2:NM_001005862:exon22:c.T2174C:p.L725S,ERBB2:NM_001289936:exon23:c.T2219C:p.L740S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.490	30	0.0	5.18	17	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ERBB2:uc010wek.2:exon13:c.T1436C:p.L479S,ERBB2:uc002hso.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsp.3:exon19:c.T1673C:p.L558S,ERBB2:uc010cwb.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsm.3:exon22:c.T2174C:p.L725S,ERBB2:uc010cwa.3:exon23:c.T2219C:p.L740S;ERBB2:uc010wek.2:exon13:c.T1436C:p.L479S,ERBB2:uc002hso.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsp.3:exon19:c.T1673C:p.L558S,ERBB2:uc010cwb.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsm.3:exon22:c.T2174C:p.L725S,ERBB2:uc010cwa.3:exon23:c.T2219C:p.L740S	0.206	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	COC-PR
17	37880220	37880220	T	G	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	.	ENSG00000141736:ENST00000445658:exon13:c.T1436G:p.L479W,ENSG00000141736:ENST00000269571:exon19:c.T2264G:p.L755W,ENSG00000141736:ENST00000540147:exon19:c.T2174G:p.L725W,ENSG00000141736:ENST00000541774:exon19:c.T2219G:p.L740W,ENSG00000141736:ENST00000584450:exon19:c.T2264G:p.L755W,ENSG00000141736:ENST00000406381:exon21:c.T2174G:p.L725W,ENSG00000141736:ENST00000584601:exon23:c.T2174G:p.L725W	ERBB2:NM_001289937:exon19:c.T2264G:p.L755W,ERBB2:NM_004448:exon19:c.T2264G:p.L755W,ERBB2:NM_001005862:exon22:c.T2174G:p.L725W,ERBB2:NM_001289936:exon23:c.T2219G:p.L740W	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.489	30	0.0	5.18	17	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ERBB2:uc010wek.2:exon13:c.T1436G:p.L479W,ERBB2:uc002hso.3:exon19:c.T2264G:p.L755W,ERBB2:uc002hsp.3:exon19:c.T1673G:p.L558W,ERBB2:uc010cwb.3:exon19:c.T2264G:p.L755W,ERBB2:uc002hsm.3:exon22:c.T2174G:p.L725W,ERBB2:uc010cwa.3:exon23:c.T2219G:p.L740W	0.469	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	BRACA
17	37880261	37880261	G	C	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	rs121913468	ENSG00000141736:ENST00000445658:exon13:c.G1477C:p.D493H,ENSG00000141736:ENST00000269571:exon19:c.G2305C:p.D769H,ENSG00000141736:ENST00000540147:exon19:c.G2215C:p.D739H,ENSG00000141736:ENST00000541774:exon19:c.G2260C:p.D754H,ENSG00000141736:ENST00000584450:exon19:c.G2305C:p.D769H,ENSG00000141736:ENST00000406381:exon21:c.G2215C:p.D739H,ENSG00000141736:ENST00000584601:exon23:c.G2215C:p.D739H	ERBB2:NM_001289937:exon19:c.G2305C:p.D769H,ERBB2:NM_004448:exon19:c.G2305C:p.D769H,ERBB2:NM_001005862:exon22:c.G2215C:p.D739H,ERBB2:NM_001289936:exon23:c.G2260C:p.D754H	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.838	33	0.001	5.02	17	0.7428	0.688	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ERBB2:uc010wek.2:exon13:c.G1477C:p.D493H,ERBB2:uc002hso.3:exon19:c.G2305C:p.D769H,ERBB2:uc002hsp.3:exon19:c.G1714C:p.D572H,ERBB2:uc010cwb.3:exon19:c.G2305C:p.D769H,ERBB2:uc002hsm.3:exon22:c.G2215C:p.D739H,ERBB2:uc010cwa.3:exon23:c.G2260C:p.D754H	0.262	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	BRACA
17	37880261	37880261	G	T	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	.	ENSG00000141736:ENST00000445658:exon13:c.G1477T:p.D493Y,ENSG00000141736:ENST00000269571:exon19:c.G2305T:p.D769Y,ENSG00000141736:ENST00000540147:exon19:c.G2215T:p.D739Y,ENSG00000141736:ENST00000541774:exon19:c.G2260T:p.D754Y,ENSG00000141736:ENST00000584450:exon19:c.G2305T:p.D769Y,ENSG00000141736:ENST00000406381:exon21:c.G2215T:p.D739Y,ENSG00000141736:ENST00000584601:exon23:c.G2215T:p.D739Y	ERBB2:NM_001289937:exon19:c.G2305T:p.D769Y,ERBB2:NM_004448:exon19:c.G2305T:p.D769Y,ERBB2:NM_001005862:exon22:c.G2215T:p.D739Y,ERBB2:NM_001289936:exon23:c.G2260T:p.D754Y	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	7.136	34	0.0	5.02	17	0.9633	0.71	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ERBB2:uc010wek.2:exon13:c.G1477T:p.D493Y,ERBB2:uc002hso.3:exon19:c.G2305T:p.D769Y,ERBB2:uc002hsp.3:exon19:c.G1714T:p.D572Y,ERBB2:uc010cwb.3:exon19:c.G2305T:p.D769Y,ERBB2:uc002hsm.3:exon22:c.G2215T:p.D739Y,ERBB2:uc010cwa.3:exon23:c.G2260T:p.D754Y	0.375	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	BRACA
17	37881000	37881000	G	T	ERBB2	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141736	rs121913471	ENSG00000141736:ENST00000445658:exon14:c.G1501T:p.V501L,ENSG00000141736:ENST00000269571:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000540147:exon20:c.G2239T:p.V747L,ENSG00000141736:ENST00000541774:exon20:c.G2284T:p.V762L,ENSG00000141736:ENST00000584450:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000406381:exon22:c.G2239T:p.V747L,ENSG00000141736:ENST00000584601:exon24:c.G2239T:p.V747L;ENSG00000141736:ENST00000445658:exon14:c.G1501T:p.V501L,ENSG00000141736:ENST00000269571:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000540147:exon20:c.G2239T:p.V747L,ENSG00000141736:ENST00000541774:exon20:c.G2284T:p.V762L,ENSG00000141736:ENST00000584450:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000406381:exon22:c.G2239T:p.V747L,ENSG00000141736:ENST00000584601:exon24:c.G2239T:p.V747L	ERBB2:NM_001289937:exon20:c.G2329T:p.V777L,ERBB2:NM_004448:exon20:c.G2329T:p.V777L,ERBB2:NM_001005862:exon23:c.G2239T:p.V747L,ERBB2:NM_001289936:exon24:c.G2284T:p.V762L;ERBB2:NM_001289937:exon20:c.G2329T:p.V777L,ERBB2:NM_004448:exon20:c.G2329T:p.V777L,ERBB2:NM_001005862:exon23:c.G2239T:p.V747L,ERBB2:NM_001289936:exon24:c.G2284T:p.V762L	clinvar: Uncertain significance 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 1, 2, None] 	.	.	.	3.438	23.0	0.482	5.3	17	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ERBB2:uc010wek.2:exon14:c.G1501T:p.V501L,ERBB2:uc002hso.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsp.3:exon20:c.G1738T:p.V580L,ERBB2:uc010cwb.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsm.3:exon23:c.G2239T:p.V747L,ERBB2:uc010cwa.3:exon24:c.G2284T:p.V762L;ERBB2:uc010wek.2:exon14:c.G1501T:p.V501L,ERBB2:uc002hso.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsp.3:exon20:c.G1738T:p.V580L,ERBB2:uc010cwb.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsm.3:exon23:c.G2239T:p.V747L,ERBB2:uc010cwa.3:exon24:c.G2284T:p.V762L	-0.998	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	BRACA
17	37881000	37881000	G	T	ERBB2	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141736	rs121913471	ENSG00000141736:ENST00000445658:exon14:c.G1501T:p.V501L,ENSG00000141736:ENST00000269571:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000540147:exon20:c.G2239T:p.V747L,ENSG00000141736:ENST00000541774:exon20:c.G2284T:p.V762L,ENSG00000141736:ENST00000584450:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000406381:exon22:c.G2239T:p.V747L,ENSG00000141736:ENST00000584601:exon24:c.G2239T:p.V747L;ENSG00000141736:ENST00000445658:exon14:c.G1501T:p.V501L,ENSG00000141736:ENST00000269571:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000540147:exon20:c.G2239T:p.V747L,ENSG00000141736:ENST00000541774:exon20:c.G2284T:p.V762L,ENSG00000141736:ENST00000584450:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000406381:exon22:c.G2239T:p.V747L,ENSG00000141736:ENST00000584601:exon24:c.G2239T:p.V747L	ERBB2:NM_001289937:exon20:c.G2329T:p.V777L,ERBB2:NM_004448:exon20:c.G2329T:p.V777L,ERBB2:NM_001005862:exon23:c.G2239T:p.V747L,ERBB2:NM_001289936:exon24:c.G2284T:p.V762L;ERBB2:NM_001289937:exon20:c.G2329T:p.V777L,ERBB2:NM_004448:exon20:c.G2329T:p.V777L,ERBB2:NM_001005862:exon23:c.G2239T:p.V747L,ERBB2:NM_001289936:exon24:c.G2284T:p.V762L	clinvar: Uncertain significance 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 1, 2, None] 	.	.	.	3.438	23.0	0.482	5.3	17	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ERBB2:uc010wek.2:exon14:c.G1501T:p.V501L,ERBB2:uc002hso.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsp.3:exon20:c.G1738T:p.V580L,ERBB2:uc010cwb.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsm.3:exon23:c.G2239T:p.V747L,ERBB2:uc010cwa.3:exon24:c.G2284T:p.V762L;ERBB2:uc010wek.2:exon14:c.G1501T:p.V501L,ERBB2:uc002hso.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsp.3:exon20:c.G1738T:p.V580L,ERBB2:uc010cwb.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsm.3:exon23:c.G2239T:p.V747L,ERBB2:uc010cwa.3:exon24:c.G2284T:p.V762L	-0.998	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	COC-PR
17	37881332	37881332	G	A	ERBB2	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141736	.	ENSG00000141736:ENST00000445658:exon15:c.G1696A:p.V566I,ENSG00000141736:ENST00000269571:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000540147:exon21:c.G2434A:p.V812I,ENSG00000141736:ENST00000541774:exon21:c.G2479A:p.V827I,ENSG00000141736:ENST00000584450:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000406381:exon23:c.G2434A:p.V812I,ENSG00000141736:ENST00000584601:exon25:c.G2434A:p.V812I;ENSG00000141736:ENST00000445658:exon15:c.G1696A:p.V566I,ENSG00000141736:ENST00000269571:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000540147:exon21:c.G2434A:p.V812I,ENSG00000141736:ENST00000541774:exon21:c.G2479A:p.V827I,ENSG00000141736:ENST00000584450:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000406381:exon23:c.G2434A:p.V812I,ENSG00000141736:ENST00000584601:exon25:c.G2434A:p.V812I	ERBB2:NM_001289937:exon21:c.G2524A:p.V842I,ERBB2:NM_004448:exon21:c.G2524A:p.V842I,ERBB2:NM_001005862:exon24:c.G2434A:p.V812I,ERBB2:NM_001289936:exon25:c.G2479A:p.V827I;ERBB2:NM_001289937:exon21:c.G2524A:p.V842I,ERBB2:NM_004448:exon21:c.G2524A:p.V842I,ERBB2:NM_001005862:exon24:c.G2434A:p.V812I,ERBB2:NM_001289936:exon25:c.G2479A:p.V827I	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.819	32	0.002	5.09	17	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ERBB2:uc010wek.2:exon15:c.G1696A:p.V566I,ERBB2:uc002hso.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsp.3:exon21:c.G1933A:p.V645I,ERBB2:uc010cwb.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsm.3:exon24:c.G2434A:p.V812I,ERBB2:uc010cwa.3:exon25:c.G2479A:p.V827I;ERBB2:uc010wek.2:exon15:c.G1696A:p.V566I,ERBB2:uc002hso.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsp.3:exon21:c.G1933A:p.V645I,ERBB2:uc010cwb.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsm.3:exon24:c.G2434A:p.V812I,ERBB2:uc010cwa.3:exon25:c.G2479A:p.V827I	0.233	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	BRACA
17	37881332	37881332	G	A	ERBB2	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141736	.	ENSG00000141736:ENST00000445658:exon15:c.G1696A:p.V566I,ENSG00000141736:ENST00000269571:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000540147:exon21:c.G2434A:p.V812I,ENSG00000141736:ENST00000541774:exon21:c.G2479A:p.V827I,ENSG00000141736:ENST00000584450:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000406381:exon23:c.G2434A:p.V812I,ENSG00000141736:ENST00000584601:exon25:c.G2434A:p.V812I;ENSG00000141736:ENST00000445658:exon15:c.G1696A:p.V566I,ENSG00000141736:ENST00000269571:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000540147:exon21:c.G2434A:p.V812I,ENSG00000141736:ENST00000541774:exon21:c.G2479A:p.V827I,ENSG00000141736:ENST00000584450:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000406381:exon23:c.G2434A:p.V812I,ENSG00000141736:ENST00000584601:exon25:c.G2434A:p.V812I	ERBB2:NM_001289937:exon21:c.G2524A:p.V842I,ERBB2:NM_004448:exon21:c.G2524A:p.V842I,ERBB2:NM_001005862:exon24:c.G2434A:p.V812I,ERBB2:NM_001289936:exon25:c.G2479A:p.V827I;ERBB2:NM_001289937:exon21:c.G2524A:p.V842I,ERBB2:NM_004448:exon21:c.G2524A:p.V842I,ERBB2:NM_001005862:exon24:c.G2434A:p.V812I,ERBB2:NM_001289936:exon25:c.G2479A:p.V827I	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.819	32	0.002	5.09	17	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ERBB2:uc010wek.2:exon15:c.G1696A:p.V566I,ERBB2:uc002hso.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsp.3:exon21:c.G1933A:p.V645I,ERBB2:uc010cwb.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsm.3:exon24:c.G2434A:p.V812I,ERBB2:uc010cwa.3:exon25:c.G2479A:p.V827I;ERBB2:uc010wek.2:exon15:c.G1696A:p.V566I,ERBB2:uc002hso.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsp.3:exon21:c.G1933A:p.V645I,ERBB2:uc010cwb.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsm.3:exon24:c.G2434A:p.V812I,ERBB2:uc010cwa.3:exon25:c.G2479A:p.V827I	0.233	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	COC-PR
17	37881404	37881404	C	A	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	.	ENSG00000141736:ENST00000445658:exon15:c.C1768A:p.L590M,ENSG00000141736:ENST00000269571:exon21:c.C2596A:p.L866M,ENSG00000141736:ENST00000540147:exon21:c.C2506A:p.L836M,ENSG00000141736:ENST00000541774:exon21:c.C2551A:p.L851M,ENSG00000141736:ENST00000584450:exon21:c.C2596A:p.L866M,ENSG00000141736:ENST00000406381:exon23:c.C2506A:p.L836M,ENSG00000141736:ENST00000584601:exon25:c.C2506A:p.L836M	ERBB2:NM_001289937:exon21:c.C2596A:p.L866M,ERBB2:NM_004448:exon21:c.C2596A:p.L866M,ERBB2:NM_001005862:exon24:c.C2506A:p.L836M,ERBB2:NM_001289936:exon25:c.C2551A:p.L851M	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	6.070	28.1	0.002	4.13	17	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ERBB2:uc010wek.2:exon15:c.C1768A:p.L590M,ERBB2:uc002hso.3:exon21:c.C2596A:p.L866M,ERBB2:uc002hsp.3:exon21:c.C2005A:p.L669M,ERBB2:uc010cwb.3:exon21:c.C2596A:p.L866M,ERBB2:uc002hsm.3:exon24:c.C2506A:p.L836M,ERBB2:uc010cwa.3:exon25:c.C2551A:p.L851M	0.706	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	COC-PR
17	37881616	37881616	C	T	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	rs758222990	ENSG00000141736:ENST00000445658:exon16:c.C1858T:p.R620C,ENSG00000141736:ENST00000269571:exon22:c.C2686T:p.R896C,ENSG00000141736:ENST00000540147:exon22:c.C2596T:p.R866C,ENSG00000141736:ENST00000541774:exon22:c.C2641T:p.R881C,ENSG00000141736:ENST00000584450:exon22:c.C2686T:p.R896C,ENSG00000141736:ENST00000406381:exon24:c.C2596T:p.R866C,ENSG00000141736:ENST00000584601:exon26:c.C2596T:p.R866C	ERBB2:NM_001289937:exon22:c.C2686T:p.R896C,ERBB2:NM_004448:exon22:c.C2686T:p.R896C,ERBB2:NM_001005862:exon25:c.C2596T:p.R866C,ERBB2:NM_001289936:exon26:c.C2641T:p.R881C	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 1, 2, None] 	8.242e-06	.	.	4.728	24.6	0.055	3.22	17	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ERBB2:uc010wek.2:exon16:c.C1858T:p.R620C,ERBB2:uc002hso.3:exon22:c.C2686T:p.R896C,ERBB2:uc002hsp.3:exon22:c.C2095T:p.R699C,ERBB2:uc010cwb.3:exon22:c.C2686T:p.R896C,ERBB2:uc002hsm.3:exon25:c.C2596T:p.R866C,ERBB2:uc010cwa.3:exon26:c.C2641T:p.R881C	-0.921	AFR:9.634e-05,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,SAS:0	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	BRACA
17	46805705	46805705	C	T	HOXB13	exonic	nonsynonymous SNV	ENSG00000159184	rs138213197	ENSG00000159184:ENST00000290295:exon1:c.G251A:p.G84E	HOXB13:NM_006361:exon1:c.G251A:p.G84E	clinvar: Uncertain significance|Pathogenic|other 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 1, 2, 0, None] 	0.0022	0.0015	0.000199681	6.404	29.6	0.006	4.73	17	.	.	Homeobox protein Hox1A3 N-terminal	HOXB13:uc002ioa.3:exon1:c.G251A:p.G84E	-0.278	AFR:0.0004,AMR:0,EAS:0,FIN:0.0077,NFE:0.0031,OTH:0.0011,SAS:0	604607	.	.	.	PRAD
17	7577120	7577120	C	T	TP53	exonic	nonsynonymous SNV	ENSG00000141510	rs28934576	ENSG00000141510:ENST00000509690:exon5:c.G422A:p.R141H,ENSG00000141510:ENST00000359597:exon7:c.G818A:p.R273H,ENSG00000141510:ENST00000269305:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000420246:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000445888:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000455263:exon8:c.G818A:p.R273H	TP53:NM_001126115:exon4:c.G422A:p.R141H,TP53:NM_001126116:exon4:c.G422A:p.R141H,TP53:NM_001126117:exon4:c.G422A:p.R141H,TP53:NM_001276697:exon4:c.G341A:p.R114H,TP53:NM_001276698:exon4:c.G341A:p.R114H,TP53:NM_001276699:exon4:c.G341A:p.R114H,TP53:NM_001126118:exon7:c.G701A:p.R234H,TP53:NM_000546:exon8:c.G818A:p.R273H,TP53:NM_001126112:exon8:c.G818A:p.R273H,TP53:NM_001126113:exon8:c.G818A:p.R273H,TP53:NM_001126114:exon8:c.G818A:p.R273H,TP53:NM_001276695:exon8:c.G701A:p.R234H,TP53:NM_001276696:exon8:c.G701A:p.R234H,TP53:NM_001276760:exon8:c.G701A:p.R234H,TP53:NM_001276761:exon8:c.G701A:p.R234H	clinvar: Likely pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	2.628e-05	.	0.000199681	5.846	27.3	0.011	4.92	17	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	TP53:uc002gii.2:exon4:c.G341A:p.R114H,TP53:uc010cnf.2:exon4:c.G341A:p.R114H,TP53:uc010cng.2:exon4:c.G341A:p.R114H,TP53:uc002gih.3:exon7:c.G818A:p.R273H,TP53:uc031qyq.1:exon7:c.G701A:p.R234H,TP53:uc002gij.3:exon8:c.G701A:p.R234H,TP53:uc002gim.3:exon8:c.G818A:p.R273H,TP53:uc010cnh.2:exon8:c.G818A:p.R273H,TP53:uc010cni.2:exon8:c.G818A:p.R273H	0.939	AFR:0,AMR:0,EAS:0,FIN:0,NFE:4.746e-05,OTH:0,SAS:0	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
17	7577121	7577121	G	A	TP53	exonic	nonsynonymous SNV	ENSG00000141510	rs121913343	ENSG00000141510:ENST00000509690:exon5:c.C421T:p.R141C,ENSG00000141510:ENST00000359597:exon7:c.C817T:p.R273C,ENSG00000141510:ENST00000269305:exon8:c.C817T:p.R273C,ENSG00000141510:ENST00000420246:exon8:c.C817T:p.R273C,ENSG00000141510:ENST00000445888:exon8:c.C817T:p.R273C,ENSG00000141510:ENST00000455263:exon8:c.C817T:p.R273C	TP53:NM_001126115:exon4:c.C421T:p.R141C,TP53:NM_001126116:exon4:c.C421T:p.R141C,TP53:NM_001126117:exon4:c.C421T:p.R141C,TP53:NM_001276697:exon4:c.C340T:p.R114C,TP53:NM_001276698:exon4:c.C340T:p.R114C,TP53:NM_001276699:exon4:c.C340T:p.R114C,TP53:NM_001126118:exon7:c.C700T:p.R234C,TP53:NM_000546:exon8:c.C817T:p.R273C,TP53:NM_001126112:exon8:c.C817T:p.R273C,TP53:NM_001126113:exon8:c.C817T:p.R273C,TP53:NM_001126114:exon8:c.C817T:p.R273C,TP53:NM_001276695:exon8:c.C700T:p.R234C,TP53:NM_001276696:exon8:c.C700T:p.R234C,TP53:NM_001276760:exon8:c.C700T:p.R234C,TP53:NM_001276761:exon8:c.C700T:p.R234C	clinvar: Pathogenic|Pathogenic|Uncertain significance|other|Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	8.886e-06	.	.	6.741	32	0.003	3.95	17	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	TP53:uc002gii.2:exon4:c.C340T:p.R114C,TP53:uc010cnf.2:exon4:c.C340T:p.R114C,TP53:uc010cng.2:exon4:c.C340T:p.R114C,TP53:uc002gih.3:exon7:c.C817T:p.R273C,TP53:uc031qyq.1:exon7:c.C700T:p.R234C,TP53:uc002gij.3:exon8:c.C700T:p.R234C,TP53:uc002gim.3:exon8:c.C817T:p.R273C,TP53:uc010cnh.2:exon8:c.C817T:p.R273C,TP53:uc010cni.2:exon8:c.C817T:p.R273C	0.964	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.605e-05,OTH:0,SAS:0	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
17	7577535	7577535	C	G	TP53	exonic	nonsynonymous SNV	ENSG00000141510	.	ENSG00000141510:ENST00000509690:exon4:c.G350C:p.R117T,ENSG00000141510:ENST00000359597:exon6:c.G746C:p.R249T,ENSG00000141510:ENST00000413465:exon6:c.G746C:p.R249T,ENSG00000141510:ENST00000269305:exon7:c.G746C:p.R249T,ENSG00000141510:ENST00000420246:exon7:c.G746C:p.R249T,ENSG00000141510:ENST00000445888:exon7:c.G746C:p.R249T,ENSG00000141510:ENST00000455263:exon7:c.G746C:p.R249T	TP53:NM_001126115:exon3:c.G350C:p.R117T,TP53:NM_001126116:exon3:c.G350C:p.R117T,TP53:NM_001126117:exon3:c.G350C:p.R117T,TP53:NM_001276697:exon3:c.G269C:p.R90T,TP53:NM_001276698:exon3:c.G269C:p.R90T,TP53:NM_001276699:exon3:c.G269C:p.R90T,TP53:NM_001126118:exon6:c.G629C:p.R210T,TP53:NM_000546:exon7:c.G746C:p.R249T,TP53:NM_001126112:exon7:c.G746C:p.R249T,TP53:NM_001126113:exon7:c.G746C:p.R249T,TP53:NM_001126114:exon7:c.G746C:p.R249T,TP53:NM_001276695:exon7:c.G629C:p.R210T,TP53:NM_001276696:exon7:c.G629C:p.R210T,TP53:NM_001276760:exon7:c.G629C:p.R210T,TP53:NM_001276761:exon7:c.G629C:p.R210T	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	5.974	27.7	0.0	3.64	17	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	TP53:uc002gii.2:exon3:c.G269C:p.R90T,TP53:uc010cnf.2:exon3:c.G269C:p.R90T,TP53:uc010cng.2:exon3:c.G269C:p.R90T,TP53:uc002gio.3:exon4:c.G350C:p.R117T,TP53:uc002gig.1:exon6:c.G746C:p.R249T,TP53:uc002gih.3:exon6:c.G746C:p.R249T,TP53:uc002gin.3:exon6:c.G467C:p.R156T,TP53:uc031qyq.1:exon6:c.G629C:p.R210T,TP53:uc002gij.3:exon7:c.G629C:p.R210T,TP53:uc002gim.3:exon7:c.G746C:p.R249T,TP53:uc010cnh.2:exon7:c.G746C:p.R249T,TP53:uc010cni.2:exon7:c.G746C:p.R249T	0.954	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
17	7577538	7577538	C	T	TP53	exonic	nonsynonymous SNV	ENSG00000141510	rs11540652	ENSG00000141510:ENST00000509690:exon4:c.G347A:p.R116Q,ENSG00000141510:ENST00000359597:exon6:c.G743A:p.R248Q,ENSG00000141510:ENST00000413465:exon6:c.G743A:p.R248Q,ENSG00000141510:ENST00000514944:exon6:c.G464A:p.R155Q,ENSG00000141510:ENST00000269305:exon7:c.G743A:p.R248Q,ENSG00000141510:ENST00000420246:exon7:c.G743A:p.R248Q,ENSG00000141510:ENST00000445888:exon7:c.G743A:p.R248Q,ENSG00000141510:ENST00000455263:exon7:c.G743A:p.R248Q	TP53:NM_001126115:exon3:c.G347A:p.R116Q,TP53:NM_001126116:exon3:c.G347A:p.R116Q,TP53:NM_001126117:exon3:c.G347A:p.R116Q,TP53:NM_001276697:exon3:c.G266A:p.R89Q,TP53:NM_001276698:exon3:c.G266A:p.R89Q,TP53:NM_001276699:exon3:c.G266A:p.R89Q,TP53:NM_001126118:exon6:c.G626A:p.R209Q,TP53:NM_000546:exon7:c.G743A:p.R248Q,TP53:NM_001126112:exon7:c.G743A:p.R248Q,TP53:NM_001126113:exon7:c.G743A:p.R248Q,TP53:NM_001126114:exon7:c.G743A:p.R248Q,TP53:NM_001276695:exon7:c.G626A:p.R209Q,TP53:NM_001276696:exon7:c.G626A:p.R209Q,TP53:NM_001276760:exon7:c.G626A:p.R209Q,TP53:NM_001276761:exon7:c.G626A:p.R209Q	clinvar: Likely pathogenic,Uncertain significance,Pathogenic|other|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	5.768e-05	7.7e-05	.	7.525	34	0.008	3.65	17	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	TP53:uc002gii.2:exon3:c.G266A:p.R89Q,TP53:uc010cnf.2:exon3:c.G266A:p.R89Q,TP53:uc010cng.2:exon3:c.G266A:p.R89Q,TP53:uc002gio.3:exon4:c.G347A:p.R116Q,TP53:uc002gig.1:exon6:c.G743A:p.R248Q,TP53:uc002gih.3:exon6:c.G743A:p.R248Q,TP53:uc002gin.3:exon6:c.G464A:p.R155Q,TP53:uc031qyq.1:exon6:c.G626A:p.R209Q,TP53:uc002gij.3:exon7:c.G626A:p.R209Q,TP53:uc002gim.3:exon7:c.G743A:p.R248Q,TP53:uc010cnh.2:exon7:c.G743A:p.R248Q,TP53:uc010cni.2:exon7:c.G743A:p.R248Q	0.960	AFR:0,AMR:0,EAS:0.0002,FIN:0,NFE:7.493e-05,OTH:0,SAS:0	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
17	7577539	7577539	G	A	TP53	exonic	nonsynonymous SNV	ENSG00000141510	rs121912651	ENSG00000141510:ENST00000509690:exon4:c.C346T:p.R116W,ENSG00000141510:ENST00000359597:exon6:c.C742T:p.R248W,ENSG00000141510:ENST00000413465:exon6:c.C742T:p.R248W,ENSG00000141510:ENST00000514944:exon6:c.C463T:p.R155W,ENSG00000141510:ENST00000269305:exon7:c.C742T:p.R248W,ENSG00000141510:ENST00000420246:exon7:c.C742T:p.R248W,ENSG00000141510:ENST00000445888:exon7:c.C742T:p.R248W,ENSG00000141510:ENST00000455263:exon7:c.C742T:p.R248W	TP53:NM_001126115:exon3:c.C346T:p.R116W,TP53:NM_001126116:exon3:c.C346T:p.R116W,TP53:NM_001126117:exon3:c.C346T:p.R116W,TP53:NM_001276697:exon3:c.C265T:p.R89W,TP53:NM_001276698:exon3:c.C265T:p.R89W,TP53:NM_001276699:exon3:c.C265T:p.R89W,TP53:NM_001126118:exon6:c.C625T:p.R209W,TP53:NM_000546:exon7:c.C742T:p.R248W,TP53:NM_001126112:exon7:c.C742T:p.R248W,TP53:NM_001126113:exon7:c.C742T:p.R248W,TP53:NM_001126114:exon7:c.C742T:p.R248W,TP53:NM_001276695:exon7:c.C625T:p.R209W,TP53:NM_001276696:exon7:c.C625T:p.R209W,TP53:NM_001276760:exon7:c.C625T:p.R209W,TP53:NM_001276761:exon7:c.C625T:p.R209W	clinvar: Pathogenic|Pathogenic|other|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.24e-06	.	.	7.204	34	0.003	2.56	17	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	TP53:uc002gii.2:exon3:c.C265T:p.R89W,TP53:uc010cnf.2:exon3:c.C265T:p.R89W,TP53:uc010cng.2:exon3:c.C265T:p.R89W,TP53:uc002gio.3:exon4:c.C346T:p.R116W,TP53:uc002gig.1:exon6:c.C742T:p.R248W,TP53:uc002gih.3:exon6:c.C742T:p.R248W,TP53:uc002gin.3:exon6:c.C463T:p.R155W,TP53:uc031qyq.1:exon6:c.C625T:p.R209W,TP53:uc002gij.3:exon7:c.C625T:p.R209W,TP53:uc002gim.3:exon7:c.C742T:p.R248W,TP53:uc010cnh.2:exon7:c.C742T:p.R248W,TP53:uc010cni.2:exon7:c.C742T:p.R248W	0.987	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.498e-05,OTH:0,SAS:0	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
17	7578406	7578406	C	T	TP53	exonic	nonsynonymous SNV	ENSG00000141510	rs28934578	ENSG00000141510:ENST00000509690:exon2:c.G128A:p.R43H,ENSG00000141510:ENST00000359597:exon4:c.G524A:p.R175H,ENSG00000141510:ENST00000413465:exon4:c.G524A:p.R175H,ENSG00000141510:ENST00000514944:exon4:c.G245A:p.R82H,ENSG00000141510:ENST00000269305:exon5:c.G524A:p.R175H,ENSG00000141510:ENST00000420246:exon5:c.G524A:p.R175H,ENSG00000141510:ENST00000445888:exon5:c.G524A:p.R175H,ENSG00000141510:ENST00000455263:exon5:c.G524A:p.R175H	TP53:NM_001126115:exon1:c.G128A:p.R43H,TP53:NM_001126116:exon1:c.G128A:p.R43H,TP53:NM_001126117:exon1:c.G128A:p.R43H,TP53:NM_001276697:exon1:c.G47A:p.R16H,TP53:NM_001276698:exon1:c.G47A:p.R16H,TP53:NM_001276699:exon1:c.G47A:p.R16H,TP53:NM_001126118:exon4:c.G407A:p.R136H,TP53:NM_000546:exon5:c.G524A:p.R175H,TP53:NM_001126112:exon5:c.G524A:p.R175H,TP53:NM_001126113:exon5:c.G524A:p.R175H,TP53:NM_001126114:exon5:c.G524A:p.R175H,TP53:NM_001276695:exon5:c.G407A:p.R136H,TP53:NM_001276696:exon5:c.G407A:p.R136H,TP53:NM_001276760:exon5:c.G407A:p.R136H,TP53:NM_001276761:exon5:c.G407A:p.R136H	clinvar: other,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.243e-06	.	.	4.992	25.1	0.0	5.41	17	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	TP53:uc002gii.2:exon1:c.G47A:p.R16H,TP53:uc010cnf.2:exon1:c.G47A:p.R16H,TP53:uc010cng.2:exon1:c.G47A:p.R16H,TP53:uc002gio.3:exon2:c.G128A:p.R43H,TP53:uc002gig.1:exon4:c.G524A:p.R175H,TP53:uc002gih.3:exon4:c.G524A:p.R175H,TP53:uc002gin.3:exon4:c.G245A:p.R82H,TP53:uc010vug.3:exon4:c.G407A:p.R136H,TP53:uc031qyq.1:exon4:c.G407A:p.R136H,TP53:uc002gij.3:exon5:c.G407A:p.R136H,TP53:uc002gim.3:exon5:c.G524A:p.R175H,TP53:uc010cnh.2:exon5:c.G524A:p.R175H,TP53:uc010cni.2:exon5:c.G524A:p.R175H	0.920	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.499e-05,OTH:0,SAS:0	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
17	7579472	7579472	G	C	TP53	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000141510	rs1042522	ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R;ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R;ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R	TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R;TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R;TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R	clinvar: Benign,Benign|Benign|Benign|Benign|Uncertain significance|drug response|drug response|drug response|drug response|drug response,Uncertain significance|Uncertain significance 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 0, 0, 2, 1, 2, None] 	0.6600	0.6300	0.542931	-0.415	0.355	0.642	1.87	17	.	.	.	TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R;TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R;TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R	-0.929	AFR:0.3842,AMR:0.7115,EAS:0.5892,FIN:0.7304,NFE:0.7345,OTH:0.6648,SAS:0.4988	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
17	7579472	7579472	G	C	TP53	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000141510	rs1042522	ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R;ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R;ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R	TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R;TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R;TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R	clinvar: Benign,Benign|Benign|Benign|Benign|Uncertain significance|drug response|drug response|drug response|drug response|drug response,Uncertain significance|Uncertain significance 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 0, 0, 2, 1, 2, None] 	0.6600	0.6300	0.542931	-0.415	0.355	0.642	1.87	17	.	.	.	TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R;TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R;TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R	-0.929	AFR:0.3842,AMR:0.7115,EAS:0.5892,FIN:0.7304,NFE:0.7345,OTH:0.6648,SAS:0.4988	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	CER
17	7579472	7579472	G	C	TP53	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000141510	rs1042522	ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R;ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R;ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R	TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R;TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R;TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R	clinvar: Benign,Benign|Benign|Benign|Benign|Uncertain significance|drug response|drug response|drug response|drug response|drug response,Uncertain significance|Uncertain significance 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 0, 0, 2, 1, 2, None] 	0.6600	0.6300	0.542931	-0.415	0.355	0.642	1.87	17	.	.	.	TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R;TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R;TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R	-0.929	AFR:0.3842,AMR:0.7115,EAS:0.5892,FIN:0.7304,NFE:0.7345,OTH:0.6648,SAS:0.4988	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	L
17	7579548	7579548	G	A	TP53	exonic	nonsynonymous SNV	ENSG00000141510	rs1800371	ENSG00000141510:ENST00000359597:exon3:c.C139T:p.P47S,ENSG00000141510:ENST00000413465:exon3:c.C139T:p.P47S,ENSG00000141510:ENST00000269305:exon4:c.C139T:p.P47S,ENSG00000141510:ENST00000420246:exon4:c.C139T:p.P47S,ENSG00000141510:ENST00000445888:exon4:c.C139T:p.P47S,ENSG00000141510:ENST00000455263:exon4:c.C139T:p.P47S,ENSG00000141510:ENST00000508793:exon4:c.C139T:p.P47S,ENSG00000141510:ENST00000604348:exon4:c.C139T:p.P47S,ENSG00000141510:ENST00000503591:exon5:c.C139T:p.P47S	TP53:NM_001126118:exon3:c.C22T:p.P8S,TP53:NM_000546:exon4:c.C139T:p.P47S,TP53:NM_001126112:exon4:c.C139T:p.P47S,TP53:NM_001126113:exon4:c.C139T:p.P47S,TP53:NM_001126114:exon4:c.C139T:p.P47S,TP53:NM_001276695:exon4:c.C22T:p.P8S,TP53:NM_001276696:exon4:c.C22T:p.P8S,TP53:NM_001276760:exon4:c.C22T:p.P8S,TP53:NM_001276761:exon4:c.C22T:p.P8S	clinvar: other|Benign|Benign|Benign 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 1, 0, 0, 2, None] 	0.0017	0.0052	0.00559105	-1.738	0.002	0.232	-7.9	17	.	.	p53 transactivation domain	TP53:uc002gig.1:exon3:c.C139T:p.P47S,TP53:uc002gih.3:exon3:c.C139T:p.P47S,TP53:uc010vug.3:exon3:c.C22T:p.P8S,TP53:uc031qyq.1:exon3:c.C22T:p.P8S,TP53:uc002gij.3:exon4:c.C22T:p.P8S,TP53:uc002gim.3:exon4:c.C139T:p.P47S,TP53:uc010cnh.2:exon4:c.C139T:p.P47S,TP53:uc010cni.2:exon4:c.C139T:p.P47S,TP53:uc010cnk.2:exon5:c.C184T:p.P62S	0.794	AFR:0.0184,AMR:0.0014,EAS:0,FIN:0,NFE:3.001e-05,OTH:0,SAS:6.063e-05	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	CANCER
1	8073509	8073509	C	A	ERRFI1	exonic	stopgain	ENSG00000116285	.	ENSG00000116285:ENST00000377482:exon4:c.G1150T:p.E384X	ERRFI1:NM_018948:exon4:c.G1150T:p.E384X	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 2, 0, 0, None] 	.	.	.	13.509	42	.	5.9	1	.	.	.	ERRFI1:uc001apa.1:exon2:c.G925T:p.E309X,ERRFI1:uc001aoz.3:exon4:c.G1150T:p.E384X	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	608069	.	.	.	CH
18	42531913	42531913	G	A	SETBP1	exonic	nonsynonymous SNV	ENSG00000152217	rs267607040	ENSG00000152217:ENST00000282030:exon4:c.G2608A:p.G870S	SETBP1:NM_015559:exon4:c.G2608A:p.G870S	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 2, 1, 2, 0, None] 	1.657e-05	.	.	6.014	27.9	0.0	6.17	18	.	.	.	SETBP1:uc010dni.3:exon4:c.G2608A:p.G870S	0.675	AFR:0,AMR:0,EAS:0,FIN:0,NFE:3.02e-05,OTH:0,SAS:0	611060	269150;616078;	436151;798;	436151|Intellectual disability-loss of expressive language-facial dysmorphism syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616078 616083 ~798|SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal<br>Infancy|269150 ~	CML
19	1220489	1220489	C	A	STK11	exonic	nonsynonymous SNV	ENSG00000118046	rs786202134	ENSG00000118046:ENST00000585851:exon2:c.C408A:p.D136E,ENSG00000118046:ENST00000326873:exon4:c.C582A:p.D194E	STK11:NM_000455:exon4:c.C582A:p.D194E	clinvar: Likely pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 2, 0, 2, 0, None] 	.	.	.	5.739	26.9	0.0	4.52	19	.	.	Protein kinase domain;Protein kinase-like domain;Serine/threonine/dual specificity protein kinase, catalytic  domain	STK11:uc002lrl.1:exon4:c.C582A:p.D194E	0.997	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	602216	175200;260350;273300;	363483;363494;363504;842;876;99865;1333;2869;	363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2869|Hamartomatous intestinal polyposis<br>PJS<br>Polyps and spots syndrome|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Childhood|175200 ~	PA
19	44055726	44055726	T	C	XRCC1	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000073050	rs25487	ENSG00000073050:ENST00000543982:exon9:c.A1103G:p.Q368R,ENSG00000073050:ENST00000262887:exon10:c.A1196G:p.Q399R;ENSG00000073050:ENST00000543982:exon9:c.A1103G:p.Q368R,ENSG00000073050:ENST00000262887:exon10:c.A1196G:p.Q399R	XRCC1:NM_006297:exon10:c.A1196G:p.Q399R;XRCC1:NM_006297:exon10:c.A1196G:p.Q399R	clinvar: drug response|drug response|drug response|drug response|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 1, 1, 0, None] 	0.6834	0.7092	0.739617	0.745	9.117	1.0	4.13	19	.	.	BRCT domain	XRCC1:uc010xwp.1:exon9:c.A1103G:p.Q368R,XRCC1:uc002owt.2:exon10:c.A1196G:p.Q399R;XRCC1:uc010xwp.1:exon9:c.A1103G:p.Q368R,XRCC1:uc002owt.2:exon10:c.A1196G:p.Q399R	-0.976	AFR:0.8565,AMR:0.7491,EAS:0.7421,FIN:0.6836,NFE:0.6458,OTH:0.6748,SAS:0.6500	194360	.	.	.	CER
19	44055726	44055726	T	C	XRCC1	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000073050	rs25487	ENSG00000073050:ENST00000543982:exon9:c.A1103G:p.Q368R,ENSG00000073050:ENST00000262887:exon10:c.A1196G:p.Q399R;ENSG00000073050:ENST00000543982:exon9:c.A1103G:p.Q368R,ENSG00000073050:ENST00000262887:exon10:c.A1196G:p.Q399R	XRCC1:NM_006297:exon10:c.A1196G:p.Q399R;XRCC1:NM_006297:exon10:c.A1196G:p.Q399R	clinvar: drug response|drug response|drug response|drug response|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 1, 1, 0, None] 	0.6834	0.7092	0.739617	0.745	9.117	1.0	4.13	19	.	.	BRCT domain	XRCC1:uc010xwp.1:exon9:c.A1103G:p.Q368R,XRCC1:uc002owt.2:exon10:c.A1196G:p.Q399R;XRCC1:uc010xwp.1:exon9:c.A1103G:p.Q368R,XRCC1:uc002owt.2:exon10:c.A1196G:p.Q399R	-0.976	AFR:0.8565,AMR:0.7491,EAS:0.7421,FIN:0.6836,NFE:0.6458,OTH:0.6748,SAS:0.6500	194360	.	.	.	NSCLC
19	44057574	44057574	G	A	XRCC1	exonic	nonsynonymous SNV	ENSG00000073050	rs1799782	ENSG00000073050:ENST00000543982:exon5:c.C487T:p.R163W,ENSG00000073050:ENST00000594107:exon5:c.C469T:p.R157W,ENSG00000073050:ENST00000262887:exon6:c.C580T:p.R194W,ENSG00000073050:ENST00000598165:exon6:c.C601T:p.R201W	XRCC1:NM_006297:exon6:c.C580T:p.R194W	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 1, 1, 0, None] 	0.0928	0.0617	0.123802	6.753	32	0.001	1.03	19	.	.	.	XRCC1:uc010xwp.1:exon5:c.C487T:p.R163W,XRCC1:uc002owt.2:exon6:c.C580T:p.R194W	-0.959	AFR:0.0613,AMR:0.1656,EAS:0.3074,FIN:0.0343,NFE:0.0631,OTH:0.0828,SAS:0.0932	194360	.	.	.	NSCLC
19	45854919	45854919	T	G	ERCC2	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000104884	rs13181	ENSG00000104884:ENST00000391944:exon21:c.A2017C:p.K673Q,ENSG00000104884:ENST00000391945:exon23:c.A2251C:p.K751Q;ENSG00000104884:ENST00000391944:exon21:c.A2017C:p.K673Q,ENSG00000104884:ENST00000391945:exon23:c.A2251C:p.K751Q	ERCC2:NM_000400:exon23:c.A2251C:p.K751Q;ERCC2:NM_000400:exon23:c.A2251C:p.K751Q	clinvar: Benign 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 0, 1, 1, 1, 0, None] 	0.3308	0.3260	0.236621	0.982	10.56	0.59	4.29	19	.	.	.	ERCC2:uc002pbh.2:exon10:c.A940C:p.K314Q,ERCC2:uc002pbi.2:exon12:c.A1330C:p.K444Q,ERCC2:uc010ejz.2:exon21:c.A2017C:p.K673Q,ERCC2:uc002pbj.2:exon23:c.A2251C:p.K751Q;ERCC2:uc002pbh.2:exon10:c.A940C:p.K314Q,ERCC2:uc002pbi.2:exon12:c.A1330C:p.K444Q,ERCC2:uc010ejz.2:exon21:c.A2017C:p.K673Q,ERCC2:uc002pbj.2:exon23:c.A2251C:p.K751Q	-1.087	AFR:0.2262,AMR:0.1870,EAS:0.0757,FIN:0.4133,NFE:0.3865,OTH:0.3,SAS:0.3738	126340	278730;601675;610756;	1466;191;33364;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	NSCLC
19	45854919	45854919	T	G	ERCC2	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000104884	rs13181	ENSG00000104884:ENST00000391944:exon21:c.A2017C:p.K673Q,ENSG00000104884:ENST00000391945:exon23:c.A2251C:p.K751Q;ENSG00000104884:ENST00000391944:exon21:c.A2017C:p.K673Q,ENSG00000104884:ENST00000391945:exon23:c.A2251C:p.K751Q	ERCC2:NM_000400:exon23:c.A2251C:p.K751Q;ERCC2:NM_000400:exon23:c.A2251C:p.K751Q	clinvar: Benign 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 0, 1, 1, 1, 0, None] 	0.3308	0.3260	0.236621	0.982	10.56	0.59	4.29	19	.	.	.	ERCC2:uc002pbh.2:exon10:c.A940C:p.K314Q,ERCC2:uc002pbi.2:exon12:c.A1330C:p.K444Q,ERCC2:uc010ejz.2:exon21:c.A2017C:p.K673Q,ERCC2:uc002pbj.2:exon23:c.A2251C:p.K751Q;ERCC2:uc002pbh.2:exon10:c.A940C:p.K314Q,ERCC2:uc002pbi.2:exon12:c.A1330C:p.K444Q,ERCC2:uc010ejz.2:exon21:c.A2017C:p.K673Q,ERCC2:uc002pbj.2:exon23:c.A2251C:p.K751Q	-1.087	AFR:0.2262,AMR:0.1870,EAS:0.0757,FIN:0.4133,NFE:0.3865,OTH:0.3,SAS:0.3738	126340	278730;601675;610756;	1466;191;33364;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	OS
19	49377242	49377242	G	C	PPP1R15A	exonic	nonsynonymous SNV	ENSG00000087074	rs557806	ENSG00000087074:ENST00000200453:exon2:c.G752C:p.R251P	PPP1R15A:NM_014330:exon2:c.G752C:p.R251P	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 1, 1, 0, None] 	0.2108	0.3103	0.347843	0.443	6.982	0.467	1.24	19	.	.	.	PPP1R15A:uc002pky.4:exon2:c.G752C:p.R251P	-0.939	AFR:0.6720,AMR:0.2050,EAS:0.0995,FIN:0.1594,NFE:0.1457,OTH:0.1927,SAS:0.2669	611048	.	.	.	COREAD
1	97915614	97915614	C	T	DPYD	splicing	.	ENSG00000188641	rs3918290	.	.	clinvar: Pathogenic|Pathogenic|not provided|Uncertain significance|drug response|drug response|drug response|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 0, 0, None] 	0.0052	0.0042	0.00299521	4.038	23.7	.	5.31	1	0.9999	0.946	.	.	.	AFR:0.0007,AMR:0.0007,EAS:0,FIN:0.0221,NFE:0.0058,OTH:0.0066,SAS:0.0047	612779	274270;	1675;	1675|Familial pyrimidinemia|Unknown|-|All ages|274270 ~	CANCER
19	7975157	7975157	G	A	MAP2K7	exonic	nonsynonymous SNV	ENSG00000076984	rs28395770	ENSG00000076984:ENST00000397979:exon4:c.G346A:p.E116K,ENSG00000076984:ENST00000397981:exon4:c.G346A:p.E116K,ENSG00000076984:ENST00000545011:exon4:c.G472A:p.E158K,ENSG00000076984:ENST00000397983:exon5:c.G394A:p.E132K	MAP2K7:NM_001297556:exon4:c.G346A:p.E116K,MAP2K7:NM_145185:exon4:c.G346A:p.E116K,MAP2K7:NM_001297555:exon5:c.G394A:p.E132K	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 1, 0, None] 	.	.	.	2.891	21.8	0.509	5.31	19	.	.	Protein kinase domain;Protein kinase-like domain;Serine/threonine/dual specificity protein kinase, catalytic  domain	MAP2K7:uc002mit.3:exon4:c.G346A:p.E116K,MAP2K7:uc002miv.2:exon4:c.G346A:p.E116K,MAP2K7:uc010xkb.2:exon4:c.G346A:p.E116K	-1.048	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	603014	.	.	.	L
1	97981343	97981343	A	C	DPYD	exonic	nonsynonymous SNV	ENSG00000188641	rs55886062	ENSG00000188641:ENST00000370192:exon13:c.T1679G:p.I560S	DPYD:NM_000110:exon13:c.T1679G:p.I560S	clinvar: Pathogenic|drug response|drug response|drug response|drug response 	 CancerVar: Uncertain significance EVS=[2, None, None, 1, None, None, 1, 2, 0, 2, 0, None] 	0.0003	0.0004	0.000199681	6.560	31	0.0	5.2	1	.	.	Aldolase-type TIM barrel;Dihydroorotate dehydrogenase domain	DPYD:uc001drv.3:exon13:c.T1679G:p.I560S	-0.024	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0006,OTH:0.0011,SAS:0	612779	274270;	1675;	1675|Familial pyrimidinemia|Unknown|-|All ages|274270 ~	CANCER
21	40191638	40191638	A	G	ETS2	exonic	synonymous SNV	ENSG00000157557	rs461155	ENSG00000157557:ENST00000360938:exon8:c.A1023G:p.P341P,ENSG00000157557:ENST00000360214:exon9:c.A1023G:p.P341P	ETS2:NM_005239:exon8:c.A1023G:p.P341P,ETS2:NM_001256295:exon9:c.A1443G:p.P481P	clinvar: UNK 	 CancerVar: Benign/Likely benign EVS=[0, None, None, 0, None, None, 0, 0, 0, 0, 0, None] 	0.7228	0.7706	0.580671	.	.	.	.	21	.	.	.	ETS2:uc002yxg.4:exon8:c.A1023G:p.P341P,ETS2:uc002yxf.3:exon9:c.A1443G:p.P481P	.	AFR:0.6045,AMR:0.5486,EAS:0.4590,FIN:0.7553,NFE:0.8510,OTH:0.7466,SAS:0.5216	164740	.	.	.	NSCLC
21	44514777	44514777	T	G	U2AF1	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000160201	rs371246226	ENSG00000160201:ENST00000459639:exon5:c.A251C:p.Q84P,ENSG00000160201:ENST00000291552:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000380276:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000398137:exon7:c.A251C:p.Q84P;ENSG00000160201:ENST00000459639:exon5:c.A251C:p.Q84P,ENSG00000160201:ENST00000291552:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000380276:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000398137:exon7:c.A251C:p.Q84P	U2AF1:NM_001025203:exon6:c.A470C:p.Q157P,U2AF1:NM_006758:exon6:c.A470C:p.Q157P,U2AF1:NM_001025204:exon7:c.A251C:p.Q84P;U2AF1:NM_001025203:exon6:c.A470C:p.Q157P,U2AF1:NM_006758:exon6:c.A470C:p.Q157P,U2AF1:NM_001025204:exon7:c.A251C:p.Q84P	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 2, 0, None] 	3.306e-05	.	.	6.233	28.8	0.002	5.01	21	.	.	Nucleotide-binding alpha-beta plait domain;RNA recognition motif domain;Zinc finger, CCCH-type	U2AF1:uc002zcy.1:exon5:c.A251C:p.Q84P,U2AF1:uc002zda.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zdb.1:exon6:c.A470C:p.Q157P,U2AF1:uc010gpi.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zcz.1:exon7:c.A251C:p.Q84P;U2AF1:uc002zcy.1:exon5:c.A251C:p.Q84P,U2AF1:uc002zda.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zdb.1:exon6:c.A470C:p.Q157P,U2AF1:uc010gpi.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zcz.1:exon7:c.A251C:p.Q84P	-0.258	AFR:0,AMR:0,EAS:0.0001,FIN:0,NFE:4.515e-05,OTH:0,SAS:0	191317	.	.	.	AML
21	44514777	44514777	T	G	U2AF1	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000160201	rs371246226	ENSG00000160201:ENST00000459639:exon5:c.A251C:p.Q84P,ENSG00000160201:ENST00000291552:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000380276:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000398137:exon7:c.A251C:p.Q84P;ENSG00000160201:ENST00000459639:exon5:c.A251C:p.Q84P,ENSG00000160201:ENST00000291552:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000380276:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000398137:exon7:c.A251C:p.Q84P	U2AF1:NM_001025203:exon6:c.A470C:p.Q157P,U2AF1:NM_006758:exon6:c.A470C:p.Q157P,U2AF1:NM_001025204:exon7:c.A251C:p.Q84P;U2AF1:NM_001025203:exon6:c.A470C:p.Q157P,U2AF1:NM_006758:exon6:c.A470C:p.Q157P,U2AF1:NM_001025204:exon7:c.A251C:p.Q84P	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 2, 0, None] 	3.306e-05	.	.	6.233	28.8	0.002	5.01	21	.	.	Nucleotide-binding alpha-beta plait domain;RNA recognition motif domain;Zinc finger, CCCH-type	U2AF1:uc002zcy.1:exon5:c.A251C:p.Q84P,U2AF1:uc002zda.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zdb.1:exon6:c.A470C:p.Q157P,U2AF1:uc010gpi.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zcz.1:exon7:c.A251C:p.Q84P;U2AF1:uc002zcy.1:exon5:c.A251C:p.Q84P,U2AF1:uc002zda.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zdb.1:exon6:c.A470C:p.Q157P,U2AF1:uc010gpi.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zcz.1:exon7:c.A251C:p.Q84P	-0.258	AFR:0,AMR:0,EAS:0.0001,FIN:0,NFE:4.515e-05,OTH:0,SAS:0	191317	.	.	.	MDS
21	44524456	44524456	G	A	U2AF1	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000160201	rs371769427	ENSG00000160201:ENST00000291552:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000380276:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000464750:exon2:c.C101T:p.S34F;ENSG00000160201:ENST00000291552:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000380276:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000464750:exon2:c.C101T:p.S34F	U2AF1:NM_001025203:exon2:c.C101T:p.S34F,U2AF1:NM_006758:exon2:c.C101T:p.S34F;U2AF1:NM_001025203:exon2:c.C101T:p.S34F,U2AF1:NM_006758:exon2:c.C101T:p.S34F	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 0, None] 	4.213e-05	7.7e-05	.	6.826	32	0.0	5.47	21	.	.	Zinc finger, CCCH-type	U2AF1:uc002zda.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdb.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdc.1:exon2:c.C101T:p.S34F,U2AF1:uc010gpi.1:exon2:c.C101T:p.S34F;U2AF1:uc002zda.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdb.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdc.1:exon2:c.C101T:p.S34F,U2AF1:uc010gpi.1:exon2:c.C101T:p.S34F	0.082	AFR:0,AMR:8.675e-05,EAS:0.0001,FIN:0,NFE:3.091e-05,OTH:0,SAS:6.169e-05	191317	.	.	.	AML
21	44524456	44524456	G	A	U2AF1	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000160201	rs371769427	ENSG00000160201:ENST00000291552:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000380276:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000464750:exon2:c.C101T:p.S34F;ENSG00000160201:ENST00000291552:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000380276:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000464750:exon2:c.C101T:p.S34F	U2AF1:NM_001025203:exon2:c.C101T:p.S34F,U2AF1:NM_006758:exon2:c.C101T:p.S34F;U2AF1:NM_001025203:exon2:c.C101T:p.S34F,U2AF1:NM_006758:exon2:c.C101T:p.S34F	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 0, None] 	4.213e-05	7.7e-05	.	6.826	32	0.0	5.47	21	.	.	Zinc finger, CCCH-type	U2AF1:uc002zda.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdb.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdc.1:exon2:c.C101T:p.S34F,U2AF1:uc010gpi.1:exon2:c.C101T:p.S34F;U2AF1:uc002zda.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdb.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdc.1:exon2:c.C101T:p.S34F,U2AF1:uc010gpi.1:exon2:c.C101T:p.S34F	0.082	AFR:0,AMR:8.675e-05,EAS:0.0001,FIN:0,NFE:3.091e-05,OTH:0,SAS:6.169e-05	191317	.	.	.	MDS
2	198266834	198266834	T	C	SF3B1	exonic	nonsynonymous SNV	ENSG00000115524	rs559063155	ENSG00000115524:ENST00000335508:exon15:c.A2098G:p.K700E	SF3B1:NM_012433:exon15:c.A2098G:p.K700E	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 0, None] 	0.0002	.	0.000199681	6.029	28.0	0.004	6.02	2	.	.	Armadillo-like helical;Armadillo-type fold	SF3B1:uc002uue.3:exon15:c.A2098G:p.K700E	0.399	AFR:0.0003,AMR:8.687e-05,EAS:0.0003,FIN:0,NFE:0.0003,OTH:0,SAS:0	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	BRACA
2	198267359	198267359	C	A	SF3B1	exonic	nonsynonymous SNV	ENSG00000115524	rs377023736	ENSG00000115524:ENST00000335508:exon14:c.G1998T:p.K666N	SF3B1:NM_012433:exon14:c.G1998T:p.K666N	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 0, None] 	2.473e-05	.	.	6.554	31	0.0	4.81	2	.	.	Armadillo-like helical;Armadillo-type fold	SF3B1:uc002uue.3:exon14:c.G1998T:p.K666N	0.219	AFR:0,AMR:0,EAS:0,FIN:0,NFE:4.497e-05,OTH:0,SAS:0	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	BRACA
2	202149589	202149589	G	C	CASP8	exonic	nonsynonymous SNV	ENSG00000064012	rs1045485	ENSG00000064012:ENST00000444430:exon2:c.G190C:p.D64H,ENSG00000064012:ENST00000264274:exon6:c.G601C:p.D201H,ENSG00000064012:ENST00000323492:exon7:c.G808C:p.D270H,ENSG00000064012:ENST00000358485:exon8:c.G1030C:p.D344H,ENSG00000064012:ENST00000392263:exon8:c.G808C:p.D270H,ENSG00000064012:ENST00000264275:exon9:c.G904C:p.D302H,ENSG00000064012:ENST00000432109:exon9:c.G853C:p.D285H	CASP8:NM_033356:exon7:c.G808C:p.D270H,CASP8:NM_001080124:exon8:c.G808C:p.D270H,CASP8:NM_001080125:exon8:c.G1030C:p.D344H,CASP8:NM_001228:exon9:c.G904C:p.D302H,CASP8:NM_033355:exon9:c.G853C:p.D285H	clinvar: other 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 1, 1, 1, None] 	0.0907	0.1097	0.0527157	-0.432	0.323	0.166	-3.42	2	.	.	Caspase-like domain;Death-like domain;Peptidase C14, ICE, catalytic subunit p20;Peptidase C14, caspase domain;Peptidase C14A, caspase precursor p45, core	CASP8:uc010ftf.2:exon4:c.G601C:p.D201H,CASP8:uc002uxw.1:exon7:c.G808C:p.D270H,CASP8:uc002uxq.1:exon8:c.G808C:p.D270H,CASP8:uc002uxt.1:exon8:c.G1030C:p.D344H,CASP8:uc002uxp.1:exon9:c.G904C:p.D302H,CASP8:uc002uxr.1:exon9:c.G853C:p.D285H	-1.006	AFR:0.0636,AMR:0.0505,EAS:0.0003,FIN:0.1018,NFE:0.1242,OTH:0.0991,SAS:0.0429	601763	114480;114550;211980;607271;	275517;449;88673;227535;	275517|ALPS with recurrent viral infections<br>CEDS<br>Caspase 8 deficiency syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|607271 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	NB
2	209113112	209113112	C	T	IDH1	exonic	nonsynonymous SNV	ENSG00000138413	rs121913500	ENSG00000138413:ENST00000415282:exon3:c.G395A:p.R132H,ENSG00000138413:ENST00000345146:exon4:c.G395A:p.R132H,ENSG00000138413:ENST00000415913:exon4:c.G395A:p.R132H,ENSG00000138413:ENST00000446179:exon4:c.G395A:p.R132H	IDH1:NM_001282386:exon4:c.G395A:p.R132H,IDH1:NM_001282387:exon4:c.G395A:p.R132H,IDH1:NM_005896:exon4:c.G395A:p.R132H	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 0, None] 	1.648e-05	.	.	7.592	34	0.025	4.69	2	.	.	Isopropylmalate dehydrogenase-like domain	IDH1:uc002vcs.3:exon4:c.G395A:p.R132H,IDH1:uc002vct.3:exon4:c.G395A:p.R132H,IDH1:uc002vcu.3:exon4:c.G395A:p.R132H	0.587	AFR:0,AMR:0,EAS:0,FIN:0,NFE:2.997e-05,OTH:0,SAS:0	147700	137800;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	Anaplastic Oligodendroglioma
2	209113113	209113113	G	A	IDH1	exonic	nonsynonymous SNV	ENSG00000138413	rs121913499	ENSG00000138413:ENST00000415282:exon3:c.C394T:p.R132C,ENSG00000138413:ENST00000345146:exon4:c.C394T:p.R132C,ENSG00000138413:ENST00000415913:exon4:c.C394T:p.R132C,ENSG00000138413:ENST00000446179:exon4:c.C394T:p.R132C	IDH1:NM_001282386:exon4:c.C394T:p.R132C,IDH1:NM_001282387:exon4:c.C394T:p.R132C,IDH1:NM_005896:exon4:c.C394T:p.R132C	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 0, None] 	.	.	.	7.432	34	0.025	5.57	2	.	.	Isopropylmalate dehydrogenase-like domain	IDH1:uc002vcs.3:exon4:c.C394T:p.R132C,IDH1:uc002vct.3:exon4:c.C394T:p.R132C,IDH1:uc002vcu.3:exon4:c.C394T:p.R132C	0.732	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	147700	137800;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	AML
2	22127164	22127164	C	T	LOC645949	intergenic	.	ENSG00000233005	.	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	2	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	.	.	.	.	HNSC
2	22127164	22127164	C	T	LOC102723362	intergenic	.	ENSG00000233005	.	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	2	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	.	.	.	.	HNSC
22	30051593	30051594	-	T	.	.	.	.	.	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	22	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	.	.	.	.	Peritoneal Mesothelioma
2	29432664	29432664	C	T	ALK	exonic	nonsynonymous SNV	ENSG00000171094	rs113994087	ENSG00000171094:ENST00000389048:exon25:c.G3824A:p.R1275Q	ALK:NM_004304:exon25:c.G3824A:p.R1275Q	clinvar: other 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	8.353	35	0.002	5.47	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon6:c.G620A:p.R207Q,ALK:uc031rnw.1:exon7:c.G620A:p.R207Q,ALK:uc002rmy.3:exon25:c.G3824A:p.R1275Q	0.612	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NB
2	29432682	29432682	C	G	ALK	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000389048:exon25:c.G3806C:p.G1269A;ENSG00000171094:ENST00000389048:exon25:c.G3806C:p.G1269A	ALK:NM_004304:exon25:c.G3806C:p.G1269A;ALK:NM_004304:exon25:c.G3806C:p.G1269A	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 1, 2, None] 	.	.	.	4.642	24.5	0.575	5.47	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon6:c.G602C:p.G201A,ALK:uc031rnw.1:exon7:c.G602C:p.G201A,ALK:uc002rmy.3:exon25:c.G3806C:p.G1269A;ALK:uc010ymo.3:exon6:c.G602C:p.G201A,ALK:uc031rnw.1:exon7:c.G602C:p.G201A,ALK:uc002rmy.3:exon25:c.G3806C:p.G1269A	-0.229	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	CANCER
2	29432682	29432682	C	G	ALK	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000389048:exon25:c.G3806C:p.G1269A;ENSG00000171094:ENST00000389048:exon25:c.G3806C:p.G1269A	ALK:NM_004304:exon25:c.G3806C:p.G1269A;ALK:NM_004304:exon25:c.G3806C:p.G1269A	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 1, 2, None] 	.	.	.	4.642	24.5	0.575	5.47	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon6:c.G602C:p.G201A,ALK:uc031rnw.1:exon7:c.G602C:p.G201A,ALK:uc002rmy.3:exon25:c.G3806C:p.G1269A;ALK:uc010ymo.3:exon6:c.G602C:p.G201A,ALK:uc031rnw.1:exon7:c.G602C:p.G201A,ALK:uc002rmy.3:exon25:c.G3806C:p.G1269A	-0.229	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NSCLC
2	29436859	29436859	A	C	ALK	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094	rs863225283	ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C;ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C;ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C	ALK:NM_004304:exon24:c.T3734G:p.F1245C;ALK:NM_004304:exon24:c.T3734G:p.F1245C;ALK:NM_004304:exon24:c.T3734G:p.F1245C	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	6.652	32	0.0	5.63	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C;ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C;ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C	0.604	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	CANCER
2	29436859	29436859	A	C	ALK	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094	rs863225283	ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C;ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C;ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C	ALK:NM_004304:exon24:c.T3734G:p.F1245C;ALK:NM_004304:exon24:c.T3734G:p.F1245C;ALK:NM_004304:exon24:c.T3734G:p.F1245C	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	6.652	32	0.0	5.63	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C;ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C;ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C	0.604	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NB
2	29436859	29436859	A	C	ALK	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094	rs863225283	ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C;ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C;ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C	ALK:NM_004304:exon24:c.T3734G:p.F1245C;ALK:NM_004304:exon24:c.T3734G:p.F1245C;ALK:NM_004304:exon24:c.T3734G:p.F1245C	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	6.652	32	0.0	5.63	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C;ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C;ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C	0.604	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NSCLC
2	29443600	29443600	G	T	ALK	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000389048:exon23:c.C3617A:p.S1206Y;ENSG00000171094:ENST00000389048:exon23:c.C3617A:p.S1206Y	ALK:NM_004304:exon23:c.C3617A:p.S1206Y;ALK:NM_004304:exon23:c.C3617A:p.S1206Y	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	5.998	27.8	0.002	5.59	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon4:c.C413A:p.S138Y,ALK:uc031rnw.1:exon5:c.C413A:p.S138Y,ALK:uc002rmy.3:exon23:c.C3617A:p.S1206Y;ALK:uc010ymo.3:exon4:c.C413A:p.S138Y,ALK:uc031rnw.1:exon5:c.C413A:p.S138Y,ALK:uc002rmy.3:exon23:c.C3617A:p.S1206Y	0.530	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	CANCER
2	29443600	29443600	G	T	ALK	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000389048:exon23:c.C3617A:p.S1206Y;ENSG00000171094:ENST00000389048:exon23:c.C3617A:p.S1206Y	ALK:NM_004304:exon23:c.C3617A:p.S1206Y;ALK:NM_004304:exon23:c.C3617A:p.S1206Y	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	5.998	27.8	0.002	5.59	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon4:c.C413A:p.S138Y,ALK:uc031rnw.1:exon5:c.C413A:p.S138Y,ALK:uc002rmy.3:exon23:c.C3617A:p.S1206Y;ALK:uc010ymo.3:exon4:c.C413A:p.S138Y,ALK:uc031rnw.1:exon5:c.C413A:p.S138Y,ALK:uc002rmy.3:exon23:c.C3617A:p.S1206Y	0.530	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NSCLC
2	29443613	29443613	C	T	ALK	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R;ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R;ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R	ALK:NM_004304:exon23:c.G3604A:p.G1202R;ALK:NM_004304:exon23:c.G3604A:p.G1202R;ALK:NM_004304:exon23:c.G3604A:p.G1202R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	6.777	32	0.0	5.61	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R;ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R;ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R	0.926	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	CANCER
2	29443613	29443613	C	T	ALK	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R;ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R;ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R	ALK:NM_004304:exon23:c.G3604A:p.G1202R;ALK:NM_004304:exon23:c.G3604A:p.G1202R;ALK:NM_004304:exon23:c.G3604A:p.G1202R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	6.777	32	0.0	5.61	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R;ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R;ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R	0.926	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	LUAD
2	29443613	29443613	C	T	ALK	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R;ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R;ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R	ALK:NM_004304:exon23:c.G3604A:p.G1202R;ALK:NM_004304:exon23:c.G3604A:p.G1202R;ALK:NM_004304:exon23:c.G3604A:p.G1202R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	6.777	32	0.0	5.61	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R;ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R;ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R	0.926	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NSCLC
2	29443631	29443631	G	T	ALK	exonic	nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000389048:exon23:c.C3586A:p.L1196M	ALK:NM_004304:exon23:c.C3586A:p.L1196M	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[2, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	4.383	24.1	0.003	5.61	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon4:c.C382A:p.L128M,ALK:uc031rnw.1:exon5:c.C382A:p.L128M,ALK:uc002rmy.3:exon23:c.C3586A:p.L1196M	0.181	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NSCLC
2	29443679	29443679	C	G	ALK	exonic	nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000389048:exon23:c.G3538C:p.V1180L	ALK:NM_004304:exon23:c.G3538C:p.V1180L	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	6.105	28.3	0.003	5.61	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon4:c.G334C:p.V112L,ALK:uc031rnw.1:exon5:c.G334C:p.V112L,ALK:uc002rmy.3:exon23:c.G3538C:p.V1180L	0.584	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NSCLC
2	29443695	29443695	G	T	ALK	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094	rs863225281	ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L;ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L;ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L	ALK:NM_004304:exon23:c.C3522A:p.F1174L;ALK:NM_004304:exon23:c.C3522A:p.F1174L;ALK:NM_004304:exon23:c.C3522A:p.F1174L	clinvar: Pathogenic,Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	5.091	25.3	0.022	5.61	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L;ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L;ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L	-0.182	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	IM
2	29443695	29443695	G	T	ALK	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094	rs863225281	ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L;ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L;ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L	ALK:NM_004304:exon23:c.C3522A:p.F1174L;ALK:NM_004304:exon23:c.C3522A:p.F1174L;ALK:NM_004304:exon23:c.C3522A:p.F1174L	clinvar: Pathogenic,Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	5.091	25.3	0.022	5.61	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L;ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L;ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L	-0.182	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NB
2	29443695	29443695	G	T	ALK	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094	rs863225281	ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L;ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L;ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L	ALK:NM_004304:exon23:c.C3522A:p.F1174L;ALK:NM_004304:exon23:c.C3522A:p.F1174L;ALK:NM_004304:exon23:c.C3522A:p.F1174L	clinvar: Pathogenic,Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	5.091	25.3	0.022	5.61	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L;ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L;ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L	-0.182	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NSCLC
2	29445213	29445213	A	C	ALK	exonic	nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000453137:exon3:c.T206G:p.I69S,ENSG00000171094:ENST00000389048:exon22:c.T3512G:p.I1171S	ALK:NM_004304:exon22:c.T3512G:p.I1171S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	6.550	31	0.001	5.39	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon3:c.T308G:p.I103S,ALK:uc031rnw.1:exon4:c.T308G:p.I103S,ALK:uc002rmy.3:exon22:c.T3512G:p.I1171S	0.017	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NSCLC
2	29445213	29445213	A	G	ALK	exonic	nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000453137:exon3:c.T206C:p.I69T,ENSG00000171094:ENST00000389048:exon22:c.T3512C:p.I1171T	ALK:NM_004304:exon22:c.T3512C:p.I1171T	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[2, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	6.057	28.1	0.002	5.39	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon3:c.T308C:p.I103T,ALK:uc031rnw.1:exon4:c.T308C:p.I103T,ALK:uc002rmy.3:exon22:c.T3512C:p.I1171T	0.044	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NSCLC
2	29445213	29445213	A	T	ALK	exonic	nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000453137:exon3:c.T206A:p.I69N,ENSG00000171094:ENST00000389048:exon22:c.T3512A:p.I1171N	ALK:NM_004304:exon22:c.T3512A:p.I1171N	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.581	31	0.001	5.39	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon3:c.T308A:p.I103N,ALK:uc031rnw.1:exon4:c.T308A:p.I103N,ALK:uc002rmy.3:exon22:c.T3512A:p.I1171N	0.252	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NSCLC
2	29445258	29445258	C	T	ALK	exonic	nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000453137:exon3:c.G161A:p.C54Y,ENSG00000171094:ENST00000389048:exon22:c.G3467A:p.C1156Y	ALK:NM_004304:exon22:c.G3467A:p.C1156Y	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[2, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	6.503	31	0.02	5.39	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon3:c.G263A:p.C88Y,ALK:uc031rnw.1:exon4:c.G263A:p.C88Y,ALK:uc002rmy.3:exon22:c.G3467A:p.C1156Y	0.133	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NSCLC
2	29445270	29445270	A	C	ALK	exonic	nonsynonymous SNV	ENSG00000171094	.	ENSG00000171094:ENST00000453137:exon3:c.T149G:p.L50R,ENSG00000171094:ENST00000389048:exon22:c.T3455G:p.L1152R	ALK:NM_004304:exon22:c.T3455G:p.L1152R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	6.066	28.1	0.009	5.15	2	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ALK:uc010ymo.3:exon3:c.T251G:p.L84R,ALK:uc031rnw.1:exon4:c.T251G:p.L84R,ALK:uc002rmy.3:exon22:c.T3455G:p.L1152R	0.994	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	NSCLC
2	47630413	47630414	-	G	.	.	.	.	.	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	2	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	.	.	.	.	Lynch Syndrome
2	47656951	47656951	C	T	MSH2	exonic	stopgain	ENSG00000095002	rs63749849	ENSG00000095002:ENST00000233146:exon7:c.C1147T:p.R383X,ENSG00000095002:ENST00000406134:exon7:c.C1147T:p.R383X,ENSG00000095002:ENST00000543555:exon8:c.C949T:p.R317X	MSH2:NM_000251:exon7:c.C1147T:p.R383X,MSH2:NM_001258281:exon8:c.C949T:p.R317X	clinvar: Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 0, 2, None] 	.	.	.	12.911	40	.	3.81	2	.	.	DNA mismatch repair protein MutS, core	MSH2:uc010fbg.3:exon4:c.C577T:p.R193X,MSH2:uc002rvy.2:exon7:c.C1147T:p.R383X,MSH2:uc002rvz.4:exon7:c.C1147T:p.R383X,MSH2:uc010yoh.2:exon8:c.C949T:p.R317X	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	609309	120435;158320;276300;	252202;587;144;	252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~587|Multiple keratoacanthoma, Muir-Torre type|Unknown|Autosomal dominant|Adult|158320 ~144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	Lynch Syndrome
2	47690231	47690231	A	G	MSH2	exonic	nonsynonymous SNV	ENSG00000095002	.	ENSG00000095002:ENST00000233146:exon9:c.A1448G:p.E483G,ENSG00000095002:ENST00000406134:exon9:c.A1448G:p.E483G,ENSG00000095002:ENST00000543555:exon10:c.A1250G:p.E417G	MSH2:NM_000251:exon9:c.A1448G:p.E483G,MSH2:NM_001258281:exon10:c.A1250G:p.E417G	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	3.056	22.4	0.115	5.4	2	.	.	DNA mismatch repair protein MutS, clamp;DNA mismatch repair protein MutS, core	MSH2:uc010fbg.3:exon6:c.A878G:p.E293G,MSH2:uc002rvy.2:exon9:c.A1448G:p.E483G,MSH2:uc002rvz.4:exon9:c.A1448G:p.E483G,MSH2:uc010yoh.2:exon10:c.A1250G:p.E417G	0.065	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	609309	120435;158320;276300;	252202;587;144;	252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~587|Multiple keratoacanthoma, Muir-Torre type|Unknown|Autosomal dominant|Adult|158320 ~144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	Lynch Syndrome
2	48018217	48018217	C	A	MSH6	exonic	nonsynonymous SNV	ENSG00000116062	.	ENSG00000116062:ENST00000234420:exon2:c.C412A:p.P138T,ENSG00000116062:ENST00000411819:exon2:c.C115A:p.P39T,ENSG00000116062:ENST00000420813:exon2:c.C115A:p.P39T,ENSG00000116062:ENST00000445503:exon2:c.C412A:p.P138T,ENSG00000116062:ENST00000455383:exon2:c.C115A:p.P39T,ENSG00000116062:ENST00000606499:exon4:c.C115A:p.P39T	MSH6:NM_000179:exon2:c.C412A:p.P138T	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	6.136	28.4	0.0	5.63	2	.	.	PWWP domain	MSH6:uc002rwc.2:exon2:c.C412A:p.P138T,MSH6:uc002rwd.4:exon2:c.C412A:p.P138T	-0.049	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	600678	276300;608089;614350;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	Lynch Syndrome
2	48026176	48026176	G	A	MSH6	exonic	nonsynonymous SNV	ENSG00000116062	rs730881787	ENSG00000116062:ENST00000540021:exon2:c.G664A:p.V222I,ENSG00000116062:ENST00000234420:exon4:c.G1054A:p.V352I,ENSG00000116062:ENST00000538136:exon4:c.G148A:p.V50I	MSH6:NM_001281492:exon2:c.G664A:p.V222I,MSH6:NM_001281493:exon3:c.G148A:p.V50I,MSH6:NM_000179:exon4:c.G1054A:p.V352I,MSH6:NM_001281494:exon4:c.G148A:p.V50I	clinvar: Likely benign|Uncertain significance|Uncertain significance|Uncertain significance 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 1, 2, None] 	8.247e-05	.	.	-1.201	0.007	0.837	-2.05	2	.	.	.	MSH6:uc010fbj.3:exon3:c.G148A:p.V50I,MSH6:uc002rwc.2:exon4:c.G1054A:p.V352I,MSH6:uc002rwd.4:exon4:c.G1054A:p.V352I,MSH6:uc010yoj.2:exon4:c.G148A:p.V50I	-0.752	AFR:0,AMR:0,EAS:0,FIN:0,NFE:7.501e-05,OTH:0,SAS:0.0003	600678	276300;608089;614350;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	Lynch Syndrome
2	48033420	48033420	C	T	MSH6	exonic	nonsynonymous SNV	ENSG00000116062	.	ENSG00000116062:ENST00000540021:exon6:c.C3334T:p.R1112C,ENSG00000116062:ENST00000234420:exon8:c.C3724T:p.R1242C,ENSG00000116062:ENST00000538136:exon8:c.C2818T:p.R940C	MSH6:NM_001281492:exon6:c.C3334T:p.R1112C,MSH6:NM_001281493:exon7:c.C2818T:p.R940C,MSH6:NM_000179:exon8:c.C3724T:p.R1242C,MSH6:NM_001281494:exon8:c.C2818T:p.R940C	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	7.006	33	0.0	4.59	2	.	.	DNA mismatch repair protein MutS, C-terminal;DNA mismatch repair protein MutS, clamp;DNA mismatch repair protein MutS, core;P-loop containing nucleoside triphosphate hydrolase	MSH6:uc010fbj.3:exon7:c.C2818T:p.R940C,MSH6:uc002rwd.4:exon8:c.C3724T:p.R1242C,MSH6:uc010yoj.2:exon8:c.C2818T:p.R940C	0.811	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	600678	276300;608089;614350;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	Lynch Syndrome
2	48033421	48033421	G	A	MSH6	exonic	nonsynonymous SNV	ENSG00000116062	rs63750119	ENSG00000116062:ENST00000540021:exon6:c.G3335A:p.R1112H,ENSG00000116062:ENST00000234420:exon8:c.G3725A:p.R1242H,ENSG00000116062:ENST00000538136:exon8:c.G2819A:p.R940H	MSH6:NM_001281492:exon6:c.G3335A:p.R1112H,MSH6:NM_001281493:exon7:c.G2819A:p.R940H,MSH6:NM_000179:exon8:c.G3725A:p.R1242H,MSH6:NM_001281494:exon8:c.G2819A:p.R940H	clinvar: Likely pathogenic|Likely pathogenic,Uncertain significance|Uncertain significance 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	8.25e-06	.	.	6.639	32	0.0	5.5	2	.	.	DNA mismatch repair protein MutS, C-terminal;DNA mismatch repair protein MutS, clamp;DNA mismatch repair protein MutS, core;P-loop containing nucleoside triphosphate hydrolase	MSH6:uc010fbj.3:exon7:c.G2819A:p.R940H,MSH6:uc002rwd.4:exon8:c.G3725A:p.R1242H,MSH6:uc010yoj.2:exon8:c.G2819A:p.R940H	0.720	AFR:0,AMR:0,EAS:0.0001,FIN:0,NFE:0,OTH:0,SAS:0	600678	276300;608089;614350;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	Lynch Syndrome
3	10183694	10183694	G	-	VHL	exonic	frameshift deletion	ENSG00000134086	.	ENSG00000134086:ENST00000256474:exon1:c.163delG:p.E55fs,ENSG00000134086:ENST00000345392:exon1:c.163delG:p.E55fs	VHL:NM_000551:exon1:c.163delG:p.E55fs,VHL:NM_198156:exon1:c.163delG:p.E55fs	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 0, 2, None] 	.	.	.	.	.	.	.	3	.	.	.	VHL:uc003bvc.3:exon1:c.163delG:p.E55fs,VHL:uc003bvd.3:exon1:c.163delG:p.E55fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	608537	144700;171300;193300;263400;	238557;892;29072;422526;	238557|Chuvash polycythemia<br>Von Hippel-Lindau-dependent polycythemia|Unknown|Autosomal recessive|Infancy<br>Neonatal|263400 ~892|Familial cerebelloretinal angiomatosis<br>Lindau disease<br>VHL<br>Von Hippel-Lindau syndrome|1-9 / 100 000|Autosomal dominant|Adult|193300 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	Von Hippel-Lindau Disease
3	10183695	10183696	-	A	.	.	.	.	.	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	3	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	.	.	.	.	Von Hippel-Lindau Disease
3	10183695	10183696	-	G	.	.	.	.	.	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	3	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	.	.	.	.	Von Hippel-Lindau Disease
3	10183696	10183696	G	A	VHL	exonic	synonymous SNV	ENSG00000134086	.	ENSG00000134086:ENST00000256474:exon1:c.G165A:p.E55E,ENSG00000134086:ENST00000345392:exon1:c.G165A:p.E55E	VHL:NM_000551:exon1:c.G165A:p.E55E,VHL:NM_198156:exon1:c.G165A:p.E55E	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 0, None, None, 1, 0, 0, 0, 2, None] 	.	.	.	.	.	.	.	3	.	.	.	VHL:uc003bvc.3:exon1:c.G165A:p.E55E,VHL:uc003bvd.3:exon1:c.G165A:p.E55E	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	608537	144700;171300;193300;263400;	238557;892;29072;422526;	238557|Chuvash polycythemia<br>Von Hippel-Lindau-dependent polycythemia|Unknown|Autosomal recessive|Infancy<br>Neonatal|263400 ~892|Familial cerebelloretinal angiomatosis<br>Lindau disease<br>VHL<br>Von Hippel-Lindau syndrome|1-9 / 100 000|Autosomal dominant|Adult|193300 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	Von Hippel-Lindau Disease
3	10188302	10188302	G	T	VHL	exonic	nonsynonymous SNV	ENSG00000134086	rs587780077	ENSG00000134086:ENST00000256474:exon2:c.G445T:p.A149S	VHL:NM_000551:exon2:c.G445T:p.A149S	clinvar: Pathogenic,Uncertain significance,Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	5.524	26.3	.	4.89	3	.	.	von Hippel-Lindau disease tumour suppressor,  beta domain;von Hippel-Lindau disease tumour suppressor, beta/alpha domain	VHL:uc003bvc.3:exon2:c.G445T:p.A149S	1.019	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	608537	144700;171300;193300;263400;	238557;892;29072;422526;	238557|Chuvash polycythemia<br>Von Hippel-Lindau-dependent polycythemia|Unknown|Autosomal recessive|Infancy<br>Neonatal|263400 ~892|Familial cerebelloretinal angiomatosis<br>Lindau disease<br>VHL<br>Von Hippel-Lindau syndrome|1-9 / 100 000|Autosomal dominant|Adult|193300 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	Von Hippel-Lindau Disease
3	10191605	10191605	C	T	VHL	exonic	nonsynonymous SNV	ENSG00000134086	rs28940298	ENSG00000134086:ENST00000345392:exon2:c.C475T:p.R159W,ENSG00000134086:ENST00000256474:exon3:c.C598T:p.R200W	VHL:NM_198156:exon2:c.C475T:p.R159W,VHL:NM_000551:exon3:c.C598T:p.R200W	clinvar: Pathogenic|Uncertain significance|Likely benign|Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	0.0002	0.0002	.	8.095	35	0.0	4.03	3	.	.	von Hippel-Lindau disease tumour suppressor, alpha domain;von Hippel-Lindau disease tumour suppressor, beta/alpha domain	VHL:uc003bvd.3:exon2:c.C475T:p.R159W,VHL:uc003bvc.3:exon3:c.C598T:p.R200W	0.958	AFR:9.787e-05,AMR:0,EAS:0,FIN:0,NFE:0.0003,OTH:0,SAS:0.0006	608537	144700;171300;193300;263400;	238557;892;29072;422526;	238557|Chuvash polycythemia<br>Von Hippel-Lindau-dependent polycythemia|Unknown|Autosomal recessive|Infancy<br>Neonatal|263400 ~892|Familial cerebelloretinal angiomatosis<br>Lindau disease<br>VHL<br>Von Hippel-Lindau syndrome|1-9 / 100 000|Autosomal dominant|Adult|193300 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	Chuvash Polycythemia
3	105439026	105439026	G	A	CBLB	exonic	synonymous SNV	ENSG00000114423	rs2305035	ENSG00000114423:ENST00000264122:exon10:c.C1272T:p.D424D,ENSG00000114423:ENST00000394027:exon10:c.C1338T:p.D446D,ENSG00000114423:ENST00000403724:exon10:c.C1272T:p.D424D,ENSG00000114423:ENST00000405772:exon10:c.C1272T:p.D424D	CBLB:NM_170662:exon10:c.C1272T:p.D424D	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 0, None, None, 0, 0, 1, 0, 0, None] 	0.2204	0.2043	0.210064	.	.	.	.	3	.	.	.	CBLB:uc003dwc.3:exon10:c.C1272T:p.D424D,CBLB:uc003dwd.2:exon10:c.C1272T:p.D424D,CBLB:uc003dwe.2:exon10:c.C1272T:p.D424D,CBLB:uc011bhi.2:exon10:c.C1338T:p.D446D	.	AFR:0.1883,AMR:0.3289,EAS:0.2354,FIN:0.2639,NFE:0.2176,OTH:0.2249,SAS:0.1506	604491	.	.	.	NSCLC
3	138665163	138665163	G	C	FOXL2	exonic	nonsynonymous SNV	ENSG00000183770	.	ENSG00000183770:ENST00000330315:exon1:c.C402G:p.C134W	FOXL2:NM_023067:exon1:c.C402G:p.C134W	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 2, 0, None] 	.	.	.	6.510	31	0.001	3.76	3	.	.	Transcription factor, fork head;Winged helix-turn-helix DNA-binding domain	FOXL2:uc003esw.3:exon1:c.C402G:p.C134W	1.051	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	605597	110100;608996;	126;	126|Blepharophimosis types 1 and 2|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|110100 ~	OVG
3	142274740	142274740	A	-	ATR	exonic	frameshift deletion	ENSG00000175054	rs757500301	ENSG00000175054:ENST00000383101:exon9:c.2128delA:p.I710fs,ENSG00000175054:ENST00000350721:exon10:c.2320delA:p.I774fs	ATR:NM_001184:exon10:c.2320delA:p.I774fs	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 0, 0, 2, 0, 0, None] 	0.0053	.	.	.	.	.	.	3	.	.	.	ATR:uc003eux.4:exon10:c.2320delA:p.I774fs	.	AFR:0.0030,AMR:0.0011,EAS:0.0039,FIN:0.0002,NFE:0.0075,OTH:0.0084,SAS:0.0030	601215	210600;614564;	313846;808;	313846|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614564 ~808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	EDA
3	178928226	178928226	C	T	PIK3CA	exonic	nonsynonymous SNV	ENSG00000121879	.	ENSG00000121879:ENST00000263967:exon9:c.C1412T:p.P471L	PIK3CA:NM_006218:exon9:c.C1412T:p.P471L	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	5.609	26.5	0.031	5.64	3	.	.	C2 domain;Phosphatidylinositol 3-kinase, C2 domain	PIK3CA:uc003fjk.3:exon9:c.C1412T:p.P471L	-0.098	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	MERC
3	178936082	178936082	G	A	PIK3CA	exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs121913273	ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K	PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K	clinvar: Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	5.844	27.3	0.016	5.78	3	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K	-0.729	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
3	178936082	178936082	G	A	PIK3CA	exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs121913273	ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K	PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K	clinvar: Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	5.844	27.3	0.016	5.78	3	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K	-0.729	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	COREAD
3	178936082	178936082	G	A	PIK3CA	exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs121913273	ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K	PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K	clinvar: Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	5.844	27.3	0.016	5.78	3	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K	-0.729	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	HNSC
3	178936082	178936082	G	A	PIK3CA	exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs121913273	ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K	PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K	clinvar: Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	5.844	27.3	0.016	5.78	3	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K	-0.729	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	TH
3	178936091	178936091	G	A	PIK3CA	exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs104886003	ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K	PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|not provided 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.34e-06	.	.	6.953	33	0.002	5.78	3	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K	-0.529	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.508e-05,OTH:0,SAS:0	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
3	178936091	178936091	G	A	PIK3CA	exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs104886003	ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K	PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|not provided 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.34e-06	.	.	6.953	33	0.002	5.78	3	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K	-0.529	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.508e-05,OTH:0,SAS:0	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	CANCER
3	178936091	178936091	G	A	PIK3CA	exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs104886003	ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K	PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|not provided 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.34e-06	.	.	6.953	33	0.002	5.78	3	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K	-0.529	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.508e-05,OTH:0,SAS:0	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	COREAD
3	178936091	178936091	G	A	PIK3CA	exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs104886003	ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K	PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|not provided 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.34e-06	.	.	6.953	33	0.002	5.78	3	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K	-0.529	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.508e-05,OTH:0,SAS:0	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	Her2-receptor Positive Breast Cancer
3	178936091	178936091	G	A	PIK3CA	exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs104886003	ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K	PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|not provided 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.34e-06	.	.	6.953	33	0.002	5.78	3	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K	-0.529	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.508e-05,OTH:0,SAS:0	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	LUAD
3	178952085	178952085	A	G	PIK3CA	exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs121913279	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.317e-06	.	.	2.589	20.1	0.019	6.08	3	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	-0.565	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.505e-05,OTH:0,SAS:0	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
3	178952085	178952085	A	G	PIK3CA	exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs121913279	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.317e-06	.	.	2.589	20.1	0.019	6.08	3	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	-0.565	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.505e-05,OTH:0,SAS:0	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	COREAD
3	178952085	178952085	A	G	PIK3CA	exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs121913279	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.317e-06	.	.	2.589	20.1	0.019	6.08	3	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	-0.565	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.505e-05,OTH:0,SAS:0	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	HNC
3	178952085	178952085	A	G	PIK3CA	exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs121913279	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.317e-06	.	.	2.589	20.1	0.019	6.08	3	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	-0.565	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.505e-05,OTH:0,SAS:0	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	HNSC
3	178952085	178952085	A	G	PIK3CA	exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs121913279	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.317e-06	.	.	2.589	20.1	0.019	6.08	3	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	-0.565	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.505e-05,OTH:0,SAS:0	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	Her2-receptor Positive Breast Cancer
3	178952085	178952085	A	G	PIK3CA	exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs121913279	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.317e-06	.	.	2.589	20.1	0.019	6.08	3	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	-0.565	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.505e-05,OTH:0,SAS:0	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	LUAD
3	178952085	178952085	A	G	PIK3CA	exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879	rs121913279	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.317e-06	.	.	2.589	20.1	0.019	6.08	3	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	-0.565	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.505e-05,OTH:0,SAS:0	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	TH
3	38182641	38182641	T	C	MYD88	exonic;exonic	stoploss;stoploss	ENSG00000172936	rs387907272	ENSG00000172936:ENST00000495303:exon3:c.T478C:p.X160R,ENSG00000172936:ENST00000443433:exon4:c.T613C:p.X205R;ENSG00000172936:ENST00000495303:exon3:c.T478C:p.X160R,ENSG00000172936:ENST00000443433:exon4:c.T613C:p.X205R	MYD88:NM_001172566:exon3:c.T478C:p.X160R,MYD88:NM_001172569:exon4:c.T613C:p.X205R;MYD88:NM_001172566:exon3:c.T478C:p.X160R,MYD88:NM_001172569:exon4:c.T613C:p.X205R	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 0, None, None, 1, 2, 2, 2, 0, None] 	9.885e-05	.	0.000199681	6.636	32	0.0	5.74	3	.	.	Toll/interleukin-1 receptor homology (TIR) domain	MYD88:uc011ayk.2:exon3:c.T478C:p.X160R,MYD88:uc011ayj.2:exon4:c.T613C:p.X205R;MYD88:uc011ayk.2:exon3:c.T478C:p.X160R,MYD88:uc011ayj.2:exon4:c.T613C:p.X205R	-0.482	AFR:0,AMR:0,EAS:0.0001,FIN:0.0002,NFE:0.0001,OTH:0,SAS:0	602170	153600;612260;	183713;33226;	183713|MyD88 deficiency|Unknown|Autosomal recessive|Childhood|612260 ~33226|-|1-9 / 100 000|Multigenic/multifactorial|Elderly|153600 610430 ~	CLL
3	38182641	38182641	T	C	MYD88	exonic;exonic	stoploss;stoploss	ENSG00000172936	rs387907272	ENSG00000172936:ENST00000495303:exon3:c.T478C:p.X160R,ENSG00000172936:ENST00000443433:exon4:c.T613C:p.X205R;ENSG00000172936:ENST00000495303:exon3:c.T478C:p.X160R,ENSG00000172936:ENST00000443433:exon4:c.T613C:p.X205R	MYD88:NM_001172566:exon3:c.T478C:p.X160R,MYD88:NM_001172569:exon4:c.T613C:p.X205R;MYD88:NM_001172566:exon3:c.T478C:p.X160R,MYD88:NM_001172569:exon4:c.T613C:p.X205R	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 0, None, None, 1, 2, 2, 2, 0, None] 	9.885e-05	.	0.000199681	6.636	32	0.0	5.74	3	.	.	Toll/interleukin-1 receptor homology (TIR) domain	MYD88:uc011ayk.2:exon3:c.T478C:p.X160R,MYD88:uc011ayj.2:exon4:c.T613C:p.X205R;MYD88:uc011ayk.2:exon3:c.T478C:p.X160R,MYD88:uc011ayj.2:exon4:c.T613C:p.X205R	-0.482	AFR:0,AMR:0,EAS:0.0001,FIN:0.0002,NFE:0.0001,OTH:0,SAS:0	602170	153600;612260;	183713;33226;	183713|MyD88 deficiency|Unknown|Autosomal recessive|Childhood|612260 ~33226|-|1-9 / 100 000|Multigenic/multifactorial|Elderly|153600 610430 ~	Waldenstr.ms Macroglobulinemia
4	1803568	1803568	C	G	FGFR3	exonic	nonsynonymous SNV	ENSG00000068078	rs121913483	ENSG00000068078:ENST00000507588:exon3:c.C206G:p.S69C,ENSG00000068078:ENST00000260795:exon6:c.C746G:p.S249C,ENSG00000068078:ENST00000352904:exon6:c.C746G:p.S249C,ENSG00000068078:ENST00000340107:exon7:c.C746G:p.S249C,ENSG00000068078:ENST00000412135:exon7:c.C746G:p.S249C,ENSG00000068078:ENST00000440486:exon7:c.C746G:p.S249C,ENSG00000068078:ENST00000481110:exon7:c.C746G:p.S249C	FGFR3:NM_000142:exon7:c.C746G:p.S249C,FGFR3:NM_001163213:exon7:c.C746G:p.S249C,FGFR3:NM_022965:exon7:c.C746G:p.S249C	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	9.654e-06	.	.	3.567	23.1	0.045	3.94	4	.	.	.	FGFR3:uc003gdt.1:exon3:c.C272G:p.S91C,FGFR3:uc010icb.1:exon3:c.C272G:p.S91C,FGFR3:uc003gdq.3:exon7:c.C746G:p.S249C,FGFR3:uc003gdr.3:exon7:c.C746G:p.S249C,FGFR3:uc003gds.3:exon7:c.C746G:p.S249C,FGFR3:uc003gdu.2:exon7:c.C746G:p.S249C	0.799	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.777e-05,OTH:0,SAS:0	134934	100800;109800;114500;146000;149730;162900;187600;187601;273300;602849;603956;610474;612247;616482;	85165;93262;85164;53271;363483;363494;363504;842;876;99865;2655;93274;1860;2655;79414;2363;429;15;	85165|SADDAN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|616482 ~93262|Crouzon-dermoskeletal syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|612247 ~85164|CATSHL syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610474 ~53271|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|602849 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~93274|Cloverleaf skull-micromelic bone dysplasia syndrome<br>TD2<br>Thanatophoric dwarfism type 2<br>Thanatophoric dwarfism-cloverleaf skull syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|156830 187601 ~1860|TD1<br>Thanatophoric dwarfism type 1|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal|187600 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~429|-|1-9 / 100 000|Autosomal dominant|Childhood|146000 ~15|-|1-9 / 100 000|Autosomal dominant|Neonatal|100800 ~	UTH
4	1806099	1806099	A	G	FGFR3	exonic	nonsynonymous SNV	ENSG00000068078	rs121913485	ENSG00000068078:ENST00000260795:exon8:c.A1118G:p.Y373C,ENSG00000068078:ENST00000340107:exon9:c.A1124G:p.Y375C,ENSG00000068078:ENST00000440486:exon9:c.A1118G:p.Y373C,ENSG00000068078:ENST00000481110:exon9:c.A1118G:p.Y373C	FGFR3:NM_000142:exon9:c.A1118G:p.Y373C,FGFR3:NM_001163213:exon9:c.A1124G:p.Y375C	clinvar: Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	3.448	23.0	0.003	1.93	4	.	.	.	FGFR3:uc003gdq.3:exon9:c.A1118G:p.Y373C,FGFR3:uc003gdr.3:exon9:c.A1118G:p.Y373C,FGFR3:uc003gdu.2:exon9:c.A1124G:p.Y375C	0.732	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	134934	100800;109800;114500;146000;149730;162900;187600;187601;273300;602849;603956;610474;612247;616482;	85165;93262;85164;53271;363483;363494;363504;842;876;99865;2655;93274;1860;2655;79414;2363;429;15;	85165|SADDAN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|616482 ~93262|Crouzon-dermoskeletal syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|612247 ~85164|CATSHL syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610474 ~53271|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|602849 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~93274|Cloverleaf skull-micromelic bone dysplasia syndrome<br>TD2<br>Thanatophoric dwarfism type 2<br>Thanatophoric dwarfism-cloverleaf skull syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|156830 187601 ~1860|TD1<br>Thanatophoric dwarfism type 1|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal|187600 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~429|-|1-9 / 100 000|Autosomal dominant|Childhood|146000 ~15|-|1-9 / 100 000|Autosomal dominant|Neonatal|100800 ~	BLCA
4	55141036	55141036	T	C	PDGFRA	exonic	nonsynonymous SNV	ENSG00000134853	.	ENSG00000134853:ENST00000257290:exon12:c.T1682C:p.V561A,ENSG00000134853:ENST00000509490:exon12:c.T1682C:p.V561A	PDGFRA:NM_006206:exon12:c.T1682C:p.V561A	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	5.603	26.5	0.005	4.67	4	.	.	.	PDGFRA:uc010igq.1:exon11:c.T1364C:p.V455A,PDGFRA:uc003han.4:exon12:c.T1682C:p.V561A	0.938	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	GIST
4	55144547	55144547	C	T	PDGFRA	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000134853,ENSG00000145216	rs121908587	ENSG00000134853:ENST00000257290:exon15:c.C2021T:p.T674I,ENSG00000134853:ENST00000509490:exon15:c.C2021T:p.T674I,ENSG00000145216:ENST00000507166:exon16:c.C1301T:p.T434I;ENSG00000134853:ENST00000257290:exon15:c.C2021T:p.T674I,ENSG00000134853:ENST00000509490:exon15:c.C2021T:p.T674I,ENSG00000145216:ENST00000507166:exon16:c.C1301T:p.T434I	PDGFRA:NM_006206:exon15:c.C2021T:p.T674I;PDGFRA:NM_006206:exon15:c.C2021T:p.T674I	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	6.999	33	0.007	6.06	4	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	PDGFRA:uc003hao.1:exon3:c.C158T:p.T53I,PDGFRA:uc010igq.1:exon14:c.C1703T:p.T568I,PDGFRA:uc003han.4:exon15:c.C2021T:p.T674I,PDGFRA:uc003haa.3:exon16:c.C1301T:p.T434I;PDGFRA:uc003hao.1:exon3:c.C158T:p.T53I,PDGFRA:uc010igq.1:exon14:c.C1703T:p.T568I,PDGFRA:uc003han.4:exon15:c.C2021T:p.T674I,PDGFRA:uc003haa.3:exon16:c.C1301T:p.T434I	0.554	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	Chronic Eosinophilic Leukemia
4	55144547	55144547	C	T	PDGFRA	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000134853,ENSG00000145216	rs121908587	ENSG00000134853:ENST00000257290:exon15:c.C2021T:p.T674I,ENSG00000134853:ENST00000509490:exon15:c.C2021T:p.T674I,ENSG00000145216:ENST00000507166:exon16:c.C1301T:p.T434I;ENSG00000134853:ENST00000257290:exon15:c.C2021T:p.T674I,ENSG00000134853:ENST00000509490:exon15:c.C2021T:p.T674I,ENSG00000145216:ENST00000507166:exon16:c.C1301T:p.T434I	PDGFRA:NM_006206:exon15:c.C2021T:p.T674I;PDGFRA:NM_006206:exon15:c.C2021T:p.T674I	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	6.999	33	0.007	6.06	4	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	PDGFRA:uc003hao.1:exon3:c.C158T:p.T53I,PDGFRA:uc010igq.1:exon14:c.C1703T:p.T568I,PDGFRA:uc003han.4:exon15:c.C2021T:p.T674I,PDGFRA:uc003haa.3:exon16:c.C1301T:p.T434I;PDGFRA:uc003hao.1:exon3:c.C158T:p.T53I,PDGFRA:uc010igq.1:exon14:c.C1703T:p.T568I,PDGFRA:uc003han.4:exon15:c.C2021T:p.T674I,PDGFRA:uc003haa.3:exon16:c.C1301T:p.T434I	0.554	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	Hypereosinophilic Syndrome, Myeloproliferative Subtype
4	55152092	55152092	G	T	PDGFRA	exonic	nonsynonymous SNV	ENSG00000134853,ENSG00000145216	rs121913265	ENSG00000134853:ENST00000257290:exon18:c.G2524T:p.D842Y,ENSG00000145216:ENST00000507166:exon19:c.G1804T:p.D602Y	PDGFRA:NM_006206:exon18:c.G2524T:p.D842Y	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	7.212	34	0.011	6.04	4	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	PDGFRA:uc003han.4:exon18:c.G2524T:p.D842Y,PDGFRA:uc003haa.3:exon19:c.G1804T:p.D602Y	0.289	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	GIST
4	55152093	55152093	A	T	PDGFRA	exonic	nonsynonymous SNV	ENSG00000134853,ENSG00000145216	rs121908585	ENSG00000134853:ENST00000257290:exon18:c.A2525T:p.D842V,ENSG00000145216:ENST00000507166:exon19:c.A1805T:p.D602V	PDGFRA:NM_006206:exon18:c.A2525T:p.D842V	clinvar: Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	6.552	31	0.001	5.85	4	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	PDGFRA:uc003han.4:exon18:c.A2525T:p.D842V,PDGFRA:uc003haa.3:exon19:c.A1805T:p.D602V	0.265	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	GIST
4	55593464	55593464	A	C	KIT	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157404	rs3822214	ENSG00000157404:ENST00000288135:exon10:c.A1621C:p.M541L,ENSG00000157404:ENST00000412167:exon10:c.A1609C:p.M537L;ENSG00000157404:ENST00000288135:exon10:c.A1621C:p.M541L,ENSG00000157404:ENST00000412167:exon10:c.A1609C:p.M537L	KIT:NM_000222:exon10:c.A1621C:p.M541L,KIT:NM_001093772:exon10:c.A1609C:p.M537L;KIT:NM_000222:exon10:c.A1621C:p.M541L,KIT:NM_001093772:exon10:c.A1609C:p.M537L	clinvar: Benign|Benign 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 0, 1, 1, 1, 2, None] 	0.0789	0.0955	0.0644968	0.183	4.498	0.804	1.82	4	.	.	.	KIT:uc010igr.3:exon10:c.A1621C:p.M541L,KIT:uc010igs.3:exon10:c.A1609C:p.M537L;KIT:uc010igr.3:exon10:c.A1621C:p.M541L,KIT:uc010igs.3:exon10:c.A1609C:p.M537L	-1.131	AFR:0.0601,AMR:0.0423,EAS:0.0446,FIN:0.0392,NFE:0.0970,OTH:0.0771,SAS:0.0771	164920	154800;172800;273300;601626;606764;	44890;519;363483;363494;363504;842;876;99865;2884;79457;98292;	44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2884|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|172800 ~79457|Urticaria pigmentosa|Unknown|Not applicable|All ages|154800 ~98292|-|1-9 / 100 000|-|All ages|154800 ~	Chronic Leukemia
4	55593464	55593464	A	C	KIT	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157404	rs3822214	ENSG00000157404:ENST00000288135:exon10:c.A1621C:p.M541L,ENSG00000157404:ENST00000412167:exon10:c.A1609C:p.M537L;ENSG00000157404:ENST00000288135:exon10:c.A1621C:p.M541L,ENSG00000157404:ENST00000412167:exon10:c.A1609C:p.M537L	KIT:NM_000222:exon10:c.A1621C:p.M541L,KIT:NM_001093772:exon10:c.A1609C:p.M537L;KIT:NM_000222:exon10:c.A1621C:p.M541L,KIT:NM_001093772:exon10:c.A1609C:p.M537L	clinvar: Benign|Benign 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 0, 1, 1, 1, 2, None] 	0.0789	0.0955	0.0644968	0.183	4.498	0.804	1.82	4	.	.	.	KIT:uc010igr.3:exon10:c.A1621C:p.M541L,KIT:uc010igs.3:exon10:c.A1609C:p.M537L;KIT:uc010igr.3:exon10:c.A1621C:p.M541L,KIT:uc010igs.3:exon10:c.A1609C:p.M537L	-1.131	AFR:0.0601,AMR:0.0423,EAS:0.0446,FIN:0.0392,NFE:0.0970,OTH:0.0771,SAS:0.0771	164920	154800;172800;273300;601626;606764;	44890;519;363483;363494;363504;842;876;99865;2884;79457;98292;	44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2884|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|172800 ~79457|Urticaria pigmentosa|Unknown|Not applicable|All ages|154800 ~98292|-|1-9 / 100 000|-|All ages|154800 ~	CML
4	55593661	55593661	T	C	KIT	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157404	rs121913513	ENSG00000157404:ENST00000288135:exon11:c.T1727C:p.L576P,ENSG00000157404:ENST00000412167:exon11:c.T1715C:p.L572P;ENSG00000157404:ENST00000288135:exon11:c.T1727C:p.L576P,ENSG00000157404:ENST00000412167:exon11:c.T1715C:p.L572P	KIT:NM_000222:exon11:c.T1727C:p.L576P,KIT:NM_001093772:exon11:c.T1715C:p.L572P;KIT:NM_000222:exon11:c.T1727C:p.L576P,KIT:NM_001093772:exon11:c.T1715C:p.L572P	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	4.652	24.5	0.0	6.06	4	.	.	Protein kinase-like domain	KIT:uc010igt.2:exon1:c.T74C:p.L25P,KIT:uc010igr.3:exon11:c.T1727C:p.L576P,KIT:uc010igs.3:exon11:c.T1715C:p.L572P;KIT:uc010igt.2:exon1:c.T74C:p.L25P,KIT:uc010igr.3:exon11:c.T1727C:p.L576P,KIT:uc010igs.3:exon11:c.T1715C:p.L572P	1.019	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164920	154800;172800;273300;601626;606764;	44890;519;363483;363494;363504;842;876;99865;2884;79457;98292;	44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2884|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|172800 ~79457|Urticaria pigmentosa|Unknown|Not applicable|All ages|154800 ~98292|-|1-9 / 100 000|-|All ages|154800 ~	M
4	55593661	55593661	T	C	KIT	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157404	rs121913513	ENSG00000157404:ENST00000288135:exon11:c.T1727C:p.L576P,ENSG00000157404:ENST00000412167:exon11:c.T1715C:p.L572P;ENSG00000157404:ENST00000288135:exon11:c.T1727C:p.L576P,ENSG00000157404:ENST00000412167:exon11:c.T1715C:p.L572P	KIT:NM_000222:exon11:c.T1727C:p.L576P,KIT:NM_001093772:exon11:c.T1715C:p.L572P;KIT:NM_000222:exon11:c.T1727C:p.L576P,KIT:NM_001093772:exon11:c.T1715C:p.L572P	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	4.652	24.5	0.0	6.06	4	.	.	Protein kinase-like domain	KIT:uc010igt.2:exon1:c.T74C:p.L25P,KIT:uc010igr.3:exon11:c.T1727C:p.L576P,KIT:uc010igs.3:exon11:c.T1715C:p.L572P;KIT:uc010igt.2:exon1:c.T74C:p.L25P,KIT:uc010igr.3:exon11:c.T1727C:p.L576P,KIT:uc010igs.3:exon11:c.T1715C:p.L572P	1.019	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164920	154800;172800;273300;601626;606764;	44890;519;363483;363494;363504;842;876;99865;2884;79457;98292;	44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2884|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|172800 ~79457|Urticaria pigmentosa|Unknown|Not applicable|All ages|154800 ~98292|-|1-9 / 100 000|-|All ages|154800 ~	NSCLC
4	55594258	55594258	T	C	KIT	exonic	nonsynonymous SNV	ENSG00000157404	rs121913523	ENSG00000157404:ENST00000288135:exon13:c.T1961C:p.V654A,ENSG00000157404:ENST00000412167:exon13:c.T1949C:p.V650A	KIT:NM_000222:exon13:c.T1961C:p.V654A,KIT:NM_001093772:exon13:c.T1949C:p.V650A	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	5.700	26.8	0.021	6.06	4	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain;Tyrosine-protein kinase, receptor class III, conserved site	KIT:uc010igt.2:exon3:c.T308C:p.V103A,KIT:uc010igr.3:exon13:c.T1961C:p.V654A,KIT:uc010igs.3:exon13:c.T1949C:p.V650A	0.818	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164920	154800;172800;273300;601626;606764;	44890;519;363483;363494;363504;842;876;99865;2884;79457;98292;	44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2884|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|172800 ~79457|Urticaria pigmentosa|Unknown|Not applicable|All ages|154800 ~98292|-|1-9 / 100 000|-|All ages|154800 ~	GIST
4	55599321	55599321	A	T	KIT	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157404	rs121913507	ENSG00000157404:ENST00000288135:exon17:c.A2447T:p.D816V,ENSG00000157404:ENST00000412167:exon17:c.A2435T:p.D812V;ENSG00000157404:ENST00000288135:exon17:c.A2447T:p.D816V,ENSG00000157404:ENST00000412167:exon17:c.A2435T:p.D812V	KIT:NM_000222:exon17:c.A2447T:p.D816V,KIT:NM_001093772:exon17:c.A2435T:p.D812V;KIT:NM_000222:exon17:c.A2447T:p.D816V,KIT:NM_001093772:exon17:c.A2435T:p.D812V	clinvar: Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	6.511	31	0.0	5.62	4	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	KIT:uc010igr.3:exon17:c.A2447T:p.D816V,KIT:uc010igs.3:exon17:c.A2435T:p.D812V;KIT:uc010igr.3:exon17:c.A2447T:p.D816V,KIT:uc010igs.3:exon17:c.A2435T:p.D812V	0.303	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164920	154800;172800;273300;601626;606764;	44890;519;363483;363494;363504;842;876;99865;2884;79457;98292;	44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2884|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|172800 ~79457|Urticaria pigmentosa|Unknown|Not applicable|All ages|154800 ~98292|-|1-9 / 100 000|-|All ages|154800 ~	AML
4	55599321	55599321	A	T	KIT	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157404	rs121913507	ENSG00000157404:ENST00000288135:exon17:c.A2447T:p.D816V,ENSG00000157404:ENST00000412167:exon17:c.A2435T:p.D812V;ENSG00000157404:ENST00000288135:exon17:c.A2447T:p.D816V,ENSG00000157404:ENST00000412167:exon17:c.A2435T:p.D812V	KIT:NM_000222:exon17:c.A2447T:p.D816V,KIT:NM_001093772:exon17:c.A2435T:p.D812V;KIT:NM_000222:exon17:c.A2447T:p.D816V,KIT:NM_001093772:exon17:c.A2435T:p.D812V	clinvar: Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	6.511	31	0.0	5.62	4	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	KIT:uc010igr.3:exon17:c.A2447T:p.D816V,KIT:uc010igs.3:exon17:c.A2435T:p.D812V;KIT:uc010igr.3:exon17:c.A2447T:p.D816V,KIT:uc010igs.3:exon17:c.A2435T:p.D812V	0.303	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164920	154800;172800;273300;601626;606764;	44890;519;363483;363494;363504;842;876;99865;2884;79457;98292;	44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2884|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|172800 ~79457|Urticaria pigmentosa|Unknown|Not applicable|All ages|154800 ~98292|-|1-9 / 100 000|-|All ages|154800 ~	SM
4	55602765	55602765	G	C	KIT	exonic	synonymous SNV	ENSG00000157404	rs3733542	ENSG00000157404:ENST00000288135:exon18:c.G2586C:p.L862L,ENSG00000157404:ENST00000412167:exon18:c.G2574C:p.L858L	KIT:NM_000222:exon18:c.G2586C:p.L862L,KIT:NM_001093772:exon18:c.G2574C:p.L858L	clinvar: Benign 	 CancerVar: Uncertain significance EVS=[1, None, None, 0, None, None, 0, 1, 1, 0, 2, None] 	0.1159	0.1931	0.164137	.	.	.	.	4	.	.	.	KIT:uc010igr.3:exon18:c.G2586C:p.L862L,KIT:uc010igs.3:exon18:c.G2574C:p.L858L	.	AFR:0.3357,AMR:0.0545,EAS:0.0495,FIN:0.0527,NFE:0.1095,OTH:0.0993,SAS:0.1068	164920	154800;172800;273300;601626;606764;	44890;519;363483;363494;363504;842;876;99865;2884;79457;98292;	44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2884|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|172800 ~79457|Urticaria pigmentosa|Unknown|Not applicable|All ages|154800 ~98292|-|1-9 / 100 000|-|All ages|154800 ~	AML
4	55955969	55955969	C	T	KDR	exonic	nonsynonymous SNV	ENSG00000128052	rs56302315	ENSG00000128052:ENST00000263923:exon24:c.G3193A:p.A1065T	KDR:NM_002253:exon24:c.G3193A:p.A1065T	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	0.0004	0.0004	.	7.336	34	0.144	5.81	4	0.9990	0.886	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	KDR:uc003has.3:exon24:c.G3193A:p.A1065T,KDR:uc003hat.1:exon24:c.G3193A:p.A1065T	0.437	AFR:0,AMR:8.652e-05,EAS:0,FIN:0,NFE:0.0008,OTH:0.0011,SAS:0	191306	602089;	.	.	AS
4	55961059	55961059	G	A	KDR	exonic	nonsynonymous SNV	ENSG00000128052	rs530419081	ENSG00000128052:ENST00000263923:exon21:c.C2881T:p.R961W	KDR:NM_002253:exon21:c.C2881T:p.R961W	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 0, None] 	6.593e-05	.	0.000199681	7.079	33	0.004	4.08	4	.	.	Protein kinase domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	KDR:uc003has.3:exon21:c.C2881T:p.R961W,KDR:uc003hat.1:exon21:c.C2881T:p.R961W	-0.226	AFR:0,AMR:8.663e-05,EAS:0.0001,FIN:0,NFE:1.499e-05,OTH:0,SAS:0.0003	191306	602089;	.	.	COREAD
4	55968180	55968180	T	A	KDR	exonic	nonsynonymous SNV	ENSG00000128052	.	ENSG00000128052:ENST00000263923:exon15:c.A2150T:p.D717V	KDR:NM_002253:exon15:c.A2150T:p.D717V	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	5.926	27.6	0.008	4.76	4	.	.	Immunoglobulin I-set;Immunoglobulin subtype 2;Immunoglobulin-like domain;Immunoglobulin-like fold	KDR:uc003has.3:exon15:c.A2150T:p.D717V,KDR:uc003hat.1:exon15:c.A2150T:p.D717V	-0.648	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	191306	602089;	.	.	AS
4	89052323	89052323	G	T	ABCG2	exonic	nonsynonymous SNV	ENSG00000118777	rs2231142	ENSG00000118777:ENST00000237612:exon5:c.C421A:p.Q141K,ENSG00000118777:ENST00000515655:exon5:c.C421A:p.Q141K	ABCG2:NM_001257386:exon5:c.C421A:p.Q141K,ABCG2:NM_004827:exon5:c.C421A:p.Q141K	clinvar: other|other|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 1, 1, 0, None] 	0.1180	0.0845	0.119409	2.305	18.20	0.42	5.37	4	.	.	AAA+ ATPase domain;ABC transporter-like;P-loop containing nucleoside triphosphate hydrolase	ABCG2:uc003hrf.3:exon2:c.C31A:p.Q11K,ABCG2:uc003hrg.3:exon5:c.C421A:p.Q141K,ABCG2:uc003hrh.3:exon5:c.C421A:p.Q141K	-0.942	AFR:0.0274,AMR:0.2407,EAS:0.3007,FIN:0.0732,NFE:0.0991,OTH:0.0639,SAS:0.0908	603756	138900;614490;	.	.	OV-PR
5	1286516	1286516	C	A	TERT	intronic	.	ENSG00000164362	rs2736100	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 1, 0, 0, None] 	.	.	0.515375	.	.	.	.	5	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	187270	601626;613989;614742;615134;	618;88;1775;3322;519;	618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~1775|DC<br>DKC<br>Zinsser-Engman-Cole syndrome|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|127550 224230 305000 613987 613988 613989 613990 615190 616353 ~3322|Progressive pancytopenia-immunodeficiency-cerebellar hypoplasia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|305000 613989 613990 615190 616353 616553 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	Brain Glioma
5	1295228	1295228	G	A	TERT	upstream;upstream	.	ENSG00000164362	.	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 1, 0, 0, None] 	.	.	.	.	.	.	.	5	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	187270	601626;613989;614742;615134;	618;88;1775;3322;519;	618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~1775|DC<br>DKC<br>Zinsser-Engman-Cole syndrome|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|127550 224230 305000 613987 613988 613989 613990 615190 616353 ~3322|Progressive pancytopenia-immunodeficiency-cerebellar hypoplasia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|305000 613989 613990 615190 616353 616553 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	Papillary Thyroid Carcinoma
5	1295228	1295228	G	A	TERT	upstream;upstream	.	ENSG00000164362	.	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 1, 0, 0, None] 	.	.	.	.	.	.	.	5	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	187270	601626;613989;614742;615134;	618;88;1775;3322;519;	618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~1775|DC<br>DKC<br>Zinsser-Engman-Cole syndrome|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|127550 224230 305000 613987 613988 613989 613990 615190 616353 ~3322|Progressive pancytopenia-immunodeficiency-cerebellar hypoplasia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|305000 613989 613990 615190 616353 616553 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	TH
6	117630062	117630062	A	G	ROS1	exonic	nonsynonymous SNV	ENSG00000047936	.	ENSG00000047936:ENST00000368508:exon41:c.T6464C:p.L2155S,ENSG00000047936:ENST00000368507:exon42:c.T6446C:p.L2149S	ROS1:NM_002944:exon41:c.T6464C:p.L2155S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	6.262	29.0	0.007	5.05	6	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ROS1:uc003pxp.1:exon41:c.T6464C:p.L2155S	0.234	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	165020	.	.	.	NSCLC
6	117631376	117631376	C	G	ROS1	exonic	nonsynonymous SNV	ENSG00000047936	.	ENSG00000047936:ENST00000368508:exon40:c.G6302C:p.G2101A,ENSG00000047936:ENST00000368507:exon41:c.G6284C:p.G2095A	ROS1:NM_002944:exon40:c.G6302C:p.G2101A	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	5.655	26.7	0.0	4.66	6	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ROS1:uc003pxp.1:exon40:c.G6302C:p.G2101A	-0.090	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	165020	.	.	.	NSCLC
6	117638347	117638347	C	T	ROS1	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000047936	.	ENSG00000047936:ENST00000368508:exon38:c.G6094A:p.G2032R,ENSG00000047936:ENST00000368507:exon39:c.G6076A:p.G2026R;ENSG00000047936:ENST00000368508:exon38:c.G6094A:p.G2032R,ENSG00000047936:ENST00000368507:exon39:c.G6076A:p.G2026R	ROS1:NM_002944:exon38:c.G6094A:p.G2032R;ROS1:NM_002944:exon38:c.G6094A:p.G2032R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	7.541	34	0.0	5.31	6	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ROS1:uc003pxp.1:exon38:c.G6094A:p.G2032R;ROS1:uc003pxp.1:exon38:c.G6094A:p.G2032R	0.891	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	165020	.	.	.	LUAD
6	117638347	117638347	C	T	ROS1	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000047936	.	ENSG00000047936:ENST00000368508:exon38:c.G6094A:p.G2032R,ENSG00000047936:ENST00000368507:exon39:c.G6076A:p.G2026R;ENSG00000047936:ENST00000368508:exon38:c.G6094A:p.G2032R,ENSG00000047936:ENST00000368507:exon39:c.G6076A:p.G2026R	ROS1:NM_002944:exon38:c.G6094A:p.G2032R;ROS1:NM_002944:exon38:c.G6094A:p.G2032R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	7.541	34	0.0	5.31	6	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ROS1:uc003pxp.1:exon38:c.G6094A:p.G2032R;ROS1:uc003pxp.1:exon38:c.G6094A:p.G2032R	0.891	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	165020	.	.	.	NSCLC
6	117638365	117638365	G	T	ROS1	exonic	nonsynonymous SNV	ENSG00000047936	.	ENSG00000047936:ENST00000368508:exon38:c.C6076A:p.L2026M,ENSG00000047936:ENST00000368507:exon39:c.C6058A:p.L2020M	ROS1:NM_002944:exon38:c.C6076A:p.L2026M	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 1, 0, None] 	.	.	.	4.177	23.8	0.169	1.33	6	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ROS1:uc003pxp.1:exon38:c.C6076A:p.L2026M	-0.301	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	165020	.	.	.	NSCLC
6	152415537	152415537	T	C	ESR1	exonic	nonsynonymous SNV	ENSG00000091831	.	ENSG00000091831:ENST00000406599:exon3:c.T604C:p.S202P,ENSG00000091831:ENST00000206249:exon7:c.T1387C:p.S463P,ENSG00000091831:ENST00000456483:exon7:c.T1051C:p.S351P,ENSG00000091831:ENST00000338799:exon8:c.T1387C:p.S463P,ENSG00000091831:ENST00000443427:exon8:c.T1387C:p.S463P,ENSG00000091831:ENST00000440973:exon9:c.T1387C:p.S463P	ESR1:NM_000125:exon7:c.T1387C:p.S463P,ESR1:NM_001122740:exon8:c.T1387C:p.S463P,ESR1:NM_001122741:exon8:c.T1387C:p.S463P,ESR1:NM_001291230:exon8:c.T1393C:p.S465P,ESR1:NM_001291241:exon8:c.T1384C:p.S462P,ESR1:NM_001122742:exon9:c.T1387C:p.S463P	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	4.626	24.5	0.223	5.43	6	.	.	Nuclear hormone receptor, ligand-binding;Nuclear hormone receptor, ligand-binding, core	ESR1:uc011eev.2:exon2:c.T142C:p.S48P,ESR1:uc010kir.3:exon3:c.T604C:p.S202P,ESR1:uc010kiq.3:exon4:c.T181C:p.S61P,ESR1:uc010kis.3:exon5:c.T532C:p.S178P,ESR1:uc003qoo.4:exon7:c.T1387C:p.S463P,ESR1:uc003qon.4:exon8:c.T1387C:p.S463P,ESR1:uc010kin.3:exon8:c.T1387C:p.S463P,ESR1:uc010kio.3:exon8:c.T1393C:p.S465P,ESR1:uc010kip.3:exon8:c.T1384C:p.S462P,ESR1:uc003qom.4:exon9:c.T1387C:p.S463P	0.780	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	Estrogen-receptor Positive Breast Cancer
6	152419922	152419922	T	A	ESR1	exonic	nonsynonymous SNV	ENSG00000091831	.	ENSG00000091831:ENST00000406599:exon4:c.T826A:p.Y276N,ENSG00000091831:ENST00000206249:exon8:c.T1609A:p.Y537N,ENSG00000091831:ENST00000456483:exon8:c.T1273A:p.Y425N,ENSG00000091831:ENST00000338799:exon9:c.T1609A:p.Y537N,ENSG00000091831:ENST00000443427:exon9:c.T1609A:p.Y537N,ENSG00000091831:ENST00000440973:exon10:c.T1609A:p.Y537N	ESR1:NM_000125:exon8:c.T1609A:p.Y537N,ESR1:NM_001122740:exon9:c.T1609A:p.Y537N,ESR1:NM_001122741:exon9:c.T1609A:p.Y537N,ESR1:NM_001291230:exon9:c.T1615A:p.Y539N,ESR1:NM_001291241:exon9:c.T1606A:p.Y536N,ESR1:NM_001122742:exon10:c.T1609A:p.Y537N	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.428	29.7	0.001	5.31	6	.	.	Nuclear hormone receptor, ligand-binding	ESR1:uc011eev.2:exon3:c.T364A:p.Y122N,ESR1:uc021zha.1:exon3:c.T238A:p.Y80N,ESR1:uc010kir.3:exon4:c.T826A:p.Y276N,ESR1:uc011eex.2:exon4:c.T634A:p.Y212N,ESR1:uc010kiq.3:exon5:c.T403A:p.Y135N,ESR1:uc003qoo.4:exon8:c.T1609A:p.Y537N,ESR1:uc003qon.4:exon9:c.T1609A:p.Y537N,ESR1:uc010kin.3:exon9:c.T1609A:p.Y537N,ESR1:uc010kio.3:exon9:c.T1615A:p.Y539N,ESR1:uc010kip.3:exon9:c.T1606A:p.Y536N,ESR1:uc003qom.4:exon10:c.T1609A:p.Y537N	0.822	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
6	152419923	152419923	A	C	ESR1	exonic	nonsynonymous SNV	ENSG00000091831	.	ENSG00000091831:ENST00000406599:exon4:c.A827C:p.Y276S,ENSG00000091831:ENST00000206249:exon8:c.A1610C:p.Y537S,ENSG00000091831:ENST00000456483:exon8:c.A1274C:p.Y425S,ENSG00000091831:ENST00000338799:exon9:c.A1610C:p.Y537S,ENSG00000091831:ENST00000443427:exon9:c.A1610C:p.Y537S,ENSG00000091831:ENST00000440973:exon10:c.A1610C:p.Y537S	ESR1:NM_000125:exon8:c.A1610C:p.Y537S,ESR1:NM_001122740:exon9:c.A1610C:p.Y537S,ESR1:NM_001122741:exon9:c.A1610C:p.Y537S,ESR1:NM_001291230:exon9:c.A1616C:p.Y539S,ESR1:NM_001291241:exon9:c.A1607C:p.Y536S,ESR1:NM_001122742:exon10:c.A1610C:p.Y537S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.401	29.6	0.014	5.31	6	.	.	Nuclear hormone receptor, ligand-binding	ESR1:uc011eev.2:exon3:c.A365C:p.Y122S,ESR1:uc021zha.1:exon3:c.A239C:p.Y80S,ESR1:uc010kir.3:exon4:c.A827C:p.Y276S,ESR1:uc011eex.2:exon4:c.A635C:p.Y212S,ESR1:uc010kiq.3:exon5:c.A404C:p.Y135S,ESR1:uc003qoo.4:exon8:c.A1610C:p.Y537S,ESR1:uc003qon.4:exon9:c.A1610C:p.Y537S,ESR1:uc010kin.3:exon9:c.A1610C:p.Y537S,ESR1:uc010kio.3:exon9:c.A1616C:p.Y539S,ESR1:uc010kip.3:exon9:c.A1607C:p.Y536S,ESR1:uc003qom.4:exon10:c.A1610C:p.Y537S	0.883	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
6	152419923	152419923	A	G	ESR1	exonic	nonsynonymous SNV	ENSG00000091831	.	ENSG00000091831:ENST00000406599:exon4:c.A827G:p.Y276C,ENSG00000091831:ENST00000206249:exon8:c.A1610G:p.Y537C,ENSG00000091831:ENST00000456483:exon8:c.A1274G:p.Y425C,ENSG00000091831:ENST00000338799:exon9:c.A1610G:p.Y537C,ENSG00000091831:ENST00000443427:exon9:c.A1610G:p.Y537C,ENSG00000091831:ENST00000440973:exon10:c.A1610G:p.Y537C	ESR1:NM_000125:exon8:c.A1610G:p.Y537C,ESR1:NM_001122740:exon9:c.A1610G:p.Y537C,ESR1:NM_001122741:exon9:c.A1610G:p.Y537C,ESR1:NM_001291230:exon9:c.A1616G:p.Y539C,ESR1:NM_001291241:exon9:c.A1607G:p.Y536C,ESR1:NM_001122742:exon10:c.A1610G:p.Y537C	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.155	28.5	0.0	5.31	6	.	.	Nuclear hormone receptor, ligand-binding	ESR1:uc011eev.2:exon3:c.A365G:p.Y122C,ESR1:uc021zha.1:exon3:c.A239G:p.Y80C,ESR1:uc010kir.3:exon4:c.A827G:p.Y276C,ESR1:uc011eex.2:exon4:c.A635G:p.Y212C,ESR1:uc010kiq.3:exon5:c.A404G:p.Y135C,ESR1:uc003qoo.4:exon8:c.A1610G:p.Y537C,ESR1:uc003qon.4:exon9:c.A1610G:p.Y537C,ESR1:uc010kin.3:exon9:c.A1610G:p.Y537C,ESR1:uc010kio.3:exon9:c.A1616G:p.Y539C,ESR1:uc010kip.3:exon9:c.A1607G:p.Y536C,ESR1:uc003qom.4:exon10:c.A1610G:p.Y537C	0.837	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
6	152419926	152419926	A	G	ESR1	exonic	nonsynonymous SNV	ENSG00000091831	.	ENSG00000091831:ENST00000406599:exon4:c.A830G:p.D277G,ENSG00000091831:ENST00000206249:exon8:c.A1613G:p.D538G,ENSG00000091831:ENST00000456483:exon8:c.A1277G:p.D426G,ENSG00000091831:ENST00000338799:exon9:c.A1613G:p.D538G,ENSG00000091831:ENST00000443427:exon9:c.A1613G:p.D538G,ENSG00000091831:ENST00000440973:exon10:c.A1613G:p.D538G	ESR1:NM_000125:exon8:c.A1613G:p.D538G,ESR1:NM_001122740:exon9:c.A1613G:p.D538G,ESR1:NM_001122741:exon9:c.A1613G:p.D538G,ESR1:NM_001291230:exon9:c.A1619G:p.D540G,ESR1:NM_001291241:exon9:c.A1610G:p.D537G,ESR1:NM_001122742:exon10:c.A1613G:p.D538G	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	4.909	25.0	0.031	5.31	6	.	.	Nuclear hormone receptor, ligand-binding	ESR1:uc011eev.2:exon3:c.A368G:p.D123G,ESR1:uc021zha.1:exon3:c.A242G:p.D81G,ESR1:uc010kir.3:exon4:c.A830G:p.D277G,ESR1:uc011eex.2:exon4:c.A638G:p.D213G,ESR1:uc010kiq.3:exon5:c.A407G:p.D136G,ESR1:uc003qoo.4:exon8:c.A1613G:p.D538G,ESR1:uc003qon.4:exon9:c.A1613G:p.D538G,ESR1:uc010kin.3:exon9:c.A1613G:p.D538G,ESR1:uc010kio.3:exon9:c.A1619G:p.D540G,ESR1:uc010kip.3:exon9:c.A1610G:p.D537G,ESR1:uc003qom.4:exon10:c.A1613G:p.D538G	0.909	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRACA
7	116423407	116423407	G	A	MET	exonic	nonsynonymous SNV	ENSG00000105976	rs121913671	ENSG00000105976:ENST00000539704:exon5:c.G292A:p.D98N,ENSG00000105976:ENST00000318493:exon19:c.G3736A:p.D1246N,ENSG00000105976:ENST00000397752:exon19:c.G3682A:p.D1228N	MET:NM_000245:exon19:c.G3682A:p.D1228N,MET:NM_001127500:exon19:c.G3736A:p.D1246N	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 0, 2, 2, None] 	.	.	.	6.532	31	0.0	5.46	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	MET:uc003vij.3:exon19:c.G3682A:p.D1228N,MET:uc010lkh.3:exon19:c.G3736A:p.D1246N,MET:uc011knj.2:exon19:c.G2392A:p.D798N	0.426	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	NSCLC
7	116423408	116423408	A	T	MET	exonic	nonsynonymous SNV	ENSG00000105976	.	ENSG00000105976:ENST00000539704:exon5:c.A293T:p.D98V,ENSG00000105976:ENST00000318493:exon19:c.A3737T:p.D1246V,ENSG00000105976:ENST00000397752:exon19:c.A3683T:p.D1228V	MET:NM_000245:exon19:c.A3683T:p.D1228V,MET:NM_001127500:exon19:c.A3737T:p.D1246V	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	5.663	26.7	0.0	5.46	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	MET:uc003vij.3:exon19:c.A3683T:p.D1228V,MET:uc010lkh.3:exon19:c.A3737T:p.D1246V,MET:uc011knj.2:exon19:c.A2393T:p.D798V	0.425	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	NSCLC
7	128849189	128849189	G	C	SMO	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000128602	rs17710891	ENSG00000128602:ENST00000249373:exon8:c.G1417C:p.D473H;ENSG00000128602:ENST00000249373:exon8:c.G1417C:p.D473H	SMO:NM_005631:exon8:c.G1417C:p.D473H;SMO:NM_005631:exon8:c.G1417C:p.D473H	clinvar: not provided 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	6.823	32	0.004	5.4	7	.	.	GPCR, family 2-like	SMO:uc003vos.3:exon4:c.G442C:p.D148H,SMO:uc003vor.3:exon8:c.G1417C:p.D473H;SMO:uc003vos.3:exon4:c.G442C:p.D148H,SMO:uc003vor.3:exon8:c.G1417C:p.D473H	0.478	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	601500	601707;605462;	1553;	1553|Corpus callosum agenesis-polysyndactyly syndrome|<1 / 1 000 000|Not applicable|Neonatal|601707 ~	BCC
7	128849189	128849189	G	C	SMO	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000128602	rs17710891	ENSG00000128602:ENST00000249373:exon8:c.G1417C:p.D473H;ENSG00000128602:ENST00000249373:exon8:c.G1417C:p.D473H	SMO:NM_005631:exon8:c.G1417C:p.D473H;SMO:NM_005631:exon8:c.G1417C:p.D473H	clinvar: not provided 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	6.823	32	0.004	5.4	7	.	.	GPCR, family 2-like	SMO:uc003vos.3:exon4:c.G442C:p.D148H,SMO:uc003vor.3:exon8:c.G1417C:p.D473H;SMO:uc003vos.3:exon4:c.G442C:p.D148H,SMO:uc003vor.3:exon8:c.G1417C:p.D473H	0.478	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	601500	601707;605462;	1553;	1553|Corpus callosum agenesis-polysyndactyly syndrome|<1 / 1 000 000|Not applicable|Neonatal|601707 ~	Brain Medulloblastoma
7	140453134	140453134	T	C	BRAF	exonic	nonsynonymous SNV	ENSG00000157764	rs121913364	ENSG00000157764:ENST00000479537:exon2:c.A85G:p.K29E,ENSG00000157764:ENST00000288602:exon15:c.A1801G:p.K601E	BRAF:NM_004333:exon15:c.A1801G:p.K601E	clinvar: Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	4.670	24.5	0.0	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.A1801G:p.K601E	-0.875	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	Skin Melanoma
7	140453136	140453136	A	T	BRAF	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs113488022	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	clinvar: Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.65e-05	.	.	6.642	32	0.001	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	-0.768	AFR:0,AMR:8.715e-05,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.06e-05	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	CANCER
7	140453136	140453136	A	T	BRAF	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs113488022	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	clinvar: Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.65e-05	.	.	6.642	32	0.001	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	-0.768	AFR:0,AMR:8.715e-05,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.06e-05	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	COREAD
7	140453136	140453136	A	T	BRAF	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs113488022	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	clinvar: Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.65e-05	.	.	6.642	32	0.001	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	-0.768	AFR:0,AMR:8.715e-05,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.06e-05	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	Gastrointestinal Neuroendocrine Tumor
7	140453136	140453136	A	T	BRAF	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs113488022	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	clinvar: Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.65e-05	.	.	6.642	32	0.001	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	-0.768	AFR:0,AMR:8.715e-05,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.06e-05	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	HCL
7	140453136	140453136	A	T	BRAF	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs113488022	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	clinvar: Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.65e-05	.	.	6.642	32	0.001	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	-0.768	AFR:0,AMR:8.715e-05,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.06e-05	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	M
7	140453136	140453136	A	T	BRAF	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs113488022	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	clinvar: Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.65e-05	.	.	6.642	32	0.001	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	-0.768	AFR:0,AMR:8.715e-05,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.06e-05	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	MM
7	140453136	140453136	A	T	BRAF	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs113488022	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	clinvar: Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.65e-05	.	.	6.642	32	0.001	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	-0.768	AFR:0,AMR:8.715e-05,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.06e-05	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	MYMA
7	140453136	140453136	A	T	BRAF	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs113488022	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	clinvar: Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.65e-05	.	.	6.642	32	0.001	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	-0.768	AFR:0,AMR:8.715e-05,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.06e-05	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	NSCLC
7	140453136	140453136	A	T	BRAF	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs113488022	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	clinvar: Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.65e-05	.	.	6.642	32	0.001	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	-0.768	AFR:0,AMR:8.715e-05,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.06e-05	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	Papillary Thyroid Carcinoma
7	140453136	140453136	A	T	BRAF	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs113488022	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	clinvar: Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.65e-05	.	.	6.642	32	0.001	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	-0.768	AFR:0,AMR:8.715e-05,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.06e-05	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	Skin Melanoma
7	140453136	140453136	A	T	BRAF	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs113488022	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	clinvar: Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.65e-05	.	.	6.642	32	0.001	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	-0.768	AFR:0,AMR:8.715e-05,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.06e-05	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	TH
7	140453145	140453145	A	C	BRAF	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs121913366	ENSG00000157764:ENST00000479537:exon2:c.T74G:p.L25R,ENSG00000157764:ENST00000288602:exon15:c.T1790G:p.L597R;ENSG00000157764:ENST00000479537:exon2:c.T74G:p.L25R,ENSG00000157764:ENST00000288602:exon15:c.T1790G:p.L597R	BRAF:NM_004333:exon15:c.T1790G:p.L597R;BRAF:NM_004333:exon15:c.T1790G:p.L597R	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	4.592	24.4	0.0	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1790G:p.L597R;BRAF:uc003vwc.4:exon15:c.T1790G:p.L597R	0.599	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	M
7	140453145	140453145	A	C	BRAF	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs121913366	ENSG00000157764:ENST00000479537:exon2:c.T74G:p.L25R,ENSG00000157764:ENST00000288602:exon15:c.T1790G:p.L597R;ENSG00000157764:ENST00000479537:exon2:c.T74G:p.L25R,ENSG00000157764:ENST00000288602:exon15:c.T1790G:p.L597R	BRAF:NM_004333:exon15:c.T1790G:p.L597R;BRAF:NM_004333:exon15:c.T1790G:p.L597R	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	4.592	24.4	0.0	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1790G:p.L597R;BRAF:uc003vwc.4:exon15:c.T1790G:p.L597R	0.599	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	Skin Melanoma
7	140453145	140453145	A	T	BRAF	exonic	nonsynonymous SNV	ENSG00000157764	rs121913366	ENSG00000157764:ENST00000479537:exon2:c.T74A:p.L25Q,ENSG00000157764:ENST00000288602:exon15:c.T1790A:p.L597Q	BRAF:NM_004333:exon15:c.T1790A:p.L597Q	clinvar: Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	6.239	28.8	0.0	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1790A:p.L597Q	0.298	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	Skin Melanoma
7	140453146	140453146	G	C	BRAF	exonic	nonsynonymous SNV	ENSG00000157764	rs121913369	ENSG00000157764:ENST00000479537:exon2:c.C73G:p.L25V,ENSG00000157764:ENST00000288602:exon15:c.C1789G:p.L597V	BRAF:NM_004333:exon15:c.C1789G:p.L597V	clinvar: Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	4.979	25.1	0.001	2.86	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.C1789G:p.L597V	0.564	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	Skin Melanoma
7	140453149	140453149	C	A	BRAF	exonic	nonsynonymous SNV	ENSG00000157764	rs121913361	ENSG00000157764:ENST00000479537:exon2:c.G70T:p.G24C,ENSG00000157764:ENST00000288602:exon15:c.G1786T:p.G596C	BRAF:NM_004333:exon15:c.G1786T:p.G596C	clinvar: Uncertain significance 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	7.486	34	0.0	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.G1786T:p.G596C	0.707	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	NSCLC
7	140453154	140453154	T	A	BRAF	exonic	nonsynonymous SNV	ENSG00000157764	rs121913338	ENSG00000157764:ENST00000479537:exon2:c.A65T:p.D22V,ENSG00000157764:ENST00000288602:exon15:c.A1781T:p.D594V	BRAF:NM_004333:exon15:c.A1781T:p.D594V	clinvar: Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	6.796	32	0.001	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.A1781T:p.D594V	0.795	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	Skin Melanoma
7	140453154	140453154	T	C	BRAF	exonic	nonsynonymous SNV	ENSG00000157764	rs121913338	ENSG00000157764:ENST00000479537:exon2:c.A65G:p.D22G,ENSG00000157764:ENST00000288602:exon15:c.A1781G:p.D594G	BRAF:NM_004333:exon15:c.A1781G:p.D594G	clinvar: Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	6.419	29.7	0.002	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.A1781G:p.D594G	0.452	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	COREAD
7	140453154	140453154	T	G	BRAF	exonic	nonsynonymous SNV	ENSG00000157764	.	ENSG00000157764:ENST00000479537:exon2:c.A65C:p.D22A,ENSG00000157764:ENST00000288602:exon15:c.A1781C:p.D594A	BRAF:NM_004333:exon15:c.A1781C:p.D594A	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.325	29.2	0.028	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.A1781C:p.D594A	0.795	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	Skin Melanoma
7	140477794	140477794	A	T	BRAF	exonic	nonsynonymous SNV	ENSG00000157764	.	ENSG00000157764:ENST00000288602:exon12:c.T1514A:p.L505H	BRAF:NM_004333:exon12:c.T1514A:p.L505H	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	6.461	29.9	0.0	4.96	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon12:c.T1514A:p.L505H	-0.302	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	M
7	55227884	55227884	C	T	EGFR	exonic	nonsynonymous SNV	ENSG00000146648	rs377567759	ENSG00000146648:ENST00000455089:exon11:c.C1216T:p.R406C,ENSG00000146648:ENST00000275493:exon12:c.C1351T:p.R451C,ENSG00000146648:ENST00000342916:exon12:c.C1351T:p.R451C,ENSG00000146648:ENST00000344576:exon12:c.C1351T:p.R451C,ENSG00000146648:ENST00000442591:exon12:c.C1351T:p.R451C,ENSG00000146648:ENST00000454757:exon12:c.C1192T:p.R398C	EGFR:NM_005228:exon12:c.C1351T:p.R451C,EGFR:NM_201282:exon12:c.C1351T:p.R451C,EGFR:NM_201284:exon12:c.C1351T:p.R451C	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	7.7e-05	.	7.668	35	0.0	4.93	7	.	.	Receptor L-domain	EGFR:uc010kzg.2:exon11:c.C1216T:p.R406C,EGFR:uc022adn.1:exon11:c.C1216T:p.R406C,EGFR:uc003tqi.3:exon12:c.C1351T:p.R451C,EGFR:uc003tqj.3:exon12:c.C1351T:p.R451C,EGFR:uc003tqk.3:exon12:c.C1351T:p.R451C,EGFR:uc011kco.2:exon12:c.C1192T:p.R398C,EGFR:uc022adm.1:exon12:c.C1351T:p.R451C	0.669	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	COREAD
7	55227926	55227926	G	A	EGFR	exonic	nonsynonymous SNV	ENSG00000146648	.	ENSG00000146648:ENST00000455089:exon11:c.G1258A:p.G420R,ENSG00000146648:ENST00000275493:exon12:c.G1393A:p.G465R,ENSG00000146648:ENST00000342916:exon12:c.G1393A:p.G465R,ENSG00000146648:ENST00000344576:exon12:c.G1393A:p.G465R,ENSG00000146648:ENST00000442591:exon12:c.G1393A:p.G465R,ENSG00000146648:ENST00000454757:exon12:c.G1234A:p.G412R	EGFR:NM_005228:exon12:c.G1393A:p.G465R,EGFR:NM_201282:exon12:c.G1393A:p.G465R,EGFR:NM_201284:exon12:c.G1393A:p.G465R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[2, None, None, 1, None, None, 1, 0, 1, 1, 2, None] 	.	.	.	2.555	19.82	0.789	4.84	7	.	.	Receptor L-domain	EGFR:uc010kzg.2:exon11:c.G1258A:p.G420R,EGFR:uc022adn.1:exon11:c.G1258A:p.G420R,EGFR:uc003tqi.3:exon12:c.G1393A:p.G465R,EGFR:uc003tqj.3:exon12:c.G1393A:p.G465R,EGFR:uc003tqk.3:exon12:c.G1393A:p.G465R,EGFR:uc011kco.2:exon12:c.G1234A:p.G412R,EGFR:uc022adm.1:exon12:c.G1393A:p.G465R	-1.028	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	COREAD
7	55227933	55227933	A	C	EGFR	exonic	nonsynonymous SNV	ENSG00000146648	.	ENSG00000146648:ENST00000455089:exon11:c.A1265C:p.K422T,ENSG00000146648:ENST00000275493:exon12:c.A1400C:p.K467T,ENSG00000146648:ENST00000342916:exon12:c.A1400C:p.K467T,ENSG00000146648:ENST00000344576:exon12:c.A1400C:p.K467T,ENSG00000146648:ENST00000442591:exon12:c.A1400C:p.K467T,ENSG00000146648:ENST00000454757:exon12:c.A1241C:p.K414T	EGFR:NM_005228:exon12:c.A1400C:p.K467T,EGFR:NM_201282:exon12:c.A1400C:p.K467T,EGFR:NM_201284:exon12:c.A1400C:p.K467T	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 1, 2, None] 	.	.	.	0.429	6.861	0.584	-3.64	7	.	.	Receptor L-domain	EGFR:uc010kzg.2:exon11:c.A1265C:p.K422T,EGFR:uc022adn.1:exon11:c.A1265C:p.K422T,EGFR:uc003tqi.3:exon12:c.A1400C:p.K467T,EGFR:uc003tqj.3:exon12:c.A1400C:p.K467T,EGFR:uc003tqk.3:exon12:c.A1400C:p.K467T,EGFR:uc011kco.2:exon12:c.A1241C:p.K414T,EGFR:uc022adm.1:exon12:c.A1400C:p.K467T	-0.994	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	COREAD
7	55228009	55228009	C	A	EGFR	exonic	nonsynonymous SNV	ENSG00000146648	.	ENSG00000146648:ENST00000455089:exon11:c.C1341A:p.S447R,ENSG00000146648:ENST00000275493:exon12:c.C1476A:p.S492R,ENSG00000146648:ENST00000342916:exon12:c.C1476A:p.S492R,ENSG00000146648:ENST00000344576:exon12:c.C1476A:p.S492R,ENSG00000146648:ENST00000442591:exon12:c.C1476A:p.S492R,ENSG00000146648:ENST00000454757:exon12:c.C1317A:p.S439R	EGFR:NM_005228:exon12:c.C1476A:p.S492R,EGFR:NM_201282:exon12:c.C1476A:p.S492R,EGFR:NM_201284:exon12:c.C1476A:p.S492R	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 1, 2, None] 	.	.	.	2.980	22.2	0.634	5.66	7	.	.	Receptor L-domain	EGFR:uc010kzg.2:exon11:c.C1341A:p.S447R,EGFR:uc022adn.1:exon11:c.C1341A:p.S447R,EGFR:uc003tqi.3:exon12:c.C1476A:p.S492R,EGFR:uc003tqj.3:exon12:c.C1476A:p.S492R,EGFR:uc003tqk.3:exon12:c.C1476A:p.S492R,EGFR:uc011kco.2:exon12:c.C1317A:p.S439R,EGFR:uc022adm.1:exon12:c.C1476A:p.S492R	-0.898	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	COREAD
7	55241707	55241707	G	A	EGFR	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648	rs28929495	ENSG00000146648:ENST00000455089:exon17:c.G2020A:p.G674S,ENSG00000146648:ENST00000275493:exon18:c.G2155A:p.G719S,ENSG00000146648:ENST00000454757:exon18:c.G1996A:p.G666S;ENSG00000146648:ENST00000455089:exon17:c.G2020A:p.G674S,ENSG00000146648:ENST00000275493:exon18:c.G2155A:p.G719S,ENSG00000146648:ENST00000454757:exon18:c.G1996A:p.G666S	EGFR:NM_005228:exon18:c.G2155A:p.G719S;EGFR:NM_005228:exon18:c.G2155A:p.G719S	clinvar: drug response|drug response,Likely pathogenic|drug response,drug response|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	5.520	26.3	0.003	5.83	7	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	EGFR:uc010kzg.2:exon17:c.G2020A:p.G674S,EGFR:uc022adn.1:exon17:c.G2020A:p.G674S,EGFR:uc003tqk.3:exon18:c.G2155A:p.G719S,EGFR:uc011kco.2:exon18:c.G1996A:p.G666S,EGFR:uc022adm.1:exon18:c.G2155A:p.G719S;EGFR:uc010kzg.2:exon17:c.G2020A:p.G674S,EGFR:uc022adn.1:exon17:c.G2020A:p.G674S,EGFR:uc003tqk.3:exon18:c.G2155A:p.G719S,EGFR:uc011kco.2:exon18:c.G1996A:p.G666S,EGFR:uc022adm.1:exon18:c.G2155A:p.G719S	0.769	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	COREAD
7	55241707	55241707	G	A	EGFR	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648	rs28929495	ENSG00000146648:ENST00000455089:exon17:c.G2020A:p.G674S,ENSG00000146648:ENST00000275493:exon18:c.G2155A:p.G719S,ENSG00000146648:ENST00000454757:exon18:c.G1996A:p.G666S;ENSG00000146648:ENST00000455089:exon17:c.G2020A:p.G674S,ENSG00000146648:ENST00000275493:exon18:c.G2155A:p.G719S,ENSG00000146648:ENST00000454757:exon18:c.G1996A:p.G666S	EGFR:NM_005228:exon18:c.G2155A:p.G719S;EGFR:NM_005228:exon18:c.G2155A:p.G719S	clinvar: drug response|drug response,Likely pathogenic|drug response,drug response|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	5.520	26.3	0.003	5.83	7	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	EGFR:uc010kzg.2:exon17:c.G2020A:p.G674S,EGFR:uc022adn.1:exon17:c.G2020A:p.G674S,EGFR:uc003tqk.3:exon18:c.G2155A:p.G719S,EGFR:uc011kco.2:exon18:c.G1996A:p.G666S,EGFR:uc022adm.1:exon18:c.G2155A:p.G719S;EGFR:uc010kzg.2:exon17:c.G2020A:p.G674S,EGFR:uc022adn.1:exon17:c.G2020A:p.G674S,EGFR:uc003tqk.3:exon18:c.G2155A:p.G719S,EGFR:uc011kco.2:exon18:c.G1996A:p.G666S,EGFR:uc022adm.1:exon18:c.G2155A:p.G719S	0.769	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	NSCLC
7	55241722	55241722	G	A	EGFR	exonic	nonsynonymous SNV	ENSG00000146648	.	ENSG00000146648:ENST00000455089:exon17:c.G2035A:p.G679S,ENSG00000146648:ENST00000275493:exon18:c.G2170A:p.G724S,ENSG00000146648:ENST00000454757:exon18:c.G2011A:p.G671S	EGFR:NM_005228:exon18:c.G2170A:p.G724S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.169	28.5	0.001	5.5	7	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	EGFR:uc010kzg.2:exon17:c.G2035A:p.G679S,EGFR:uc022adn.1:exon17:c.G2035A:p.G679S,EGFR:uc003tqk.3:exon18:c.G2170A:p.G724S,EGFR:uc011kco.2:exon18:c.G2011A:p.G671S,EGFR:uc022adm.1:exon18:c.G2170A:p.G724S	0.478	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	COREAD
7	55242487	55242487	C	T	EGFR	exonic	nonsynonymous SNV	ENSG00000146648	rs121913231	ENSG00000146648:ENST00000455089:exon18:c.C2122T:p.P708S,ENSG00000146648:ENST00000275493:exon19:c.C2257T:p.P753S,ENSG00000146648:ENST00000454757:exon19:c.C2098T:p.P700S	EGFR:NM_005228:exon19:c.C2257T:p.P753S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	8.243e-06	.	.	5.180	25.5	0.013	5.45	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	EGFR:uc010kzg.2:exon18:c.C2122T:p.P708S,EGFR:uc022adn.1:exon18:c.C2122T:p.P708S,EGFR:uc003tqk.3:exon19:c.C2257T:p.P753S,EGFR:uc011kco.2:exon19:c.C2098T:p.P700S,EGFR:uc022adm.1:exon19:c.C2257T:p.P753S	-0.053	AFR:0,AMR:0,EAS:0.0001,FIN:0,NFE:0,OTH:0,SAS:0	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	Skin Squamous Cell Carcinoma
7	55242511	55242511	G	T	EGFR	exonic	nonsynonymous SNV	ENSG00000146648	rs121913418	ENSG00000146648:ENST00000455089:exon18:c.G2146T:p.D716Y,ENSG00000146648:ENST00000275493:exon19:c.G2281T:p.D761Y,ENSG00000146648:ENST00000454757:exon19:c.G2122T:p.D708Y	EGFR:NM_005228:exon19:c.G2281T:p.D761Y	clinvar: Uncertain significance 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	.	.	.	7.250	34	0.0	5.45	7	0.9703	0.782	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	EGFR:uc010kzg.2:exon18:c.G2146T:p.D716Y,EGFR:uc022adn.1:exon18:c.G2146T:p.D716Y,EGFR:uc003tqk.3:exon19:c.G2281T:p.D761Y,EGFR:uc011kco.2:exon19:c.G2122T:p.D708Y,EGFR:uc022adm.1:exon19:c.G2281T:p.D761Y	0.305	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	NSCLC
7	55249005	55249005	G	T	EGFR	exonic	nonsynonymous SNV	ENSG00000146648	rs121913465	ENSG00000146648:ENST00000455089:exon19:c.G2168T:p.S723I,ENSG00000146648:ENST00000275493:exon20:c.G2303T:p.S768I,ENSG00000146648:ENST00000454757:exon20:c.G2144T:p.S715I	EGFR:NM_005228:exon20:c.G2303T:p.S768I	clinvar: Pathogenic 	 CancerVar: Uncertain significance EVS=[2, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	6.143	28.4	0.002	5.85	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	EGFR:uc022ado.1:exon1:c.G8T:p.S3I,EGFR:uc010kzg.2:exon19:c.G2168T:p.S723I,EGFR:uc022adn.1:exon19:c.G2168T:p.S723I,EGFR:uc003tqk.3:exon20:c.G2303T:p.S768I,EGFR:uc011kco.2:exon20:c.G2144T:p.S715I,EGFR:uc022adm.1:exon20:c.G2303T:p.S768I	0.454	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	LUAD
7	55249071	55249071	C	T	EGFR	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648	rs121434569	ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M;ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M;ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M	EGFR:NM_005228:exon20:c.C2369T:p.T790M;EGFR:NM_005228:exon20:c.C2369T:p.T790M;EGFR:NM_005228:exon20:c.C2369T:p.T790M	clinvar: other|drug response|Likely pathogenic|drug response|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	4.122e-05	.	.	7.364	34	0.003	5.92	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M;EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M;EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M	-0.467	AFR:9.63e-05,AMR:0,EAS:0,FIN:0,NFE:6e-05,OTH:0,SAS:0	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	LUAD
7	55249071	55249071	C	T	EGFR	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648	rs121434569	ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M;ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M;ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M	EGFR:NM_005228:exon20:c.C2369T:p.T790M;EGFR:NM_005228:exon20:c.C2369T:p.T790M;EGFR:NM_005228:exon20:c.C2369T:p.T790M	clinvar: other|drug response|Likely pathogenic|drug response|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	4.122e-05	.	.	7.364	34	0.003	5.92	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M;EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M;EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M	-0.467	AFR:9.63e-05,AMR:0,EAS:0,FIN:0,NFE:6e-05,OTH:0,SAS:0	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	L
7	55249071	55249071	C	T	EGFR	exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648	rs121434569	ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M;ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M;ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M	EGFR:NM_005228:exon20:c.C2369T:p.T790M;EGFR:NM_005228:exon20:c.C2369T:p.T790M;EGFR:NM_005228:exon20:c.C2369T:p.T790M	clinvar: other|drug response|Likely pathogenic|drug response|drug response 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	4.122e-05	.	.	7.364	34	0.003	5.92	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M;EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M;EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M	-0.467	AFR:9.63e-05,AMR:0,EAS:0,FIN:0,NFE:6e-05,OTH:0,SAS:0	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	NSCLC
7	55249091	55249091	T	A	EGFR	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648	.	ENSG00000146648:ENST00000455089:exon19:c.T2254A:p.C752S,ENSG00000146648:ENST00000275493:exon20:c.T2389A:p.C797S,ENSG00000146648:ENST00000454757:exon20:c.T2230A:p.C744S;ENSG00000146648:ENST00000455089:exon19:c.T2254A:p.C752S,ENSG00000146648:ENST00000275493:exon20:c.T2389A:p.C797S,ENSG00000146648:ENST00000454757:exon20:c.T2230A:p.C744S	EGFR:NM_005228:exon20:c.T2389A:p.C797S;EGFR:NM_005228:exon20:c.T2389A:p.C797S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 1, 2, None] 	.	.	.	4.789	24.7	0.397	5.92	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	EGFR:uc022ado.1:exon1:c.T94A:p.C32S,EGFR:uc010kzg.2:exon19:c.T2254A:p.C752S,EGFR:uc022adn.1:exon19:c.T2254A:p.C752S,EGFR:uc003tqk.3:exon20:c.T2389A:p.C797S,EGFR:uc011kco.2:exon20:c.T2230A:p.C744S,EGFR:uc022adm.1:exon20:c.T2389A:p.C797S;EGFR:uc022ado.1:exon1:c.T94A:p.C32S,EGFR:uc010kzg.2:exon19:c.T2254A:p.C752S,EGFR:uc022adn.1:exon19:c.T2254A:p.C752S,EGFR:uc003tqk.3:exon20:c.T2389A:p.C797S,EGFR:uc011kco.2:exon20:c.T2230A:p.C744S,EGFR:uc022adm.1:exon20:c.T2389A:p.C797S	-0.700	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	LUAD
7	55249091	55249091	T	A	EGFR	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648	.	ENSG00000146648:ENST00000455089:exon19:c.T2254A:p.C752S,ENSG00000146648:ENST00000275493:exon20:c.T2389A:p.C797S,ENSG00000146648:ENST00000454757:exon20:c.T2230A:p.C744S;ENSG00000146648:ENST00000455089:exon19:c.T2254A:p.C752S,ENSG00000146648:ENST00000275493:exon20:c.T2389A:p.C797S,ENSG00000146648:ENST00000454757:exon20:c.T2230A:p.C744S	EGFR:NM_005228:exon20:c.T2389A:p.C797S;EGFR:NM_005228:exon20:c.T2389A:p.C797S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 1, 2, None] 	.	.	.	4.789	24.7	0.397	5.92	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	EGFR:uc022ado.1:exon1:c.T94A:p.C32S,EGFR:uc010kzg.2:exon19:c.T2254A:p.C752S,EGFR:uc022adn.1:exon19:c.T2254A:p.C752S,EGFR:uc003tqk.3:exon20:c.T2389A:p.C797S,EGFR:uc011kco.2:exon20:c.T2230A:p.C744S,EGFR:uc022adm.1:exon20:c.T2389A:p.C797S;EGFR:uc022ado.1:exon1:c.T94A:p.C32S,EGFR:uc010kzg.2:exon19:c.T2254A:p.C752S,EGFR:uc022adn.1:exon19:c.T2254A:p.C752S,EGFR:uc003tqk.3:exon20:c.T2389A:p.C797S,EGFR:uc011kco.2:exon20:c.T2230A:p.C744S,EGFR:uc022adm.1:exon20:c.T2389A:p.C797S	-0.700	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	NSCLC
7	6022512	6022512	T	-	PMS2	exonic	frameshift deletion	ENSG00000122512	rs587782704	ENSG00000122512:ENST00000382321:exon8:c.914delA:p.K305fs,ENSG00000122512:ENST00000441476:exon9:c.1799delA:p.K600fs,ENSG00000122512:ENST00000265849:exon12:c.2117delA:p.K706fs	PMS2:NM_000535:exon12:c.2117delA:p.K706fs	clinvar: Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 0, 0, 0, None] 	.	.	.	.	.	.	.	7	.	.	.	PMS2:uc010kte.3:exon8:c.914delA:p.K305fs,PMS2:uc003spj.3:exon9:c.1799delA:p.K600fs,PMS2:uc011jwl.2:exon11:c.1712delA:p.K571fs,PMS2:uc003spk.3:exon12:c.1712delA:p.K571fs,PMS2:uc003spl.3:exon12:c.2117delA:p.K706fs,PMS2:uc010ktg.3:exon12:c.1184delA:p.K395fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	GBM
7	6426892	6426892	C	T	RAC1	exonic	nonsynonymous SNV	ENSG00000136238	.	ENSG00000136238:ENST00000348035:exon2:c.C85T:p.P29S,ENSG00000136238:ENST00000356142:exon2:c.C85T:p.P29S	RAC1:NM_006908:exon2:c.C85T:p.P29S,RAC1:NM_018890:exon2:c.C85T:p.P29S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.512	31	0.0	6.05	7	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	RAC1:uc003spw.3:exon2:c.C85T:p.P29S,RAC1:uc003spx.3:exon2:c.C85T:p.P29S	-0.013	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	602048	.	.	.	M
7	87138645	87138645	A	G	ABCB1	exonic;exonic	synonymous SNV;synonymous SNV	ENSG00000085563	rs1045642	ENSG00000085563:ENST00000543898:exon24:c.T3243C:p.I1081I,ENSG00000085563:ENST00000265724:exon27:c.T3435C:p.I1145I;ENSG00000085563:ENST00000543898:exon24:c.T3243C:p.I1081I,ENSG00000085563:ENST00000265724:exon27:c.T3435C:p.I1145I	ABCB1:NM_000927:exon27:c.T3435C:p.I1145I;ABCB1:NM_000927:exon27:c.T3435C:p.I1145I	clinvar: drug response|drug response|drug response|drug response|drug response|drug response|drug response|drug response|drug response|drug response 	 CancerVar: Benign/Likely benign EVS=[0, None, None, 0, None, None, 0, 0, 0, 0, 0, None] 	0.5034	0.5767	0.604832	.	.	.	.	7	.	.	.	ABCB1:uc011khc.2:exon24:c.T3243C:p.I1081I,ABCB1:uc003uiz.2:exon27:c.T3435C:p.I1145I;ABCB1:uc011khc.2:exon24:c.T3243C:p.I1081I,ABCB1:uc003uiz.2:exon27:c.T3435C:p.I1145I	.	AFR:0.7980,AMR:0.5467,EAS:0.6245,FIN:0.3895,NFE:0.4719,OTH:0.4890,SAS:0.3981	171050	120080;612244;	.	.	BRACA
7	87138645	87138645	A	G	ABCB1	exonic;exonic	synonymous SNV;synonymous SNV	ENSG00000085563	rs1045642	ENSG00000085563:ENST00000543898:exon24:c.T3243C:p.I1081I,ENSG00000085563:ENST00000265724:exon27:c.T3435C:p.I1145I;ENSG00000085563:ENST00000543898:exon24:c.T3243C:p.I1081I,ENSG00000085563:ENST00000265724:exon27:c.T3435C:p.I1145I	ABCB1:NM_000927:exon27:c.T3435C:p.I1145I;ABCB1:NM_000927:exon27:c.T3435C:p.I1145I	clinvar: drug response|drug response|drug response|drug response|drug response|drug response|drug response|drug response|drug response|drug response 	 CancerVar: Benign/Likely benign EVS=[0, None, None, 0, None, None, 0, 0, 0, 0, 0, None] 	0.5034	0.5767	0.604832	.	.	.	.	7	.	.	.	ABCB1:uc011khc.2:exon24:c.T3243C:p.I1081I,ABCB1:uc003uiz.2:exon27:c.T3435C:p.I1145I;ABCB1:uc011khc.2:exon24:c.T3243C:p.I1081I,ABCB1:uc003uiz.2:exon27:c.T3435C:p.I1145I	.	AFR:0.7980,AMR:0.5467,EAS:0.6245,FIN:0.3895,NFE:0.4719,OTH:0.4890,SAS:0.3981	171050	120080;612244;	.	.	NSCLC
7	87160618	87160618	A	C	ABCB1	exonic	nonsynonymous SNV	ENSG00000085563	rs2032582	ENSG00000085563:ENST00000543898:exon19:c.T2485G:p.S829A,ENSG00000085563:ENST00000265724:exon22:c.T2677G:p.S893A	ABCB1:NM_000927:exon22:c.T2677G:p.S893A	clinvar: Benign|drug response|drug response,Benign 	 CancerVar: Benign/Likely benign EVS=[0, None, None, 0, None, None, 0, 1, 0, 1, 0, None] 	0.5432	0.6781	0.617013	0.796	9.437	1.0	3.72	7	.	.	ABC transporter type 1, transmembrane domain	ABCB1:uc011khc.2:exon19:c.T2485G:p.S829A,ABCB1:uc003uiz.2:exon22:c.T2677G:p.S893A	-0.903	AFR:0.9101,AMR:0.5395,EAS:0.4653,FIN:0.4700,NFE:0.5523,OTH:0.5187,SAS:0.3496	171050	120080;612244;	.	.	BRACA
7	87160618	87160618	A	T	ABCB1	exonic	nonsynonymous SNV	ENSG00000085563	rs2032582	ENSG00000085563:ENST00000543898:exon19:c.T2485A:p.S829T,ENSG00000085563:ENST00000265724:exon22:c.T2677A:p.S893T	ABCB1:NM_000927:exon22:c.T2677A:p.S893T	clinvar: Benign|drug response|drug response,Benign 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 1, 0, 2, 0, None] 	0.0371	.	0.048722	3.597	23.2	0.027	3.72	7	.	.	ABC transporter type 1, transmembrane domain	ABCB1:uc011khc.2:exon19:c.T2485A:p.S829T,ABCB1:uc003uiz.2:exon22:c.T2677A:p.S893T	-0.264	AFR:0.0045,AMR:0.0571,EAS:0.1393,FIN:0.0344,NFE:0.0244,OTH:0.0297,SAS:0.0434	171050	120080;612244;	.	.	OV-PR
8	38274849	38274849	G	T	FGFR1	exonic	nonsynonymous SNV	ENSG00000077782	.	ENSG00000077782:ENST00000397103:exon10:c.C1371A:p.N457K,ENSG00000077782:ENST00000326324:exon11:c.C1365A:p.N455K,ENSG00000077782:ENST00000356207:exon11:c.C1371A:p.N457K,ENSG00000077782:ENST00000341462:exon12:c.C1638A:p.N546K,ENSG00000077782:ENST00000397091:exon12:c.C1632A:p.N544K,ENSG00000077782:ENST00000397113:exon12:c.C1632A:p.N544K,ENSG00000077782:ENST00000447712:exon12:c.C1638A:p.N546K,ENSG00000077782:ENST00000532791:exon12:c.C1632A:p.N544K,ENSG00000077782:ENST00000335922:exon13:c.C1608A:p.N536K,ENSG00000077782:ENST00000397108:exon13:c.C1632A:p.N544K,ENSG00000077782:ENST00000425967:exon13:c.C1731A:p.N577K	FGFR1:NM_001174066:exon11:c.C1371A:p.N457K,FGFR1:NM_023105:exon11:c.C1371A:p.N457K,FGFR1:NM_023106:exon11:c.C1365A:p.N455K,FGFR1:NM_001174063:exon12:c.C1632A:p.N544K,FGFR1:NM_001174065:exon12:c.C1632A:p.N544K,FGFR1:NM_015850:exon12:c.C1632A:p.N544K,FGFR1:NM_023110:exon12:c.C1638A:p.N546K,FGFR1:NM_001174064:exon13:c.C1608A:p.N536K,FGFR1:NM_001174067:exon13:c.C1731A:p.N577K	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	.	.	.	6.413	29.7	0.0	3.76	8	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	FGFR1:uc011lbw.2:exon11:c.C1371A:p.N457K,FGFR1:uc022auc.1:exon11:c.C1371A:p.N457K,FGFR1:uc022aud.1:exon11:c.C1365A:p.N455K,FGFR1:uc003xlp.3:exon12:c.C1632A:p.N544K,FGFR1:uc011lbv.2:exon12:c.C1632A:p.N544K,FGFR1:uc022aua.1:exon12:c.C1638A:p.N546K,FGFR1:uc022aub.1:exon12:c.C1632A:p.N544K,FGFR1:uc010lwk.3:exon13:c.C1608A:p.N536K,FGFR1:uc011lbu.2:exon13:c.C1731A:p.N577K	0.313	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	136350	101600;123150;147950;166250;190440;613001;615465;	2117;2396;3366;2645;432;478;1540;710;	2117|Holoprosencephaly-ectrodactyly-cleft lip palate syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|615465 ~2396|Haberland syndrome|<1 / 1 000 000|Not applicable|Childhood|613001 ~3366|Non-syndromic metopic craniosynostosis|-|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|190440 614485 ~2645|-|<1 / 1 000 000|Autosomal dominant|Neonatal|166250 ~432|Gonadotropic deficiency<br>Isolated congenital gonadotropin deficiency<br>Normosmic idiopathic hypogonadotropic hypogonadism<br>nIHH|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|146110 147950 244200 308700 610628 612370 612702 614837 614838 614839 614840 614841 614842 614858 614880 615266 615269 615270 ~478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~1540|Craniosynostosis-midfacial hypoplasia-foot abnormalities syndrome<br>JWS|<1 / 1 000 000|Autosomal dominant|Neonatal|123150 ~710|ACS5<br>Acrocephalosyndactyly type 5|Unknown|Autosomal dominant|Antenatal<br>Neonatal|101600 ~	Bone Ewings Sarcoma
9	133738363	133738363	G	A	ABL1	exonic	nonsynonymous SNV	ENSG00000097007	rs121913448	ENSG00000097007:ENST00000318560:exon4:c.G763A:p.E255K,ENSG00000097007:ENST00000372348:exon4:c.G820A:p.E274K	ABL1:NM_005157:exon4:c.G763A:p.E255K,ABL1:NM_007313:exon4:c.G820A:p.E274K	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 2, 1, None] 	.	.	.	7.269	34	0.001	6.03	9	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;SH2 domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ABL1:uc004bzv.3:exon4:c.G820A:p.E274K,ABL1:uc004bzw.3:exon4:c.G763A:p.E255K	0.271	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	189980	.	.	.	CML
9	133748283	133748283	C	T	ABL1	exonic	nonsynonymous SNV	ENSG00000097007	rs121913459	ENSG00000097007:ENST00000318560:exon6:c.C944T:p.T315I,ENSG00000097007:ENST00000372348:exon6:c.C1001T:p.T334I	ABL1:NM_005157:exon6:c.C944T:p.T315I,ABL1:NM_007313:exon6:c.C1001T:p.T334I	clinvar: Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 1, 2, 1, None] 	.	.	.	6.838	33	0.002	6.04	9	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ABL1:uc004bzv.3:exon6:c.C1001T:p.T334I,ABL1:uc004bzw.3:exon6:c.C944T:p.T315I	-0.417	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	189980	.	.	.	CML
9	133748288	133748288	T	C	ABL1	exonic	nonsynonymous SNV	ENSG00000097007	.	ENSG00000097007:ENST00000318560:exon6:c.T949C:p.F317L,ENSG00000097007:ENST00000372348:exon6:c.T1006C:p.F336L	ABL1:NM_005157:exon6:c.T949C:p.F317L,ABL1:NM_007313:exon6:c.T1006C:p.F336L	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 1, 1, None] 	.	.	.	5.220	25.6	0.269	6.04	9	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ABL1:uc004bzv.3:exon6:c.T1006C:p.F336L,ABL1:uc004bzw.3:exon6:c.T949C:p.F317L	-0.647	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	189980	.	.	.	CML
9	139390861	139390861	G	TGT	NOTCH1	exonic	frameshift substitution	ENSG00000148400	.	ENSG00000148400:ENST00000277541:exon34:c.7330_7330delinsACA	NOTCH1:NM_017617:exon34:c.7330_7330delinsACA	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 0, 2, None] 	.	.	.	.	.	.	.	9	.	.	.	NOTCH1:uc004chz.3:exon34:c.7330_7330delinsACA	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	NSCLC
9	139391212	139391212	G	A	NOTCH1	exonic	nonsynonymous SNV	ENSG00000148400	rs751007903	ENSG00000148400:ENST00000277541:exon34:c.C6979T:p.R2327W	NOTCH1:NM_017617:exon34:c.C6979T:p.R2327W	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	1.702e-05	.	.	5.012	25.1	0.185	2.02	9	.	.	.	NOTCH1:uc004chz.3:exon34:c.C6979T:p.R2327W	-0.204	AFR:0,AMR:8.673e-05,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.061e-05	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	NSCLC
9	139391369	139391370	-	A	.	.	.	.	.	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	9	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	.	.	.	.	NSCLC
9	139399219	139399219	C	G	NOTCH1	exonic	nonsynonymous SNV	ENSG00000148400	.	ENSG00000148400:ENST00000277541:exon26:c.G4924C:p.D1642H	NOTCH1:NM_017617:exon26:c.G4924C:p.D1642H	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 1, 2, None] 	.	.	.	-0.745	0.057	0.086	0.901	9	.	.	.	NOTCH1:uc004cia.1:exon13:c.G2614C:p.D872H,NOTCH1:uc004chz.3:exon26:c.G4924C:p.D1642H	-0.883	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	NSCLC
9	21975017	21975017	C	T	CDKN2A	UTR5	.	ENSG00000147889	rs3814960	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 0, 0, 0, 0, 2, None] 	.	.	0.487819	.	.	.	.	9	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	600160	155601;155755;606719;	404560;252206;618;	404560|B-K mole syndrome<br>FAMM-PC syndrome<br>FAMMM syndrome<br>Familial Clark nevus syndrome<br>Familial atypical mole syndrome<br>Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome<br>Familial dysplastic nevus syndrome<br>Melanoma-pancreatic cancer syndrome|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|155600 606719 ~252206|Melanoma-astrocytoma syndrome|-|Autosomal dominant<br>or&nbsp;Unknown|-|155755 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~	ESSC
9	5070053	5070054	-	G	.	.	.	.	.	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 0, 0, 0, None] 	.	.	.	.	.	.	.	9	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	.	.	.	.	Skin Melanoma
9	5073770	5073770	G	T	JAK2	exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000096968	rs77375493	ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F	JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F	clinvar: Pathogenic,Pathogenic|Pathogenic|Pathogenic|other|Pathogenic|other 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 0, None] 	0.0007	0.0002	.	6.874	33	0.002	5.51	9	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F	0.442	AFR:0.0006,AMR:0.0003,EAS:0.0006,FIN:0.0005,NFE:0.0008,OTH:0,SAS:0.0005	147796	133100;254450;263300;600800;601626;614521;	3318;71493;519;729;824;90042;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~729|Acquired primary erythrocytosis<br>Osler-Vaquez disease<br>PV<br>Polycythemia rubra vera<br>Vaquez disease|1-5 / 10 000|Not applicable|All ages|263300 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~90042|Congenital erythrocytosis due to erythropoietin receptor mutation<br>Congenital polycythemia due to erythropoietin receptor mutation<br>Familial erythrocytosis<br>PFCP<br>Primary congenital erythrocytosis<br>Primary familial and congenital polycythemia|Unknown|Autosomal dominant|All ages|133100 ~	Bone Marrow Cancer
9	5073770	5073770	G	T	JAK2	exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000096968	rs77375493	ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F	JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F	clinvar: Pathogenic,Pathogenic|Pathogenic|Pathogenic|other|Pathogenic|other 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 0, None] 	0.0007	0.0002	.	6.874	33	0.002	5.51	9	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F	0.442	AFR:0.0006,AMR:0.0003,EAS:0.0006,FIN:0.0005,NFE:0.0008,OTH:0,SAS:0.0005	147796	133100;254450;263300;600800;601626;614521;	3318;71493;519;729;824;90042;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~729|Acquired primary erythrocytosis<br>Osler-Vaquez disease<br>PV<br>Polycythemia rubra vera<br>Vaquez disease|1-5 / 10 000|Not applicable|All ages|263300 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~90042|Congenital erythrocytosis due to erythropoietin receptor mutation<br>Congenital polycythemia due to erythropoietin receptor mutation<br>Familial erythrocytosis<br>PFCP<br>Primary congenital erythrocytosis<br>Primary familial and congenital polycythemia|Unknown|Autosomal dominant|All ages|133100 ~	CML
9	5073770	5073770	G	T	JAK2	exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000096968	rs77375493	ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F	JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F	clinvar: Pathogenic,Pathogenic|Pathogenic|Pathogenic|other|Pathogenic|other 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 0, None] 	0.0007	0.0002	.	6.874	33	0.002	5.51	9	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F	0.442	AFR:0.0006,AMR:0.0003,EAS:0.0006,FIN:0.0005,NFE:0.0008,OTH:0,SAS:0.0005	147796	133100;254450;263300;600800;601626;614521;	3318;71493;519;729;824;90042;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~729|Acquired primary erythrocytosis<br>Osler-Vaquez disease<br>PV<br>Polycythemia rubra vera<br>Vaquez disease|1-5 / 10 000|Not applicable|All ages|263300 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~90042|Congenital erythrocytosis due to erythropoietin receptor mutation<br>Congenital polycythemia due to erythropoietin receptor mutation<br>Familial erythrocytosis<br>PFCP<br>Primary congenital erythrocytosis<br>Primary familial and congenital polycythemia|Unknown|Autosomal dominant|All ages|133100 ~	Lymphoid Leukemia
9	5073770	5073770	G	T	JAK2	exonic;exonic;exonic;exonic	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000096968	rs77375493	ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F	JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F	clinvar: Pathogenic,Pathogenic|Pathogenic|Pathogenic|other|Pathogenic|other 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 2, 2, 0, None] 	0.0007	0.0002	.	6.874	33	0.002	5.51	9	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F	0.442	AFR:0.0006,AMR:0.0003,EAS:0.0006,FIN:0.0005,NFE:0.0008,OTH:0,SAS:0.0005	147796	133100;254450;263300;600800;601626;614521;	3318;71493;519;729;824;90042;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~729|Acquired primary erythrocytosis<br>Osler-Vaquez disease<br>PV<br>Polycythemia rubra vera<br>Vaquez disease|1-5 / 10 000|Not applicable|All ages|263300 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~90042|Congenital erythrocytosis due to erythropoietin receptor mutation<br>Congenital polycythemia due to erythropoietin receptor mutation<br>Familial erythrocytosis<br>PFCP<br>Primary congenital erythrocytosis<br>Primary familial and congenital polycythemia|Unknown|Autosomal dominant|All ages|133100 ~	PV
9	80409488	80409488	T	G	GNAQ	exonic	nonsynonymous SNV	ENSG00000156052	rs121913492	ENSG00000156052:ENST00000397476:exon4:c.A20C:p.Q7P,ENSG00000156052:ENST00000286548:exon5:c.A626C:p.Q209P	GNAQ:NM_002072:exon5:c.A626C:p.Q209P	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 2, 2, 0, None] 	.	.	.	5.746	26.9	0.001	5.69	9	.	.	P-loop containing nucleoside triphosphate hydrolase	GNAQ:uc011lso.2:exon4:c.A20C:p.Q7P,GNAQ:uc004akw.3:exon5:c.A626C:p.Q209P	1.066	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	600998	163000;185300;	3205;624;	3205|Encephalofacial angiomatosis<br>Encephalotrigeminal angiomatosis<br>SWS<br>Sturge-Weber-Dimitri syndrome<br>Sturge-Weber-Krabbe angiomatosis<br>Sturge-Weber-Krabbe syndrome|1-9 / 100 000|Not applicable|Infancy<br>Neonatal<br>Childhood<br>Adolescent|185300 ~624|Familial multiple port-wine stains|-|-|Neonatal|163000 ~	Skin Melanoma
X	100611165	100611165	A	T	BTK	exonic	nonsynonymous SNV	ENSG00000010671	.	ENSG00000010671:ENST00000308731:exon15:c.T1441A:p.C481S	BTK:NM_000061:exon15:c.T1441A:p.C481S,BTK:NM_001287344:exon15:c.T1543A:p.C515S	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 0, 0, 2, 0, None] 	.	.	.	3.702	23.3	0.307	5.63	X	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	BTK:uc010nnm.2:exon4:c.T151A:p.C51S,BTK:uc004ehg.2:exon15:c.T1441A:p.C481S,BTK:uc004ehi.3:exon15:c.T1441A:p.C481S,BTK:uc010nno.2:exon15:c.T1543A:p.C515S	0.074	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	300300	300755;307200;	231692;631;632;229717;47;	231692|Congenital IGHD type III<br>Congenital isolated GH deficiency type III<br>Congenital isolated growth hormone deficiency type III<br>X-linked IGHD<br>X-linked isolated growth hormone deficiency|-|X-linked recessive|Infancy<br>Neonatal|300123 307200 ~631|Congenital IGHD<br>Congenital isolated GH deficiency<br>Congenital isolated growth hormone deficiency|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal|173100 262400 262650 300123 307200 612781 ~632|-|-|X-linked recessive|Infancy<br>Neonatal|307200 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~47|BTK-deficiency<br>Bruton type agammaglobulinemia|1-9 / 1 000 000|X-linked recessive<br>or&nbsp;Not applicable|Childhood|300310 300755 ~	CLL
X	47426121	47426121	C	G	ARAF	exonic	nonsynonymous SNV	ENSG00000078061	.	ENSG00000078061:ENST00000377045:exon7:c.C641G:p.S214C	ARAF:NM_001256196:exon7:c.C650G:p.S217C,ARAF:NM_001654:exon7:c.C641G:p.S214C	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[2, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	5.211	25.6	0.0	5.37	X	.	.	.	ARAF:uc004dic.2:exon7:c.C650G:p.S217C,ARAF:uc011mlo.3:exon7:c.C239G:p.S80C,ARAF:uc011mlp.3:exon7:c.C641G:p.S214C	0.336	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	311010	.	.	.	NSCLC
X	66943549	66943549	T	C	AR	exonic	nonsynonymous SNV	ENSG00000169083	.	ENSG00000169083:ENST00000396044:exon5:c.T2195C:p.V732A,ENSG00000169083:ENST00000374690:exon8:c.T2629C:p.F877L,ENSG00000169083:ENST00000396043:exon8:c.T1033C:p.F345L	AR:NM_000044:exon8:c.T2629C:p.F877L,AR:NM_001011645:exon8:c.T1033C:p.F345L	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	5.811	27.2	0.001	5.18	X	.	.	Nuclear hormone receptor, ligand-binding;Nuclear hormone receptor, ligand-binding, core	AR:uc022byk.1:exon5:c.T2195C:p.V732A,AR:uc004dwu.2:exon8:c.T2629C:p.F877L,AR:uc004dwv.2:exon8:c.T1033C:p.F345L	0.833	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	313700	176807;300068;300633;312300;313200;	481;90797;440;99429;1331;	481|SBMA<br>SMAX1-related spinobulbar muscular atrophy<br>X-linked BSMA<br>X-linked bulbospinal amyotrophy<br>X-linked bulbospinal muscular atrophy<br>X-linked spinal and bulbar muscular atrophy|1-9 / 100 000|X-linked recessive|Adult|313200 ~90797|PAIS<br>Partial androgen resistance syndrome|Unknown|X-linked recessive|All ages|312300 ~440|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|146450 300633 300758 300856 ~99429|CAIS<br>Complete androgen resistance syndrome|1-9 / 1 000 000|X-linked recessive|All ages|300068 300274 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	PRAD
